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 The main hypothesis of this thesis was that the regulation of oxygen uptake 
( 2OV
 ) kinetics at the onset of exercise in trained young men is linked to 
cardiovascular adaptations. Two studies were conducted to investigate the 
interrelationships between oxygen (O2) transport and O2 utilization in accelerating
2OV
 kinetics at the onset of exercise. In the first study, simultaneous kinetics of 
2OV
 and cardiac output (Q ) were studied during the transition to heavy and 
moderate cycling exercise (Chapter 2). The acceleration of 2OV
 kinetics during the 
heavy exercise that followed prior moderate or heavy exercise was enabled by the 
rapid increase in Q ; whereas, the acceleration of 2OV
 kinetics during moderate 
exercise that followed a heavy warm-up was associated with small changes in Q
kinetics.  
 The objective of the second study was to determine, in a model of forearm 
exercise, if the elevation of forearm blood flow (FBF) prior to the onset of exercise by 
prior circulatory occlusion would accelerate FBF and muscle oxygen uptake             
( mus2OV
 ) kinetics during subsequent exercise as demonstrated previously for prior 
exercise (Chapter 3). Prolonged ischemia (15 min occlusion) followed by 3 min 
recovery reduced FBF and impaired mus2OV
 kinetics during subsequent heavy 
hand-grip exercise. However, prior heavy exercise confirmed the previous findings 
and resulted in a faster FBF and mus2OV
  kinetics. There was a high positive 
correlation between the time course of change in FBF and mus2OV
 at the onset heavy 
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exercise. In a follow up of the second study, to investigate a possible mechanism 
for the slower adaptation of mus2OV
 following ischemia, the prior occlusion condition 
was repeated after ingesting a high dose of ibuprofen. Prostaglandin inhibition by 
ibuprofen augmented the FBF response during reactive hyperaemia and restored 
FBF during the heavy exercise that followed 15 min of circulatory occlusion to the 
control level. 
  These two studies provide evidence that O2 delivery plays a dominant role in 
accelerating 2OV
 kinetics at the onset of heavy exercise in trained young men. The 
findings exposed differences in the mechanisms regulating pulmonary 2OV
 and 
mus2OV
 with prior exercise resulting in higher Q and FBF, but no changes in O2 
extraction to yield the faster increase in pulmonary 2OV
  and
 mus2
OV at the onset of 
subsequent heavy exercise. In contrast, prior occlusion slightly retarded the 
increase in FBF and significantly reduced O2 extraction thus delaying mus2OV
  
kinetics. The precise mechanisms impairing mus2OV
 kinetics at the onset of heavy 
forearm hand-grip exercise that starts after a brief recovery from prolonged 
occlusion are still unknown, but this impairment may be partially due to a 
vasoconstrictor effect restricting blood flow during the adaptation to exercise and 
redistribution of the blood to the periphery. 
 In a third study, the influence of muscle activity on the 2OV
 slow component 
during heavy exercise and O2 cost during moderate exercise that followed a heavy 
warm-up were examined (Chapter 4). The heavy exercise 2OV
 slow component was 
 
 v 
attenuated in a graded fashion by prior moderate and heavy warm-ups, and the 
principal components analysis showed a moderate but significant correlation 
between the changes in the integrated electromyographic activity and the 2OV
 slow 
component amplitude. The higher O2 cost of moderate exercise following a heavy 
warm-up was associated with higher mean power frequency. Changes in 2OV
 slow 
component and increased O2 cost during moderate exercise after prior heavy warm-
up appear to be related to some changes in surface electromyographic activity 
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 Oxygen uptake ( 2OV
 ) kinetics describe the time course of changes in 
muscle oxidative phosphorylation during work rate transitions. 2OV
 kinetics 
provide a unique window into understanding the efficiency of the metabolic system 
and the percentage contributions from both aerobic and non-aerobic sources.  At 
the onset of exercise, 2OV
  increases in an exponential fashion (Henry, 1951; Henry 
& Demoor, 1956) with an error signal that is progressively reduced in proportion to 
the difference between the required and the actual 2OV
 at the new work rate 
(Hughson et al., 2000; Whipp & Wasserman, 1972). A debate has developed 
surrounding the underlying physiological processes that regulate the rate of 
increase in oxidative metabolism during work rate transitions (Grassi, 2001; 
Hughson, 1990; Tschakovsky & Hughson, 1999; Whipp et al., 2005). One position 
argues that a limitation of oxidative enzyme activity and mitochondrial substrate 
availability (metabolic inertia) restricts the rate at which oxygen (O2) utilization can 
increase at the onset of exercise, independent of O2 availability under most normal 
exercise conditions from rest to approximately 50-60% of maximal 2OV
  (Barstow et 
al., 1994; Grassi, 2003; Hill et al., 1924; Mahler, 1985). The second argument 
suggests that even under these normal conditions O2 plays a critical role in 
regulating the adaptation of oxidative metabolism (Hughson & Morrissey, 1983; 
Linnarsson, 1974; MacPhee et al., 2005). A consequence of the metabolic inertia 
hypothesis is that 2OV




reductions in O2 delivery (Poole & Richardson, 1997). Whereas, the O2 delivery 
hypothesis suggests that there is a rate limiting step in the O2 cascade from the 
lungs to the mitochondria of the working muscle and a greater portion of ATP 
demand can be synthesized through the aerobic energy supply system with small 
perturbations of the metabolic controllers (phosphorylation and redox potentials), if 
more O2 is made available (Hughson et al., 2001; Wilson & Rumsey, 1988).  
 In spite of the disparate viewpoints mentioned above, it is generally accepted 
by both camps that there are conditions where altering O2 delivery can impact 2OV

kinetics. The debate remains; however, over the exact nature of these conditions. 
This debate can be distorted by a focus on the “either/or” nature of O2 transport 
versus O2 utilization limitations. Recently, the terms “regulation” or “modulation” of 
2OV
  kinetics by O2 transport have been used and these seem to be a more 
appropriate way to understand the interaction between the factors that determine 
the rate of increase in oxidative phosphorylation during work rate transitions 
(Hughson, 2005; Hughson, 2009; Hughson et al., 2001; Tschakovsky & Hughson, 
1999).  
 Several innovative experimental designs have been applied to examine the 
factors that control 2OV
 kinetics during work rate transitions. These designs 
centered mainly on alternating the metabolic environment and/or manipulating 
the rate of O2 delivery prior to the exercise onset. The priming exercise model is the 
most common experimental paradigm used to address the role of O2 delivery in 
regulating 2OV
 kinetics. Prior heavy exercise alters the local metabolic 
environment, increases muscle bed vasodilation, right-shifts the oxygen 




working muscles at the onset of a second exercise bout (Gerbino et al., 1996; 
MacDonald et al., 1997). However, prior heavy exercise also increases oxidative 
enzyme activity and elevates mitochondrial substrate availability at the onset of 
subsequent exercise (Gurd et al., 2006).Thus, the role of O2 delivery to enhance 
2OV
 kinetics remains undefined due to the conflicting results and the 
interpretation of the findings using this model. Prior occlusion is an alternative 
experimental model that could elevate muscle blood flow for several minutes prior 
to a subsequent exercise bout (Carlsson et al., 1987) without marked impact on the 
metabolic states (Mole et al., 1985). Thus, this experimental paradigm may 
precisely address the role of O2 delivery in regulating the 2OV
 kinetics during work 
rate transitions. 
 The studies applied in this thesis emphasize the influence of increased O2 
supply through the active (prior exercise) and passive (prior occlusion) warm-up, 
on accelerating pulmonary 2OV
 and muscle oxygen uptake ( mus2OV )kinetics at the 
onset of dynamic exercise in trained humans. To help clarify the issue surrounding 
the role of O2 delivery in controlling  2OV
 kinetics, it is important to monitor 
muscle blood flow in the exercising muscles or other surrogate markers of 
cardiovascular responses such as heart rate (HR) or cardiac output ( Q ) kinetics. 
Relatively few studies have simultaneously examined the kinetics of 2OV
 and Q
during exercise transitions (Perrey et al., 2003a; Yoshida & Whipp, 1994). In the 
first study, simultaneous measurements of breath-by-breath 2OV
 and estimates of 
beat-by-beat Q have been applied to investigate the relative contributions of muscle 
metabolic and cardiovascular adaptations to 2OV




and heavy cycling exercise (Chapter 2). In the second study, pulsed and echo 
Doppler ultrasound has been used to directly monitor muscle blood flow during 
rhythmic hand-grip exercise that follows identical bout of heavy hand-grip exercise 
or circulatory occlusion. The purpose of this study was to determine whether or not 
prior occlusion, followed by a brief recovery, will have similar effects as prior heavy 
exercise in accelerating forearm blood flow (FBF) and mus2OV
 kinetics during 
subsequent heavy forearm exercise (Chapter 3). Also, the effect of inhibiting 
cyclooxygenase (COX) enzyme by a high dose of ibuprofen on FBF, mus2OV
  and skin 
blood flow (SBF) during a heavy hand-grip exercise that follows prolonged ischemia 
was examined (Chapter 3). In the third study, electromyographic  (EMG) activity of 
the lower limb muscles was measured simultaneously with breath-by-breath 2OV

to examine whether or not changes in muscle activity are associated with the 2OV

slow component during heavy exercise and the higher O2 cost during moderate 
exercise that followed a heavy warm-up were examined (Chapter 4). 
1.2 Oxygen uptake following exercise onset  
1.2.1 Measurements and characteristics of oxygen uptake kinetics  
 The measurements of 2OV
 at the onset of exercise are first made at specific 
time intervals by the respirometer collection system (Krogh & Lindhard, 1913). The 
development of breath-by-breath measurements via the computerized mass 
spectrometer-based systems enabled the precise characteristics of 2OV
 dynamics 
during work rate transitions (Auchincloss et al., 1966; Hughson, 1984a; 
Linnarsson & Lindborg, 1974; Whipp & Wasserman, 1972). At the onset of 
exercise, 2OV




fashion to reach the anticipated steady-state level and the rate of increase is 
directly proportional to the exercise intensity (Krogh & Lindhard, 1913; 
Linnarsson, 1974; Whipp & Wasserman, 1972). There is an initial rapid increase in 
2OV
 lasting between 15 and 20 s (Phase I), that is attributed to a rapid increase in 
Q and pulmonary blood flow, due to the action of the muscle pump, and small 
increase in arterial-venous oxygen content difference [(a-v)DO2] (Krogh & Lindhard, 
1913; Whipp & Ward, 1982). This initial increase in Phase I is followed by a rapid 
exponential increase in 2OV
 (Phase II) that drives 2OV
 towards the essential steady 
state level. Phase II (primary phase) reflects the arrival of the venous blood from the 
exercising muscles to the lung (Whipp & Ward, 1982). Modeling studies of Q  
profiles and 2OV
 (Barstow et al., 1990), direct experiential measurements of muscle 
2OV
 (Grassi et al., 1996; Koga et al., 2005)   and characterization of PCr 
degradation by magnetic resonance spectroscopy (MRS) (Rossiter et al., 1999; 
Rossiter et al., 2002a) have shown that the Phase II pulmonary 2OV
  kinetics largely 
reflect the kinetics of O2 consumption in the exercising muscles following the onset 
of exercise. During heavy exercise, the attainment of steady-state 2OV
  is delayed or 
may be absent, and the slow component of 2OV
  (Phase III) is manifested (Whipp, 
1994; Whipp & Wasserman, 1972). The majority of pulmonary 2OV
 during Phase 
III (86%) can be attributed to the exercising muscles (Poole et al., 1991). 
1.2.2 Control of oxygen uptake following exercise onset 
 The rate of increase in oxidative phosphorylation has been debated to be limited 




of the muscle partial pressure of oxygen provides evidence to support the role of O2 
delivery in limiting the 2OV
 kinetics at the onset of exercise. Impairment of  the 
mitochondrial O2 supply in the following equation will restrict the rate of ATP 
synthesis through the oxidative energy supply system, and by consequence, the 
kinetics of 2OV
 through the transition to steady state will be slower (Poole et al., 
2008).                    
6 ADP + 6 Pi + 2(NADH + H+) + O2 → 6 ATP + 2 NAD + 2 H2O      
 Inspired hypoxic or hyperoxic gases modify the muscle energetic state (ATP + 
PCr) (Haseler et al., 1998; Linnarsson et al., 1974) and 2OV
 kinetics during 
submaximal work rates (Engelen et al., 1996; Linnarsson, 1974; MacDonald et al., 
1997; Murphy et al., 1989). Biochemical measurements of cellular metabolism 
have shown that O2 delivery may adjust the phosphorylation and redox potentials 
needed to drive the oxidative metabolism (Wilson & Rumsey, 1988). Additionally, 
Hughson (2005; 2009) suggested theoretical models that illustrate the impact of 
dynamic changes in the intracellular partial pressure of oxygen (PO2) on metabolic 
inertia (enzymes activity and metabolic substrates) and how the oxidative 
metabolism at the onset of exercise is modulated by a dynamic interaction between 
O2 delivery and utilization mechanisms.  
 In addition, altering the O2 availability to the working muscles by reducing 
HR dynamics using β-adrenergic receptor blockade drugs (Hughson, 1984b; 
Hughson & Smyth, 1983), or performing the exercise in supine posture (Hughson 
et al., 1991a; Jones et al., 2006; MacDonald et al., 1998), above the heart level 
(Hughson et al., 1996), where the blood flow to the working muscles is restricted, 




parasympathetic system on O2 delivery is limited,(Brittain et al., 2001; Hughson & 
Morrissey, 1982; MacPhee et al., 2005) has resulted in slower 2OV
 kinetics during 
the transition to moderate work rates, suggesting strong evidence to link 2OV

kinetics to O2 transport.  
 Conversely, researchers who argue against the potential role of O2 availability in 
regulating the metabolic control and support the acceleration of O2 utilization as a sole 
mechanism to control 2OV
 kinetics based their position on several experimental 
observations.  Muscle O2 transport dynamics as assessed from arterial blood flow 
(Bangsbo et al., 2000; Grassi et al., 1996; MacDonald et al., 1998), Q (Perrey et al., 
2003a; Yoshida & Whipp, 1994) or HR (MacPhee et al., 2005) have been shown to be 
faster than those of 2OV
 ; however, the assumption that microvascular perfusion can 
be extrapolated accurately from upstream arterial measurements or cardiovascular 
dynamics has been challenged. During upright exercise in healthy subjects, potentially 
reducing muscle O2 supply following blood withdrawal (Burnley et al., 2006) or 
increase O2 transport through hemodilution (Berger et al., 2006a) does not alter the 
2OV
 kinetics. Yet, the blood flow distribution within the exercising muscle is not 
known in these studies. Moreover, alterations in O2 supply by breathing hypoxic or 
hyperoxic gases have been shown to modify 2OV
 kinetics (Linnarsson, 1974; 
MacDonald et al., 1997). Several studies have reported a similar time course for the 
reduction in muscle [PCr], estimated by MRS, and the increase in pulmonary 2OV

during transition from rest to both moderate and heavy work rates (Rossiter et al., 
1999; Rossiter et al., 2002a). The exponential nature of [PCr] and 2OV
 kinetics has led 





kinetics (Bangsbo et al., 2000; Grassi, 2003). However, altering the [PCr] and other 
metabolic intermediates by changing PO2 challenge this argument (Haseler et al., 
1998; Hogan et al., 1992; Linnarsson et al., 1974). Pharmacological activation of 
pyruvate dehydrogenase (PDHa) with dichloroacetate (DCA) reduces substrate-level 
phosphorylation during subsequent exercise, suggesting an enhancement of the 
contribution of oxidative phosphorylation to energy turnover (Greenhaff et al., 2002). 
Yet, this intervention has been shown not to speed 2OV
 or mus2OV kinetics during 
heavy exercise (Bangsbo et al., 2002; Grassi et al., 2002; Jones et al., 2004b; Rossiter 
et al., 2003). Inhibition of nitric oxide (NO) synthesis with L-NAME resulted in faster
2OV
 kinetics which was thought to be associated with reduce O2 avilability and 
enhance cytochrome c oxidase activity (Jones et al., 2004a). However, NO synthesis 
inhibition elevates mean arterial blood pressure (MAP) and probably redistributes the 
blood during exercise (Frandsenn et al., 2001). Furthermore, in the pump-perfused 
canine hind-limb model, the inhibition of NO synthesis with L-NAME did not alter 
muscle blood flow distribution to the gastrocnemius–plantaris–soleus muscle group 
(Krause et al., 2005), and the direct inhibition of mitochondrial respiration by NO does 
not limit the kinetics of oxidative metabolism at exercise onset (Grassi et al., 2005).  
Effect of training on oxygen uptake kinetics 
 The sensitivity to changes in O2 demand might be increased with training. 
Short periods of physical training can enhance both O2 transport and O2 utilization 
mechanisms and speed 2OV
 kinetics (Phillips et al., 1995). Endurance exercise 
training has been shown to accelerate 2OV
 kinetics and reduce 2OV
 slow 
component amplitude (Berger et al., 2006b; Carter et al., 2000). However, it is not 





 kinetics. Interestingly, repeated high intensity anaerobic training has been 
shown to be as effective as low intensity continuous aerobic training in enhancing 
the rate of oxidative metabolism at the onset of exercise (Bailey et al., 2009a). Most 
recently, Bailey et al. (2010) have shown that 4 weeks of inspiratory muscle 
training increased blood flow to the exercising muscle and improved 2OV
 kinetics 
at the onset of high intensity exercise suggesting that enhanced O2 delivery enabled 
the increase of oxidative phosphorylation during the transition to heavy exercise. 
1.3 Cardiac output and blood flow at exercise onset  
 Blood circulation has been described by the Arab physician Ibn al-Nafis during 
the Islamic golden age in the early 13 th century. However, the quantitative methods to 
study the peripheral circulation of blood in human were not available until the 20th 
century. Both invasive and non-invasive methods for evaluating Q and blood flow in 
human during exercise have been used.  
1.3.1 Measurements of cardiac output 
 Q
 , the volume of blood being pumped by the heart in each minute, can be 
measured by several techniques. Each method has advantages and restrictions 
that may limit its application during exercise. The direct Fick method was first 
described by Adolf Eugen Fick in 1870. The Fick principle calculates the O2 
consumption from the measurement of the oxygen content of the venous, 
measured at the pulmonary artery, and arterial blood, which can be measured at 
the radial or femoral artery (Astrand et al., 1964; Chapman et al., 1950).Thus, Q
can be calculated from the following equation: Q  = 2OV




The thermodilution method was described initially by Fegler (1954) for measuring 
Q in animals.  The method was then adapted for use in man by Branthwaite and 
Bradley (1968), and developed further by use of the Swan and Ganz catheter (Ganz 
& Swan, 1972). The thermodilution method requires the infusion of ice cold saline 
into the pulmonary artery and measurements of the temperature difference of 
blood upstream and downstream of the infusion point several centimetres away 
(Ganz & Swan, 1972). Cardiac output can then be determined based upon these 
measurements and knowledge of the rate and temperature at which the saline was 
infused. High Q  will change the temperature rapidly, and low Q will change the 
temperature slowly (Runciman et al., 1981; van Grondelle et al., 1983). The Fick 
principle and thermodilution method are considered to be the gold standard 
techniques for measuring Q .However, the invasive natures of these techniques and 
the need for a medical expertise limit their use during exercise (Warburton et al., 
1999). Also, these techniques are limited to study the rate of changes in Q  during 
the transition from rest to higher work rates.  
 Rebreathing techniques have been employed in clinic settings (Hoeper et al., 
1999; Sackner et al., 1980) and exercise (Hsia et al., 1995; Johnson et al., 2000; 
Reybrouck et al., 1978; Simmons & Shephard, 1971) to determineQ . Foreign gases 
such as acetylene (C2H2) and nitrous oxide (N2O) are normally used in rebreathing 
techniques because they are inert, soluble, and enter the blood stream via 
pulmonary diffusion but do not bind with hemoglobin (Ayotte et al., 1970; 
Triebwasser et al., 1977; ZeidiFard et al., 1976). Pulmonary blood flow is directly 
related to Q  and can be estimated by the rate of disappearance of a soluble gas 




Rebreathing techniques are valid for determining Q , but they are limited to be used 
during steady state exercise. 
 An accurate, continuous and non-invasive measurement of Q during 
exercise would be of great help to characterize the time course of changes in Q
during work rate transitions. Beat by beat Q  can be obtained by Doppler 
echocardiography (Ihlen et al., 1987) and vascular impedance cardiography 
(Denniston et al., 1976; Perrey et al., 2003a) however, motion artifacts limit the use 
of these techniques to supine positions or low intensity exercise. 
 Q
 was also estimated from the finger cuff Modelflow technique that employs  
a non-linear, three-element windkessel equation (Wesseling et al., 1993). Previous 
studies have reported that the Modelflow Q  technique was valid in comparison to 
thermodilution (de Wilde et al., 2007; Wesseling et al., 1993) and Doppler 
echocardiography methods (Sugawara et al., 2003), as well as CO2 (Pitt et al., 2004) 
and C2H2 rebreathing methods (Tam et al., 2004).  
 Most recently, MRI techniques have been used to determine Q . 
Simultaneous imaging of the aorta in combination with velocity encoded phase 
contrast MRI, which measures an average blood velocity across the vessel 
diameter, provides the most accurate measure of Q in large vessels (Groepenhoff et 
al., 2007). 
1.3.2 Cardiac output at exercise onset 
 To help clarify the issue surrounding the influence of O2 delivery, it is 




blood flow kinetics during cycling exercise is a challenge. Subsequently, Q  kinetics 
(De Cort et al., 1991; Perrey et al., 2003a; Yoshida & Whipp, 1994) have been used 
as a surrogate marker. Recently, Lador et al. (2006) studied Q  kinetics, using a 
Modelflow estimation technique (Wesseling et al., 1993), during low (50W) and 
moderate (100W) cycling exercise bouts. The kinetics of Q  have been shown to be 
faster than 2OV
 kinetics. The faster Q  at the onset of exercise could be a 
consequence of a rapid increase in SV (Leyk et al., 1995) resulting from the sudden 
increase in venous return with the onset of the higher work rate mediated primarily 
by the stronger muscle pump (Sheriff et al., 1993; Tschakovsky et al., 1996), and 
increased HR (Perrey et al., 2003a) that reflects a greater reliance on 
parasympathetic activation and vagal withdrawal. Leyk et al. (1995) monitored the 
SV using Doppler ultrasound during upright cycling across exercise transitions to 
work rates of up to 200 W. They showed SV to increase rapidly and peak by 30 s 
following the onset of exercise.  
1.3.3 Measurements of blood flow 
 Early measurements of blood flow in humans during exercise were obtained by 
venous occlusion plethsmography (Humphreys & Lind, 1963). The basis of this 
technique lies in the fact that an external pressure (sub-diastolic pressure not more 
than 50 mmHg) suppresses only the venous outflow, while the arterial inflow remains 
unaffected. Joyner et al.(1990) have shown a fast adaption in exercise blood flow 
measured by venous occlusion plethsmography.  However, the method has certain 
disadvantages. First, measures taken during muscular work are not good, measures 
are usually taken during short pauses in contraction or at the end of exercise, and 




hypermia. Second, the limb must be placed above the level of the heart; which 
negatively affects the blood flow and oxygen uptake kinetics (Hughson et al., 1996). In 
comparison to Doppler ultrasound, the venous occlusion plethsmography technique 
has been shown to be accurate only in the first beats after the release from circulatory 
occlusion (Tschakovsky et al., 1995).  
The local injection technique with a radioactive label has also been used to determine 
the blood flow to the working muscles (Grimby et al., 1967; Holzman et al., 1964; 
Tonnessen, 1964). The distribution of the label can be assessed before and after 
exercise as an indication of the flow through the exercising muscle. Using the 133Xe 
clearance methods, Tonnessen (1964) reported that there is a gradual increase in the 
blood flow to the calf muscle with the increase in work rates up to 70 % of the 
maximal. Pendergast et al.(1980) concluded that changes in muscle blood flow kinetics 
are faster than those of 2OV
 . However, the 133Xe clearance method seems to have 
qualitative rather than quantitative significances due to the considerable 
underestimation of blood flow in the working muscles (Cerretelli et al., 1984). 
Quantitative determination of muscle blood flow during exercise may be obtained by 
the thermodilution method (Andersen & Saltin, 1985; Ganz et al., 1964; Richardson et 
al., 1993; Rowell et al., 1986). Ganz (1964) was the first to use the thermodilution 
method to measure the blood flow in the femoral artery during exercise. 
thermodilution method is used to assess blood flow during steady state exercise 
(Andersen & Saltin, 1985). However, attempts have been made to use it to characterize 
the time course of changes in blood flow at the onset of exercise (Grassi et al., 1996; 
Knight et al., 1993). The invasive nature of the thermodilution methods reduces the 




 Doppler ultrasound technology has been extensively used in the measurement 
of blood flow in the last two decades. It has been used to measure blood flow non-
invasively and continuously at the onset of forearm exercise (Hughson et al., 1996; 
Tschakovsky et al., 1995; van Beekvelt et al., 2001) and kicking exercise 
(Nyberg et al., 2010; Paterson et al., 2005; Shoemaker et al., 1994). Doppler 
ultrasound was shown to be reproducible in the measurements of arterial mean 
blood velocity (MBV) and diameter during both rest and exercise across different 
days (Shoemaker et al., 1996a). Previous studies have reported a strong 
relationship between Doppler ultrasound and strain-gauge plethysmography for 
MBV measurements (Tschakovsky et al., 1995; Van Leeuwen et al., 1992). 
Radegran (1997)has reported that ultrasound Doppler estimates of blood flow 
during dynamic knee extensor exercise was valid in comparison to thermodilution 
techniques.  Figure 1.1 is an example of the output of Doppler ultrasound which 





Figure 1.1: Representative tracing of mean blood velocity by Doppler ultrasound in 
the biracial artery.  
At the resting state (A), the blood flow response has three distinguish phases within 
each heart cycle. During systole, there is rapid increase in blood velocity, which 
peaks at peak systole. This initial increase in blood velocity is followed by a 
decrease in flow and reverse flow that stops as the aortic valve closes. In late 
diastole, there is a period of low forward flow or no flow as the blood passes out of 
the arteries and into the venous circulation. During exercise (B), there are large 
oscillations in the flow pattern with a reverse flow during contraction followed by 




1.3.4 Blood flow following exercise onset 
 Following the onset of exercise, muscle blood flow increases rapidly in a 
biphasic manner (Shoemaker et al., 1994; Shoemaker et al., 1996a), with initial 
rapid adaptation followed by slower adaption to match the changes in metabolic 
demand of the muscles (Hughson et al., 2003; Radegran & Saltin, 1998). Both 
neural vasoconstrictor activity and locally derived vasodilator substances 
contribute to this precise blood flow regulation (Clifford & Hellsten, 2004).  The 
initial rapid increase in blood flow, which occurs within the first 5-10 s of exercise, 
has been attributed to the muscle pump (Laughlin, 1987; Sheriff et al., 1993), 
rapid vasodilation due to mechanical factors (Kirby et al., 2007; Shoemaker et al., 
1998), and instantaneous increases in adenosine (Saltin et al., 1998), acetylcholine 
spillover from neuromuscular junctions (Segal & Kurjiaka, 1995) and potassium 
concentrations (Armstrong et al., 2007; Clifford, 2007; Hilton et al., 1978; Murrant 
& Sarelius, 2002). A second, slower increase in blood flow is characterized by the 
release of endothelium mediated vasodilator substances such as NO (Dyke et al., 
1995) and prostaglandins (PGs) (Kilbom & Wennmalm, 1976; Nyberg et al., 2010; 
Wilson & Kapoor, 1993) that influence the vascular tone and initiate further 
increases in exercise hyperemia. Following the first minute of exercise, further 
vasodilation arises due to the release of intramuscular vasoactive metabolites and 
thereby matches blood flow to the metabolic demands of the exercising muscles 
(Boushel, 2003; Rowell, 1997; Rowell, 2004). It is not the aim of this thesis to 
examine the factors controlling blood flow at the onset of exercise. Rather, the aim 
is to determine the interrelationship between the kinetics of blood flow and those of
mus2OV





 The applications of non-invasive technologies which precisely 
measure/estimate the blood flow response in a beat by beat basis can provide an 
accurate assessment to the role of O2 delivery in controlling 2OV
 kinetics at the 
onset of exercise. In the studies applied in this thesis, several cardiovascular 
variables have been measured during the transition from rest to higher work rates. 
The techniques of measuring and analyzing 2OV
 , blood flow, blood pressure (BP),Q
, and blood gases during work rate transitions have been used extensively in our 
lab over the past three decades. In addition, measurements of the muscle activity 
using surface EMG have been applied in a few studies (Perrey et al., 2001; Perrey et 
al., 2003b; Tordi et al., 2003). This section will illustrate the principles behind 
these techniques and the measurements will be described in more details in the 
methods sections of the following chapters.  
1.4.1 Oxygen uptake  
 Oxygen uptake was measured on a breath-by-breath basis (First Breath, 
Waterloo, Ontario, Canada). This system consisted of a digital volume turbine 
(UVM-17125, VacuMed, Ventura, CA) for gas volume measurement, and a mass 
spectrometer (Innovision, Amis 2000, Odense, Denmark) for gas fraction 
measurement. Correction was made for lung gas stores by the nitrogen balance 
methods described by Beaver et al. (1981). This correction allowed for the 
calculation of alveolar oxygen uptake. The volume measurement system was 
calibrated prior to each test by pumping a gas through a an automated 3 L syringe 
(Vacumed, Ventura, CA) at flow rates comparable to those observed during 




spanned the gas concentrations observed during testing. The volume and flow were 
measured with no time delay; however, the gas fractions were measured with delay 
due to the difference between the transport time and mass spectrometer response 
time. 
1.4.2 Blood flow  
 Blood flow was obtained by pulsed and echo Doppler ultrasound. The 
technique of Doppler ultrasound applied in measuring blood flow is based on the 
principle that immobile objects will reflect sound back at the same frequency as the 
transmitted sound, while the sound reflected back from moving particles will be 
shifted in frequency. The magnitude of this frequency shift will be directly 
proportional to the velocity of the moving element according to the following 
equation: 
V = fD. c . 2 . ft cos (q) 
V = velocity of the particles in cm/sec 
fD = shift frequency 
ft = transmitted frequency 
q = angle of insonation 
c = velocity of sound in tissue (blood) cm/sec 
The sound reflected by the tissue/blood is in the auditory range and can be 
monitored continuously. 
1.4.3 Blood pressure  
 A finger plethysmograph (Finometer, Finapres Medical System, Arnhem, 
Netherlands) was used to measure arterial blood pressure on a beat-by-beat basis. 




immediately opposite, such that when the cuff wrapped around the finger, light 
from the diode travels through the finger and the amount reaching the other side 
can be detected. Absorption of the light is proportional to the distance through the 
finger that it must travel. With each heart beat, the change in vessel transmural 
pressure causes the finger to "swell" proportionally. Matching the changes in 
transmural pressure via instantaneous, equal increases in cuff pressure therefore 
maintains finger volume and provides continuous estimates of arterial pressure. 
Comparisons with direct arterial blood pressure measures indicate a good 
agreement (Imholz et al., 1990). 
1.4.4 Cardiac Output  
 In this thesis,Q  has been measured non-invasively using Finometer finger 
cuff technique and validated using C2H2 rebreathing methods.    
Finometer Modelflow cardiac output  
The Modelflow algorithm implemented in the Finometer uses aortic characteristic 
impedance, windkessel compliance of the arterial system and peripheral vascular 
resistance to compute flow pulses from an arterial pressure pulses (Wesseling et 
al., 1993), and has been shown to estimate changes in Q  during moderate and 
heavy exercise with high precision. Moreover, the reconstruction of brachial artery 
waveform employed by Finometer had shown to improve the accuracy and 
sensitivity to detect the changes in cardiovascular measurements (Guelen et al., 







Acetylene rebreathing cardiac output 
 C2H2 rebreathing was used as a reference method in this study, because it 
has been shown to be valid (Bell et al., 2003; Dibski et al., 2005; Hunt et al., 1997; 
Warburton et al., 1998) and in fairly high agreement with dye-dilution and direct 
Fick methods when measuring Q  at rest and during exercise up to 90% of the 
maximal 2OV
 (Liu et al., 1997; Triebwasser et al., 1977). 
 C2H2 is used to measure blood flow through the lungs since it is soluble gas 
and enters the blood stream with a known diffusion constant. An inert, insoluble 
gas (e.g., He, Ar, or CH4) is also added to the gas mixture to ensure full 
equilibration of the system (bag/lung) before the disappearance rate of the 
acetylene is measured (Triebwasser et al., 1977). The decay curves of the soluble 
and inert gas mixture (C2H2/He) can be used to compute Q as it is directly related 
to the rate of blood flow through the lungs. 
1.5 Exponential characteristics of 2OV
 kinetics 
 The exponential function has an amplitude (A) and time constant () which 
reflects the time required to reach 63% of the total amplitude or 63% of each 
distinct phase of the 2OV
 response. Generally, the steady-state is attained and the 
response amplitude is completed after 4 time constants (Hughson, 2005).  
The curve fitting procedure calculates the various parameters of the exponential 
model by using the least-squares error approach. The best fit is defined by the 
minimum residual sum of squares between the model parameters and the actual 





 kinetics have been described using either mono or higher order exponential 
models. A mono-exponential model quantifies the overall response of the exercise 
bout using the effective time constant (Gerbino et al., 1996) that estimates the time 
required to achieve 63% of the total amplitude through the following equation  
2OV
 (at any time point) = 2OV
 (baseline) + A (1 – e - (t/)). 
 
 
Figure 1.2: A schematic illustration of the exponential characteristics of 2OV
 . 
 
However, the low sampling frequency of blood during exercise did not enable a 
precise characterization of kinetics using the effective time constant 
equation. Therefore, to estimate  kinetics in this study, the area under the 
curve (AUC) of was calculated using the first order hold method. 












the given amplitude  assuming a first order linear dynamic system. The rise time 
for was then estimated from the following equation:   
AUC ( ) = A [(tf  - ts) + τ (e- ( tf / τ) - e- ( ts / τ))] 
where, AUC ( ) is the numerical value calculated from the first order hold 
method for curve, A is the end exercise amplitude, tf  is the final time of 
exercise, ts is the start time to calculate AUC and  is the rise time of . Same 
procedures to calculate FBF kinetics were used in Chapter 3.  
 A higher order mathematical model partitions the 2OV
 response into distinct 
phases, where the Phase II time constant (τ2; time to reach 63% of the primary 
phase) characterizes the rate of increase in oxidative phosporylation (Hughson et 
al., 2001). The moderate and heavy bouts were curve fitted by two- (phases I and II) 
and three-component (phases I, II and III) exponential models respectively, 
according to the following equation. The two component model has a baseline, two 
amplitude terms (A1 and A2), two time constants (1 and 2) and two time delays 
(TD1 and TD2). The three component model has an extra amplitude (A3), time 
constant (3), and time delay (TD3) to fit the slower adaptive phase manifesting 



















                                          + A1 (1-e-(t-TD1)/τ1) U1      Phase I     
2OV
 (t) =   2OV
 (baseline) + A2 (1-e-(t-TD2)/τ2) U2      Phase II  
                                    + A3 (1-e-(t-TD3)/τ3) U3      Phase III 
 
Where,  
                  U1 = 0    for   t < TD1   and   U1 = 1    for   t > TD1    
                U2 = 0    for   t < TD2   and   U2 = 1    for   t > TD2    
                        U3 = 0    for   t < TD3   and   U3 = 1    for   t > TD3    




1.6 Aim of studies 
The fundamental idea of the following studies is to examine the control 
mechanisms of oxygen uptake following the onset of exercise. Specifically, the 
studies have been designed to investigate the interrelationships between 
cardiovascular adaptations and O2 utilization in accelerating 2OV
 kinetics in 
trained humans. The experimental objectives were to manipulate and quantify Q  
and FBF responses at the onset of dynamic exercise and infer relationships 
between O2 transport and O2 utilization in accelerating 2OV
 kinetics. The main 
hypothesis of these studies is that alterations in cardiovascular responses “ Q  and 
FBF” at the onset of exercise will be associated with alterations in the rate of 
increase in oxidative phosphorylation. 
Specific research questions: 
 
I. To examine the effects of prior moderate and heavy warm-up on pulmonary 
2OV
  and Q  kinetics at the onset of subsequent moderate and heavy cycling 
exercise (Chapters 2). 
 
II. To determine in a model of forearm exercise, if the increase of blood flow at 
exercise onset following prolonged ischemia would accelerate the blood flow 
and mus2OV
 kinetics during subsequent heavy exercise as demonstrated 






III. To quantify the role of muscle activity, as assessed by EMG, on the 
development of 2OV
 slow component during heavy exercise and increased O2 
cost during moderate exercise that followed a heavy warm-up (Chapter 4). 
 
IV. To study the effect of circadian rhythm on 2OV
 kinetics and BP regulations 








Prior moderate and heavy exercise accelerate oxygen uptake and 
cardiac output kinetics in endurance athletes 
This chapter is the basis for the published paper:  
Faisal A, Beavers KR, Robertson AD, & Hughson RL (2009). Prior moderate and 
heavy exercise accelerate oxygen uptake and cardiac output kinetics in endurance 





















 Cardiorespiratory interactions at the onset of dynamic cycling exercise are 
modified by warm-up exercises. We tested the hypotheses that 2OV
 and Q  kinetics 
would be accelerated at the onset of heavy and moderate cycling exercise by prior 
warm-up. Nine male endurance athletes (
peak2
OV : 60.5 ± 3.2 ml/min/kg) 
performed multiple rides of two different 36-minute cycling protocols involving 6-
minute bouts at moderate and heavy intensities. Breath-by-breath 2OV
  and beat-
by-beat stroke volume (SV) and Q  estimated by Modelflow from the finger pulse 
were measured simultaneously with kinetics quantified from the phase two time 
constant (2). One novel finding was that both moderate (M) and heavy (H) warm-up 
bouts accelerated phase two 2OV

 kinetics during a subsequent bout of heavy 
exercise (2: after M=22.5 ± 2.7 s, after H=22.1 ± 2.9 vs. 26.2 ± 3.2 s; P < 0.01).Q  
kinetics in heavy exercise were accelerated by both warm-up intensities (2: M=22.0 
± 4.1 s, H=23.8 ± 5.6 s vs. 27.4 ± 7.2 s; P < 0.05). During moderate exercise, prior 
heavy intensity warm-up (one or two bouts) accelerated 2OV

 kinetics and elevated 
Q  at exercise onset, with no changes in Q  kinetics. A second novel finding was a 
significant overshoot in the estimate of SV from Modelflow in the first minutes of 
each moderate and heavy exercise bout. These findings suggest that the 
acceleration of 2OV
  kinetics during heavy exercise was enabled by the acceleration 
of Q  kinetics, and that rapid increases in Q  at the onset of moderate and heavy 






 kinetics reflect the oxidative energy supply at the onset of work rate 
transitions. Prior exercise might alter the rate of increase of 2OV
  and Q  during a 
subsequent bout of exercise, but research findings utilizing this model are 
controversial. The first systematic investigation of prior exercise on 2OV
  kinetics 
by Gerbino et al. (1996) reported faster 2OV
  kinetics (shown by smaller effective 
time constant τ 2OV
 ) in a second heavy exercise bout. However, they observed no 
effects of prior heavy exercise on ensuing moderate exercise bouts or of prior 
moderate exercise on following bouts of either moderate or heavy exercise (Gerbino 
et al., 1996). Since then, many supportive and contradictory findings have been 
reported for 2OV
  kinetics while observations of Q  have been limited. 
 Faster 2OV
  kinetics have been found in a bout of heavy exercise that 
followed an identical heavy exercise bout (MacDonald et al., 1997; Perrey et al., 
2003a) or multiple sprint cycling (Tordi et al., 2003), but contrary findings of no 
change in kinetics have been reported (Burnley et al., 2000; Wilkerson et al., 2004). 
The reasons for these discrepancies in the responses to heavy exercise after a 
heavy warm-up could be a consequence of varying signal-to-noise relationships 
related to single or multiple test repetitions, to method of data analysis with overall 
kinetics versus a focus on the phase II kinetics, to differences in recovery intensity 
between exercise bouts, or to differences in physical fitness of the subjects studied. 
Likewise, varying results of accelerated or no change in kinetics have been reported 
for the effects of lower intensities of warm-up on 2OV
  kinetics on subsequent 




MacDonald et al., 1997) or moderate (Ferreira et al., 2005b; Gerbino et al., 1996) 
exercise. Several studies have reported no change in 2OV
 kinetics in moderate 
exercise that follows a bout of heavy warm-up exercise (Burnley et al., 2000; 
Gerbino et al., 1996; MacDonald et al., 1997). However, Gurd et al.(2006) recently 
reported faster phase II time constant (τ2) for 2OV
  during moderate exercise that 
followed a heavy warm-up. They observed elevated PDHa activity at baseline after 
the heavy bout and further activation during the second moderate exercise bout. 
 Kinetics of Q  have been investigated primarily in light or moderate exercise 
where a rapid increase in HR attributed to vagal withdrawal was largely responsible 
for the adaptation of Q  to steady state (Fagraeus & Linnarsson, 1976; Inman et al., 
1987; Lador et al., 2006; Linnarsson, 1974; Yoshida & Whipp, 1994). When the 
metabolic demand was elevated and sympathetic contributions were required to 
increase HR the kinetics of both Q  and 2OV
  were slower (Inman et al., 1987) but 
prior heavy exercise accelerated Q  and 2OV
  in subsequent heavy cycling exercise 
(Perrey et al., 2003a). 
 Relatively few studies have examined simultaneous kinetics of 2OV
  and Q  
during exercise transitions (Perrey et al., 2003a; Yoshida & Whipp, 1994). In the 
current study, we examined the relationship between 2OV
  and Q  kinetics to 
investigate the relative contributions of muscle metabolic and cardiovascular 
adaptations to 2OV
  kinetics at the onset of both moderate and heavy exercise. As 
well, we investigated the effect of prior warm-up in very fit young men who were 




during multiple repetitions to enhance the signal-to-noise ratio in the subsequent 
response kinetics. 
  Two primary hypotheses were tested: first, that both heavy and moderate 
prior exercise would accelerate the kinetics of 2OV
  and Q  in subsequent heavy 
exercise; and second, that prior heavy exercise would accelerate the kinetics of 
2OV
  and Q  in subsequent moderate exercise.  
2.3 Methods 
2.3.1 Subjects 
 Nine male endurance athletes (age: 22.3 ± 2.7 years, height: 178.6 ± 7.8 cm, 
weight: 71.9 ± 6.5 kg, peak oxygen uptake (
peak2
OV ): 60.5 ± 3.2 ml/min/kg; 
mean ± SD) consented to participate in this study. None of the participants was a 
cyclist, but all included some cycling in their fitness regimes and all were pre-
screened with 
peak2
OV > 55 ml/min/kg. This study was approved by the Office of 
Research Ethics at the University of Waterloo and all subjects provided written 
informed consent following full description of the protocols.  
2.3.2 Experimental design 
 peak2
OV and ventilatory threshold (VT) were determined using an 
incremental exercise test to volitional exhaustion on an electrically-braked cycle 
ergometer (Excalibur, Lode, Groningen, Netherlands). After an initial 4-min period 
of cycling at 20 W, the work rate increased as a ramp of 30 W/min. The pedaling 
cadence was maintained at ~ 80 rpm for the duration of the test. The test was 




cadence >75 rpm. The 
peak2
OV was calculated as the average of the last 15 
seconds of the test. The VT was estimated from the breakpoint in the curve of 
carbon dioxide output ( 2COV
 ) as a function of 2OV
  (V-slope method) (Beaver et al., 
1986) and confirmed by the point at which minute ventilation ( EV
 ) to 2OV
  ratio 
increased without an increase in EV
  to CO2 output ( 2COV
 ) ratio. 
 Each subject, over a 3-month period, performed multiple rides of two 
different 36-minute cycling protocols involving 6-minute bouts at moderate (M) and 
heavy (H) intensities (power output requiring 2OV
  equivalent to 80% of the 2OV
  at 
VT and 85% of
peak2
OV , respectively) interspersed with 6-minute bouts at 20 W to 
achieve similar protocols to other studies of prior exercise that have used unloaded 
cycling (Gerbino et al., 1996) , 20W (Burnley et al., 2000; Gurd et al., 2006), 25W 
(MacDonald et al., 1997) or 35% 
peak2
OV (Perrey et al., 2003a). The exercises were 
named by the intensity, bout number and protocol letter as follows: Protocol A = 
moderate (M1A) followed by heavy (H2A) followed by moderate (M3A); Protocol B = 
heavy (H1B) followed by heavy (H2B) followed by moderate (M3B); (Fig. 2.1). The 
pedaling frequency was maintained at 80 rpm throughout each protocol. The same 
cycle ergometer and individual set up (handle bar and seat position allowing nearly 
full knee extension) was used for each ride in the study. 
 The competitive athletes were in the maintenance phase of their training 
regimen. To ensure that there were no changes in their physical fitness during the 
testing period, an incremental exercise test was performed by each participant 




 On testing days, subjects reported to the laboratory in a rested, hydrated 
state. They were asked to abstain from caffeine 12 h and alcohol 24 h before 
testing. No more than two testing sessions per week were arranged; rides were 
performed at least 24 h following the participants’ last exercise regimen, 72 h 
following a heavy training session, and 48 h following their last study ride. The 
tests were completed in a quiet, air-conditioned laboratory at a temperature of 
~23°C. 
Breath-by-breath oxygen uptake 
 Ventilation and gas exchange were measured continuously in at least 8 rides 
(minimum 4 of each protocol) on a breath-by-breath basis (First Breath, Waterloo, 
ON) measuring inspired and expired concentrations of O2, CO2, and N2 by mass 
spectrometry (Innovision, Amis 2000, Odense, Denmark) and gas volumes by a 
bidirectional, low resistance, low dead space (90 ml) turbine (UVM-17125, 
VacuMed, Ventura, CA, modified to remove the signal delay on transition of flow 
direction). This system uses a modification of the Auchincloss algorithm 
incorporating an estimate of the effective lung volume to determine breath-by-
breath changes in lung gas stores (Hughson et al., 1991b).Calibrations with 
precision medical gases and an automated 3 L syringe (Vacumed, Ventura, CA) and 
measurement of the delay time to match the volume and gas signals were 







 Throughout each exercise test Q  was continuously estimated beat-by-beat 
from the pulse wave of the finger arterial pressure (Finometer, Finapres Medical 
System, Arnhem, Netherlands) utilizing the Modelflow algorithm to estimate SV 
(Wesseling et al., 1993) incorporating factors of age, sex, height and weight to 
estimate the aortic cross-sectional area (Langewouters et al., 1984). The left arm 
was supported slightly below heart level by a sling to minimize arm and hand 
movement. The support of one arm did not affect cycling mechanics or require 
additional activity in the other arm for these highly fit subjects. The MFQ
  signal 
was shifted -1s and 1 beat back to compensate for Finometer’s internal digital 
signal processing delay. The signals were linearly interpolated at 1-s intervals, the 
rides were time aligned and averaged together to yield a single data set for each 
subject in each protocol. The Modelflow algorithm follows changes in Q  (Tam et al., 
2004) but might exhibit bias relative to a standard method, especially when applied 
over a wide range of metabolic demand as in the current study. Therefore, we 
compared MFQ
  with those from acetylene rebreathing ( Q C2H2) (Triebwasser et al., 
1977) using a gas mixture containing 7% helium (He), 0.7% C2H2, 30% O2 and 
balance N2 from a 5-L rebreathing bag filled to 1.5 times each person’s tidal volume 
(Bell et al., 2003). Each subject performed multiple repetitions of Q C2H2 at the three 
work rates in 8 separate rides (total: 24 at 20 W, 12 at moderate and 12 at heavy 
work rates). Calibrations could not be performed in the exercise transients as the 
C2H2 method requires constantQ during the measurement period. Therefore, Q C2H2 




minutes (2 rides of each protocol) and these were compared to corresponding 
values for MFQ

 at each work rate. Given the small overall bias (see Results) no 
adjustment was applied to the MFQ
  as an estimate of Q during exercise. BP, MFQ

and electrocardiogram (ECG) (Pilot 9200, Colin Medical Instruments, San Antonio, 





















Figure 2.1: Two different testing protocols employed to examine the influence of 
prior exercise on 2OV
  and MFQ
  kinetics. 
 For each exercise bout, the M or H indicates moderate or heavy work rate; 1, 2 or 
3 indicates the order of the exercise bout within the sequence; and, A or B 
indicates the two different protocols. The specific bouts are M1A and H1B (moderate 
and heavy control bouts respectively), H2A and H2B (heavy exercise after a 
moderate or heavy prior exercise respectively), M3A and M3B (moderate exercise 




2.3.3 Data Analysis 
Breath-by-breath 2VO  and beat-by-beat MFQ  analysis 
 Breath-by-breath 2OV
 and beat-by-beat MFQ
  data were obtained from at 
least 4 repetitions of each of protocols A and B, linearly interpolated at 1-s 
intervals, time-aligned to the beginning of exercise, and averaged together to yield a 
single data set for each subject. The moderate and heavy bouts were curve fitted by 
two- (phases I and II) and three-component (phases I, II and III) exponential models 
respectively, according to the following equation: 
                       + A1 (1-e-(t-TD1)/τ1) U1      Phase I     
      Y(t) =   A0  + A2 (1-e-(t-TD2)/τ2) U2      Phase II  
                            + A3 (1-e-(t-TD3)/τ3) U3      Phase III 
 Where,  
                 U1 = 0    for   t < TD1   and   U1 = 1    for   t > TD1    
               U2 = 0    for   t < TD2   and   U2 = 1    for   t > TD2    
                       U3 = 0    for   t < TD3   and   U3 = 1    for   t > TD3    
Y(t) is the absolute 2OV
  or MFQ
  at a given time t; A0 is the amplitude of the 
baseline  for 2OV
  or MFQ
  measured in the 2 minutes preceding the onset of 
exercise while cycling at 20 W; A1, A2 and A3 are the amplitudes, TD1, TD2 and TD3 
are the time delays, and 1, 2 and 3 are the time constants of phases I, II and III 
respectively of the 2OV
  and MFQ




 Phase I was fit with parameters that insured a completed response before 
the start of phase II (i.e. 4 x 1 < TD2) so there was no impact of phase I on the 
phase II kinetics (Hughson et al., 2000) allowing comparison with studies which 
omitted the phase I from the fitting analysis (Barstow et al., 1996; Burnley et al., 
2000). Curve-fitting utilized an iterative non-linear regression process in which the 
best fit was defined by minimizing the residual sum of squares with a symmetrical 
distribution around the zero-line (see Fig.2.2). The rate of activation of the aerobic 
system during the exercise transition was characterized by 2 for 2OV
 .   
Acetylene cardiac output analysis  
In order to reduce signal noise and improve reliability in the rebreathing data, a 5-
point moving average was applied to every rebreathe trial. Complete mixing of the 
lung-bag system was indicated by the equilibration of He levels. After complete 
mixing was reached, 4 end-expiration points were selected from the C2H2 decay 
curve. End-tidal gas measurements were taken from the first 12s during the heavy 
bouts, and 15s during the 20 W and moderate bouts to avoid recirculation errors 
(Alves et al., 1985; Liu et al., 1997). Rebreathing trials were excluded from the 
analysis if the initial measured He and C2H2 values during the transition to 
rebreathing were disparate from the known concentrations in the tank, which may 
result from subjects being turned onto the rebreathing bag prior to complete 























where Bs is the slope of the C2H2 disappearance , VA(STPD) is the bag volume(mL), 
PB is the barometric pressure (mmHg), Vt is the lung tissue volume (mL),  and B 
are the Bunsen solubility coefficients for acetylene in the lung tissue (0.768) and 
blood (0.71) respectively (Petrini et al., 1978; Smyth et al., 1984; Triebwasser et al., 
1977). 
Arterial-venous oxygen content difference  
 To account for the lower sampling rate for 2OV
  (breath-by-breath) compared 
to the estimates of MFQ
  (beat-by-beat), the latter were averaged over each breath 
cycle to yield a single data point to match 2OV
  data. (A-v)DO2 was then calculated 
using the Fick equation:            (a-v)DO2 = 2OV
  /Q  
Baseline values for 2OV
 , MFQ
  and (a-v)DO2 were the average of the 30 s preceding 
the onset of moderate and heavy cycling bouts. The non-interpolated values of 
2OV
 , MFQ
  and (a-v)DO2 values were averaged in 10 s windows during each exercise 
bout and the relative contribution of Q  and (a-v)DO2 to the overall changes in 2OV

(expressed in %) were approximated through the differentiation of the Fick equation 
as shown by Fukuba et al. (2007): 
∆ 2OV
    ≈   (a-v)DO2 ∙ ∆ Q  +   Q  ∙ ∆ (a-v)DO2 
Dividing the differentiated equation by 2OV
  shows that the relative change in 2OV
  






















2.3.4 Statistical analysis 
 Regression and Bland-Altman analyses (Mantha et al., 2000) were used to 
examine the accuracy and reliability of the Finometer Q  method. Additionally, a 
one-way repeated measures analysis of variance (ANOVA) and coefficient of 
variation (CV) analysis were completed to demonstrate the variance of the Q  across 
the multiple bouts. The effect of prior exercise on 2OV
  and Q  kinetics as well as 
selected time values of HR and SV were analyzed using one-way repeated measures 
ANOVA. When significant effects were observed, the Bonferroni post hoc test was 
used for comparisons. Regression analyses compared the Q  and 2OV
  kinetics to 
each other. All data are expressed as mean ± SD. The data were analyzed using 








Figure 2.2: Representative 2OV
  (top) and MFQ
  (bottom) data from one participant 
during heavy exercise.  
The three-component model has been used to estimate the fitting parameters for 
both curves. The quality of fit is shown in the small residuals, which are evenly 





2.4.1 Incremental exercise test 
 The pre-study 
peak2
OV (4325 ± 516 ml/min, 60.5 ± 3.2 ml/min/kg) was 
reached at a work rate of 390 ± 44 W during the 30 W/min incremental exercise 
test. VT occurred at 65 ± 5.7 % of 
peak2
OV . The work rates during the moderate 
and heavy bouts were 146 ± 33 W and 266 ± 35 W, respectively. At the completion 
of the study 
peak2
OV (4328 ± 537 ml/min, 60.6 ± 3.9 ml/min/kg) and work rate 
(396 ± 41 W) did not differ from the pre-study values (P = 0.89). 
2.4.2 Modelflow cardiac output validation 
 The MFQ
  and Q C2H2 were highly correlated both on a subject-subject basis 
and overall. Individually, the average correlation coefficient was 0.93 ± 0.03 and 
ranged from 0.90 to 0.96 (Fig. 2.3). The overall regression equation between 
methods was MFQ
  = 0.94 Q C2H2 + 1.09 with r = 0.92 (P < 0.001). The results of the 
Bland –Altman analysis (Fig. 2.4) showed small bias at the three different work 
rates 20W, 80% VT and 85% 
peak2
OV (0.01, 0.05,-0.97; respectively). The overall 
bias (mean Q C2H2  - MFQ
 ) was low at -0.20 l/min with 95% limits of agreement from 
-4.16 to 3.76 l/min. MFQ
  variability during repeated measurements was low. There 
were no significant differences in MFQ
  across the multiple repetitions of each 
protocol (P > 0.41 for moderate bouts; P > 0.67 for heavy bouts). The mean CV in 
all subjects over all rides was 6.7 ± 2.4 % during moderate bouts (ranging from 3.7 




regression equations for both MFQ
  and Q C2H2 with 2OV
  in all subjects were similar 
[ MFQ
  = 0.005 2OV
  + 5.58 with r = 0.97 (P < 0.001); Q C2H2 = 0.004 2OV
  + 5.89 with 
r = 0.96 (P < 0.001)]. Overall, the Modelflow method provided a valid estimate of Q  
during exercise at the three different intensities of cycling exercise. 
2.4.3 Oxygen uptake and cardiac output kinetics 
 During a heavy exercise bout that followed either prior moderate or heavy 
exercise τ2 values for both 2OV
  and MFQ
  were less than when heavy exercise was 
not preceded by warm-up (Fig. 2.5, Table 2.1). 2OV
 responses were normalized to 
the amplitude at the end of the primary phase to eliminate the effect of elevated 
baseline 2OV
 (Fig. 2.6). The moderate exercise bouts that followed prior heavy 
exercise (one and two bouts) had smaller τ2 for 2OV
  than in the no warm-up 
condition. The reduction in τ2 for MFQ
  was not significantly different compared to 
the control (Fig. 2.7, Table 2.2). There was a significant relationship between the 
time constants for 2OV
  and MFQ
  determined for all heavy bouts (r = 0.47, P = 
0.01). However, the overall relationship between 2OV
 τ2 and MFQ
 τ2 during moderate 
bouts did not reach the significant level (r = 0.14, P = 0.5, Fig. 2.8). 
Baseline (A0) values for 2OV
  were significantly elevated when either moderate or 
heavy exercise was preceded by one bout of heavy exercise and there was further 
small, but significant elevation when moderate exercise was preceded by two heavy 
bouts (Table 2.1 and 2.2). Prior moderate exercise had no effect on the A0 for 2OV

. 
Neither moderate nor heavy prior exercise affected the amplitude of 2OV
  during 




(Table 2.1 and 2.2). Prior warm-up had a graded effect on the amplitude of the 
2OV
  slow component (A3), such that the prior heavy exercise resulted in a greater 
attenuation than moderate exercise (Table 2.1).  
 A0 for MFQ
  was significantly elevated by prior heavy exercise (Table 2.1 and 
2.2). There was no impact of prior exercise on the MFQ
  amplitudes A1 or A2 in the 
heavy exercise bouts (Table 2.1). During the moderate exercises both A1 and A2 
were significantly reduced by one or two bouts of prior heavy exercise (Table 2.2); 
however, due to the higher starting values the absolute average MFQ

 from 15-45 s 
after exercise onset was greater after two prior heavy bouts (M3B = 15.5 ± 4.5 
l/min, P < 0.01) compared to no prior exercise (M1A = 14.5 ± 3.3 l/min) but was not 
different after one bout of heavy prior exercise (M3A = 14.9 ± 4.2 l/min). 
 The HR and SV contributions to MFQ

 were markedly impacted by the prior 
exercise condition (Table 3, Fig. 2.9 and 2.10). During both moderate and heavy 
exercise, there was a significant overshoot of the SV within the first two minutes of 
exercise (Fig. 2.9 and 2.10, Table 2.3). During moderate bouts, one prior heavy 
exercise bout elevated HR and reduced the baseline, peak, and end bout SV, and 
these responses were further diminished by two prior heavy exercise bouts. During 
heavy bouts, baseline and end bout HR were elevated by prior heavy exercise, but 
there were no differences in the baseline, peak or end exercise SV between bouts 




2.4.4 Arterial-venous oxygen content difference 
 Prior exercise elicited changes in Q  and (a-v)DO2, combining to accelerate 
2OV
  kinetics of a subsequent moderate or heavy exercise bout. In a moderate bout 
following one heavy bout (M3A), increases in (a-v)DO2 mainly contributed to the 
speeding of 2OV
  kinetics. Relative to the bout without prior exercise (M1A), there 
were increases in the (a-v)DO2 at 30 s (129.8 ± 12.5 vs. 117.0 ± 10.5 mlO2/l blood) 
and at 90 s (145.0 ± 13.9 vs. 134.4 ± 12.7 mlO2/l blood). These increases in  
(a-v)DO2 contributed to 75 % of the change in 2OV
  kinetics [(∆(a-v)DO2 /(a-v)DO2 / 
(∆ 2OV
 / 2OV
 ) = 10.95% / 14.62%] at 30 s, and reached 100 % by 90 s.  In the 
moderate bout that followed two heavy bouts (M3B) both (a-v)DO2 and Q  
contributed to the change in 2OV
  (Fig. 2.11 - top). Q  contributed to 52 %  
[(∆Q  / Q ) / (∆ 2OV
 / 2OV
 ) = 8.26% / 15.93%] and 23 % of the changes in 2OV
  vs. 
M1A at 30 and 90 s, respectively. For the heavy exercise bouts that followed either 
moderate or heavy exercise, Q  appeared to be the major contributor to changes in 
2OV
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Figure 2.3: Linear regressions comparing the Finometer Modelflow estimated 
cardiac output and acetylene rebreathing cardiac output. 
Individual regressions (above, range: r = 0.90-0.96, P <0.001) and overall 





2H2 and Finometer Cardiac Output Average (l/min)











































Overall bias was -0.20 l/min and 95% limits of agreement ranged from -4.16 to 
3.76 l/min. This figure reflects a maximum of 24 measures taken at 20W, 12 
measures taken at 80%VT and 12 measures taken at 85% 
peak2
OV  for each 













H1B H2A H2B H1B H2A H2B 
A0, l/min 
 
0.99 ± 0.05 1.02 ± 0.07 1.17 ± 0.05 *‡ 
 
10.16 ± 0.97 10.25 ± 0.94 11.90 ± 0.75 *‡ 
A1, l/min 0.47 ± 0.16 0.49 ± 0.13 0.44 ± 0.13 3.19 ± 0.78 2.86 ± 0.63 2.99 ± 0.45 
A2, l/min 1.71 ± 0.23 1.68 ± 0.24 1.79 ± 0.26 8.18 ± 1.82 8.01 ± 1.30 8.16 ± 1.47 
A1+A2, l/min 2.18 ± 0.33 2.16 ± 0.34 2.23 ± 0.34 11.37 ± 1.68 10.87 ± 1.48 11.15 ± 1.59 
A0+A1+A2, l/min 3.17 ± 0.35 3.18 ± 0.34 3.40 ±0.36 *‡ 21.53 ± 1.88 21.12 ± 1.33 23. 05 ± 1.76 †‡ 
A3, l/min  0.64 ± 0.15 0.55 ± 0.11† 0.39 ±0.07 *‡  1.51 ± 0.61 1.59 ± 0.74 1.40 ± 0.70 
 2, s 
 
26.15 ± 3.16 22.47 ± 2.71 * 22.05 ± 2.91 * 
 
27.43 ± 7.22 22.0 ± 4.08 † 23.77 ± 5.58 † 
3, s 156.6 ± 34.6 141.2 ± 34.9 137.1 ± 29.3 98.3 ± 13.5 103.2 ± 8.8 97.1 ± 16.6 
TD2, s 11.83 ± 2.02 11.9 ± 1.47 10.29 ± 1.06 †§ 7.3 ± 1.59 7.85 ± 2.26 9.01 ± 2.86 
TD3, s 98.9 ± 15.2 81.9 ± 10.4 * 75.5 ± 7.3 * 115.4 ± 18.3 98.1 ± 7.9 † 97.8 ± 10.5 † 
End bout, l/min  3.7 ± 0.39 3.64 ± 0.37  3.73 ± 0.36   23.0 ± 1.38 22.68 ± 1.05 24.3 ±1.29 †‡ 
      
      Mean ± SD, n = 9  




































H1B (Control: No Prior Ex.)
H2A (Prior Moderate Ex.)






































 Figure 2.5: 2OV
  (top) and MFQ
  (bottom) time series data for heavy bouts. 
Insets: Tau2 (mean ± SE); * P < 0.01; † P < 0.05 compared to H1B. Data lines are the 






























































H1B ( Control: No Prior Ex.)
H2B ( Prior Heavy Ex.)
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H2A ( Prior Modertae Ex.)










H1B (Control: No Prior Ex.)
H2A (Prior Modertae Ex.)
 
Figure 2.6: Comparison of the normalized 2OV
  to the amplitude at the end of 
primary phase during heavy bouts.  




Table 2.2: Fitting parameters of oxygen uptake and cardiac output kinetics during moderate bouts 
Parameters 
 
Oxygen Uptake  Cardiac Output 
M1A M3A M3B M1A M3A M3B 
A0, l/min 
 
0.99 ± 0.05 1.15 ± 0.07 * 1.19 ± 0.06 *§ 
 
9.36 ± 0.98 11.08 ± 0.80 * 11.13 ± 0.72 * 
A1, l/min 0.33 ± 0.14 0.28 ± 0.09 0.31 ± 0.11 1.82 ± 0.42 1.24 ± 0.39 * 1.38 ± 0.31 * 
A2, l/min 0.92 ± 0.23 0.9 ± 0.26 0.89 ± 0.25 5.02 ± 1.36 3.95 ± 1015 * 4.21 ± 1.21 * 
2, s 22.85 ± 4.81 18.91 ± 3.38 † 16.92 ± 2.67 * 20.15 ±5.22 19.13 ± 5.72 18.82 ± 4.29 
TD2, s 13.6 ± 1.67 12.8 ± 1.79 14.2 ± 1.57 7.87 ± 2.65 9.65 ± 2.83 8.51 ± 3.37 
End bout, l/min 2.25 ± 0.37 2.34 ± 0.36 * 2.39 ± 0.36 *§ 16.1 ± 1.47 16.37 ± 1.49 16.81 ±1.47 † 
 
Mean ± SD, n = 9 
* P < 0.01 M1A vs. M3A-M3B; † P < 0.05 M1A vs. M3A-M3B; § P < 0.05 M3A vs. M3B        
Amplitude parameters A0, A1 and A2 for the baseline, phase 1 and phase 2 respectively; time constant (τ2) and time 
delay (TD2) for the primary phase; end bout is the average 2OV
  or MFQ
  in the last minute of each exercise bout. The 
































M1A (Control: No Prior Ex.)
M3A (One Prior Heavy Bout)








































  (top) and MFQ
  (bottom) time series data for moderate bouts. 
 Insets: Tau2 (mean ± SE); * P < 0.01; † P < 0.05 compared to M1A. Data lines are 






































Figure 2.8: Linear regressions comparing 2OV
 Tau2 to MFQ
 Tau2 for heavy and 
moderate bouts. 




Table 2.3: Cardiac output variability, heart rate and stroke volume during heavy and moderate bouts 
 
Mean ± SD, n = 9 
* P < 0.01 and † P < 0.05 compared to the control conditions (H1B, M1A); ‡ P < 0.01 H2A vs. H2B and M3A vs. M3B;  § 






H1B H2A H2B M1A M3A M3B 
Q CV,  % 
 
 
7.7 ± 3.1 7.4 ± 2.6 5.8 ± 2.6 
 
 
6.9 ± 3.2 7.2 ± 2.9 6.2 ±2.1 
Q C2H2 - MFQ

 Bias, l/min - 0.8 ± 2.5 -0.5 ± 2.7 - 1.6 ± 2.1 0.4 ± 1.5 0.5 ± 1.4 -0.3 ± 1.9 
Baseline HR, bpm 87.8 ± 7.0 91.0 ± 8.2 108.9 ± 8.7 *‡ 82.2 ± 7.2 104.9± 10.7 * 111.9 ± 10.3 *‡ 
End Bout HR, bpm 169.4 ± 5.3 169.8 ± 6.7 177.1 ± 6.2 *‡ 124.5 ± 10.3 138.3± 10.8 * 146.9 ± 9.2 *‡ 
Baseline SV, ml 115.8 ± 13.2 116.6 ± 11.5 108.0 ± 13.0 118.8 ± 13.1 106.8± 10.4† 96.1 ± 9.4 §* 
Peak SV, ml  151.8 ± 13.7 154.5 ± 11.1 151.5 ± 14.0  141.4 ± 12.5 130.1± 10.4 * 126.2 ± 12.7 * 
End Bout SV, ml  132.0 ± 8.8 137.8 ± 11.4 135.7 ± 6.7  130.9 ± 11.8 119.8± 10.5 * 115.4 ± 8.7 * 
Peak - Baseline SV, ml  36.0 ± 9.9 37.9 ± 12.8 43.5 ±8.7  22.6 ± 8.7 23.3 ± 7.3 30.9 ± 8.7 † 





















































Figure 2.9: HR (top) and SV (bottom) during heavy work rate transitions.  
SV is presented as a 5-second moving average. Data lines are the average of 9 










































(Control: No Prior Ex.)
(One Prior Heavy Bout)
(Two Prior Heavy Bouts)
 
Figure 2.10: HR (top) and SV (bottom) during moderate work rate transitions.  
SV is presented as a 5-second moving average. Data lines are the average of 9 



















































































Figure 2.11: Percent differences of 2OV
 , Q , and (a-v)DO2 within moderate and 
heavy bouts.  
Top panel: M1A (control; no prior exercise) and M3B (prior one heavy bout) and 
heavy bouts .Bottom panel: H1B (control; no prior exercise) and H2B (prior heavy 
bout) Data lines are the average of 10 s window for 9 subjects with ≥ 4 repetitions 
per each exercise condition. Changes in 2OV
  are approximately equal to changes 




2.5 Discussion  
 Our results provided several unique observations concerning 2OV
  and Q  
kinetics during moderate and heavy cycling exercise in endurance athletes. In 
support of our first hypothesis, we observed for the first time that a 6-minute 
moderate warm-up bout, as well as prior heavy exercise, was capable of reducing2 
for both 2OV
  and Q  during a subsequent heavy exercise bout. In partial support 
of our second hypothesis, we observed lower 2 for 2OV
  when moderate exercise 
followed one or two bouts of heavy exercise; but, the 2 for Q  was not significantly 
altered  although absolute Q  was elevated early in exercise that followed two prior 
bouts of heavy exercise. Our data also revealed novel responses for SV with a 
highly significant overshoot during the early phase of heavy and moderate exercise 
bouts. As well, SV recovered to a common plateau in all heavy exercise bouts 
regardless of the prior exercise condition, but remained below the no-prior exercise 
condition during moderate exercise that followed one or two bouts of heavy 
exercise. 
2.5.1 Methodological considerations and limitations 
 The current data should be put in the perspective that they were obtained in 
highly fit young men who performed multiple repetitions of exercise tests to 
enhance the ability to resolve effects of prior exercise on 2OV
  and Q  responses. 
The data then might not reflect the general population, but rather the extreme with 
well adapted cardiovascular and metabolic responses. 
 Continuous estimates of Q  were obtained in the current study by Modelflow 




in Q  during transitions to higher work rates have been examined by various non-
invasive techniques (Inman et al., 1987; Leyk et al., 1995; Perrey et al., 2003a; 
Yoshida & Whipp, 1994), including Modelflow (Lador et al., 2006); although, these 
studies involved less intense exercise than the current study. Previous studies have 
reported that the Finometer Modelflow Q  technique was valid in comparison to 
thermodilution (de Wilde et al., 2007; Wesseling et al., 1993) and Doppler 
echocardiography methods (Sugawara et al., 2003), as well as CO2 (Pitt et al., 2004) 
and C2H2 rebreathing methods (Tam et al., 2004). Since Modelflow has not been 
investigated under the conditions of our experiments we conducted a comparison 
with acetylene rebreathing. There was a high correlation between the MFQ
  and 
C2H2Q

  from steady state baseline cycling at 20 W to steady state exercise at 85% 
peak2
OV with only a small bias and a reasonably small 95% confidence interval for 
the differences between C2H2Q
 and MFQ
 (Fig. 2.3 and 2.4). As well, the bias was not 
affected by the protocol, since data from both moderate and heavy bouts confirm 
that there was no significant bias introduced by the type of prior exercise (Table 
2.3). Thus, in the steady state of exercise; there were no systematic errors in 
estimates of Q  introduced by the non-invasive Modelflow approach. 
Methodologically, it was not possible to confirm that there was no bias during the 
non-steady state phase when we observed differences in MFQ
  kinetics and the 
overshoot of SV. It is possible that rapid changes in aortic impedance in the 
transitions to higher work rates affected the accuracy of the Modelflow calculation 





  and SV. Notably, Harms et al.(1999) reported that, during a dynamic postural 
shift, changes in MFQ
  did track estimates from Doppler ultrasound. 
 The breath-by-breath measurements in the current study utilized a 
modification of the Auchincloss algorithm and estimates of a nominal lung volume 
(NLV) to follow changes in lung gas stores and adjust the gas exchange measured 
at the mouth (Hughson et al., 1991b). Based on previous observations that 
minimal breath-by-breath variation in estimates of 2OV
 was obtained with a lung 
volume smaller than functional residual capacity (FRC), we arbitrarily chose NLV to 
equal 50% of FRC (Hughson et al., 1991b). Recently, Cautero et al. (2002) 
suggested the Grønlund algorithm, which defines a respiratory cycle by equal 
fractions of O2 in expired air, might provide a more accurate measure of breath-by-
breath alveolar 2OV
  and that the phase II time constant was faster than when 
compared to the Auchincloss algorithm. In the current study, the absolute value of 
τ2 might differ if 2OV
  had been calculated with the Grønlund algorithm but our 
comparisons within subjects would not be biased by the method of calculation. 
 Characterization of 2OV
  kinetics has normally been approached through 
multi-component exponential modeling with the major emphasis on the phase II 
response that might reflect changes in muscle oxidative metabolism (Linnarsson, 
1974; Whipp & Ward, 1982). We retained this convention even though 
nonlinearities during phase II (Hughson et al., 2001; Rossiter et al., 2001) might 
question the validity of this approach because current techniques are unable to 
resolve this effect in breath-by-breath data for 2OV
 . We chose to fit the 




(1) value fast enough to achieve a complete response before the start of phase II 
(i.e. 4 * 1 < TD2) (Hughson et al., 2000). 
 There have been fewer studies of the kinetics of Q  than 2OV
 , but it is 
obvious from the HR and SV data (Fig. 2.9 and 2.10) that presenting the kinetics of 
Q  by a simple two or three component exponential model is at best an 
approximation even though residuals appear to be evenly distributed (see Fig.2.2 - 
bottom). The initial overshoot of SV while HR progressively increased violates the 
concept that one exponential term corresponds to a single physiological control 
mechanism for Q . However, using the same model for 2OV
 and MFQ
  simplified 
comparisons of these variables within our study and with other research. 
 An important limitation in the current study is that our measurement of 
MFQ
  does not provide insight into the site-specific delivery of oxygenated blood to 
the exercising muscles. Recent data from investigation of multiple muscle sites 
with near infrared spectroscopy (Koga et al., 2007) revealed considerable 
heterogeneity of tissue oxygenation suggesting that even studies that measure 
blood flow and O2 extraction across working muscles (Grassi et al., 1996; Hughson 
et al., 1996) have limitations with regard to determining the matching of perfusion 
with metabolic demand. 
2.5.2 Oxygen Uptake and Cardiac Output Kinetics during Heavy Exercise 
 In the current study we observed faster 2OV
  and MFQ
  kinetics in a second 
heavy bout following six minutes of prior heavy or moderate warm-up exercise. The 
effect of prior heavy exercise will be considered first, as there are more previous 




was capable of accelerating 2OV
  and MFQ
  kinetics during a subsequent heavy 
exercise will be examined. 
 Almost universally in previous research, 2OV
  was found to be elevated in the 
first minutes of heavy exercise that followed soon after previous single or multiple 
bouts of heavy exercise (Burnley et al., 2000; Gerbino et al., 1996; MacDonald et 
al., 1997; Tordi et al., 2003). However, what is far from universal is agreement on 
whether the 2OV

 is simply elevated without a change in kinetics (Burnley et al., 
2000; Wilkerson et al., 2004) or whether 2OV
  actually increases more rapidly 
toward the required level (MacDonald et al., 1997; Rossiter et al., 2001; Tordi et al., 
2003). 
 The current study and that of Tordi et al. (2003), where there was clear 
evidence of  faster 2, included only subjects who were well trained athletes. There 
is some evidence that O2 delivery may limit maximal oxygen consumption (Knight 
et al., 1993; Richardson, 2000; Richardson et al., 1999). Greater O2 delivery with 
increased leg blood flow during heavy exercise following prior heavy exercise 
(Fukuba et al., 2007; Hughson et al., 2003), might contribute to an enhanced 
intracellular PaO2 (Hughson, 2005; Tschakovsky & Hughson, 1999) and lessen PCr 
degradation (Rossiter et al., 2001). Physical training induces tighter metabolic 
coupling, such that smaller changes in the energy state of the muscle are needed 
to stimulate enzymes of oxidative phosphorylation (Phillips et al., 1996). This 
tighter coupling is consistent with the hypothesis that elite athletes would be more 





 Similar to Perrey et al.(2003a), we observed that prior heavy exercise 
accelerated Q  in subsequent heavy cycling exercise. The increase in MFQ
  that we 
observed during heavy exercise was a consequence of a rapid increase in SV 
resulting from increased ejection fraction and a somewhat slower increase in HR 
that probably reflects a relatively greater reliance on sympathetic activation than 
on vagal withdrawal (see Fig. 2.9). To the best of our knowledge, this is the first 
study to report an overshoot of SV in the early phase of heavy exercise; although 
our validation of Modelflow SV against C2H2 rebreathing was not specifically tested 
in this transient phase. We found that SV reached values within the first minute of 
exercise that were 15-20 mL greater than the steady state values at the end of the 
exercise bouts. Leyk et al. (1995) monitored the SV using Doppler ultrasound 
during upright cycling across exercise transitions to work rates of up to 200 W. 
They showed SV to increase rapidly and peak by 30 s of exercise onset but the 
resolution of their data was not sufficient to address the possibility of the SV 
overshoot that has been observed in the first minute of exercise transitions in this 
study (Fig. 2.9 and 2.10). It seems probable that the very rapid increase in SV 
reflects the sudden increase in venous return with the onset of the higher work 
rate mediated primarily by the stronger muscle pump (Sheriff et al., 1993; 
Tschakovsky et al., 1996). Although SV was lower in the baseline period after prior 
heavy exercise, there were no differences in peak values between the exercise 
conditions. The elevated HR after the prior heavy exercise bout was sustained 
during the subsequent bout of heavy exercise, resulting in a significantly higher Q  
at the end of exercise in this condition. The higher Q  might have been required as 




 Several interacting mechanisms are likely responsible for improved O2 
delivery following a heavy warm-up and contribute to accelerated 2OV
  kinetics 
during a subsequent heavy bout: (i) an accumulation of vasoactive metabolites 
enhances vasodilation and increases blood flow to exercising muscles (Krustrup et 
al., 2001; MacDonald et al., 2001b); (ii) a right-shift of the oxy-hemoglobin 
dissociation curve resulting from the accumulation of H+ and increased 
temperature promotes O2 offloading at the muscle (Gerbino et al., 1996; 
MacDonald et al., 2001b); and (iii) a reduction in regional perfusion heterogeneities 
in the muscle microvasculature improves the matching between O2 delivery and 
oxygen utilization (DeLorey et al., 2007; Fukuba et al., 2002).  
 While we have shown that enhanced O2 delivery plays an overriding part in 
accelerating 2OV
 kinetics following heavy exercise, others have argued that the 
overall 2OV
  kinetics acceleration are due to an increase in the primary phase 
amplitude and attenuation of the slow component amplitude (Burnley et al., 
2002b; Burnley et al., 2000; Fukuba et al., 2002; Koppo & Bouckaert, 2001; Perrey 
et al., 2003a). In agreement with these previous studies, we observed an increase 
in the absolute 2OV
  at the end of primary phase. However a higher end- primary 
phase 2OV
  showed in this study and others (Burnley et al., 2002b; Tordi et al., 
2003; Wilkerson et al., 2004) results from a higher baseline, not a real increase in 
the primary phase amplitude (Burnley et al., 2000; Jones et al., 2006; Koppo & 
Bouckaert, 2001; Marles et al., 2007; Tordi et al., 2003). To eliminate the effect of 
the elevated baseline 2OV
  following the heavy bout, Jones et al. (2003) showed the 
normalized 2OV




that the kinetics of the primary component are unaffected by a prior heavy bout. 
Contrary to their conclusion, our data (Fig. 2.6) showed that prior moderate and 
heavy bouts accelerated the primary component of 2OV
  kinetics of a subsequent 
heavy bout even after normalization to the amplitude (A1 +A2) at the end of the 
primary phase. Recently, Hughson et al. (2001) used a computer simulation model 
to demonstrate the difficulty in detecting either dynamic nonlinearities or 
differences in time constant even when they are present. Therefore, optimizing the 
experimental conditions is essential to determine altered 2 (Rossiter et al., 2001). 
In this study, a well-controlled experimental design was developed by selecting a 
homogeneous group of endurance athletes and having them complete multiple 
trials to increase the 2OV
  signal to noise ratio enabled us to detect a significant 
effect of prior exercise on the primary component 2OV
  kinetics. 
A unique finding of this study was that a prior bout of moderate cycling exercise 
accelerated 2OV
  kinetics (reduced 2) in a subsequent heavy bout. The similar 
responses shown in the acceleration of MFQ
  and 2OV
  kinetics following both prior 
heavy and moderate warm-ups - despite the expected  higher baseline [La-] 
following the heavy warm-up, as shown in Chapter 4 – provide evidence that 
accumulation of H+ during the heavy warm-up is not the sole factor contributing to 
acceleration of the 2OV
  kinetics (Burnley et al., 2002a; Koppo & Bouckaert, 2000; 
Koppo & Bouckaert, 2002). This conclusion is in agreement with Fukuba et al. 
(2002), who showed a significant difference in mean response time of the second 
heavy cycling bout after an identical heavy cycling bout, but not after a heavy arm 




findings support the idea that changes in 2OV

 kinetics are not simply due to 
systemic lactic acidosis. Highly trained athletes might exhibit an improved 
sensitivity to the local metabolic environment and a more tightly regulated O2 
delivery system to the working muscles. As a consequence of the prior moderate 
exercise, we observed slight increases in HR, MFQ
 , and [La-] during the subsequent 
baseline period. These factors might reflect conditions compatible with enhanced 
vasodilation and O2 offloading at the working muscle and speeding the kinetics of 
MFQ
  and 2OV
  during subsequent heavy bouts. 
2.5.3 Oxygen uptake and cardiac output kinetics during moderate exercise 
 Our second hypothesis proposed that both 2OV
  and Q  kinetics would also 
be accelerated when moderate exercise followed heavy warm-up exercise. There 
were faster 2OV
  kinetics after heavy warm-up (one or two bouts) exercise, but MFQ
  
kinetics were not significantly affected. The observation of faster 2OV
  kinetics 
during moderate exercise after a heavy warm-up confirmed the recent finding by 
Gurd et al. (2006), but contrasts with the results of others (Burnley et al., 2000; 
Gerbino et al., 1996; MacDonald et al., 1997).  
 The mechanism(s) that made the elevated 2OV
  possible during moderate 
exercise after heavy exercise has (have) not been investigated in detail since only 
this study and that of Gurd et al. (2006) have reported this observation in young 
men. Gurd et al. (2006) found that the intramuscular environment was enhanced 
PDHa activity and substrate concentrations (e.g. acetyl CoA and NADH) were 
elevated by a prior heavy exercise bout, but they also found greater tissue 




latter observation might appear in conflict with the current study where the 
kinetics of MFQ
  were not changed but several factors need to be considered. MFQ
  
was elevated in the baseline period before the moderate exercise bout by both one 
and two prior heavy exercise bouts. As well, MFQ
  was significantly elevated during 
the first 45 s by the two bouts of prior heavy exercise (M3B). It is possible that 
perfusion of the exercising muscles was elevated in the transition to the moderate 
exercise, but data are not available in the current study to confirm the blood flow 
distribution or to indicate how the change in whole body (a-v)DO2 reflected the O2 
extraction across the working muscle. The absence of effect of prior exercise on 
MFQ
  kinetics was similar to the report of Yoshida et al. (1995) who saw no effect 
during moderate one-legged cycling. In a more controlled assessment of the role of 
O2 extraction in accelerating 2OV
  kinetics, DCA was infused directly into the 
exercising muscle to stimulate PDHa activity (Howlett et al., 1999b). Oxidative 
metabolism was increased, as determined by PCr utilization and cellular energetic,  
at the onset of moderate (Howlett et al., 1999b) but not sprint exercise (Howlett et 
al., 1999a). It could be concluded that the muscles’ inability to increase 
metabolism during the heavy exercise was due to O2 delivery and/or other 
metabolic limitations, supporting the results shown in our study. 
2.5.4 Heart rate and stroke volume at the onset of exercise 
 The contribution of rapid increases in HR and SV to the kinetics of oxidative 
metabolism at the onset of exercise was recognized by Linnarrson (1974), but it 
was the observation of Hughson and Morrissey (1982) that kinetics of 2OV
 were 
markedly slowed when HR increased more slowly that emphasized the importance 




demonstrated that the HR response is considerably faster if HR starts from a low 
level that allows parasympathetic withdrawal to rapidly increase HR to ~100 
beats/min.  
 The magnitude and rate of increase in HR at the onset of exercise is 
determined by the interplay of several factors. First, the baseline HR is extremely 
important as it determines whether parasympathetic and sympathetic nervous 
systems can contribute to the rate of increase in HR. Second, the magnitude of 
increase in HR is proportional to the magnitude of the step increase in metabolic 
demand. Third, other factors such as requirements for thermoregulation can 
influence the HR and SV. 
 In the moderate exercise bouts, HR was relatively stable by 2-min of exercise 
and increased by less than 5 beats/min over the next 4-min of exercise. However, 
the absolute HR did differ between each exercise condition with higher absolute HR 
after one or two bouts of prior heavy exercise. The elevated baseline HR after prior 
heavy exercise to over 100 bpm in M3A and M3B (Fig. 2.10) probably contributed to 
a slower increase with the start of moderate exercise as vagal activity was already 
withdrawn and increased sympathetic activity was required to increase HR 
(Fagraeus & Linnarsson, 1976). In the heavy exercise bouts, HR was elevated by 
prior heavy but not moderate exercise, and HR was significantly elevated 
throughout the heavy exercise bout that was preceded by the heavy warm-up 
exercise. HR had not stabilized by 2-min but continued to increase through 6-min 
by 10 to 20-beats/min in each heavy exercise bout. The elevated HR after previous 
heavy exercise and the progressive rise in HR in the heavy exercise bouts might 





 There have been few studies employing techniques that determine beat-to-
beat SV, but to the best of my knowledge this is the first study to describe a 
significant overshoot in the first minutes of moderate and heavy exercise. At the 
onset of 50 or 100 W cycling exercise, Lador et al. (2006) displayed the first 45-s of 
SV but this was not sufficient to see the time course of the overshoot that 
described in this study. The overshoot and overall elevation in SV contrasts with 
the finding of a reduction in SV during mild supine exercise (Elstad et al., 2009). 
The very rapid increase in SV reflects the sudden increase in venous return with 
the onset of the higher work rate mediated primarily by the stronger muscle pump 
during upright cycling exercise (Sheriff et al., 1993; Tschakovsky et al., 1996). SV 
was not different between the moderate and heavy exercise bouts except when 
heavy exercise preceded the moderate exercise bouts. This suggests that the prior 
exercise probably induced the requirement for an increased thermoregulatory 
response with greater SBF (see Appendix A) and impaired venous return. It will be 
of interest to determine if the SV overshoot is a characteristic of well trained 













In the current study, we combined estimates of continues MFQ
 , validated in steady 
state against acetylene rebreathing, with breath-by-breath measurements of 2OV
  
to study the dynamic aspects of the cardiorespiratory responses at the onset of 
moderate and heavy exercise with prior warm-up. It was observed that the 
estimates of SV had a significant overshoot in the first minute of both moderate 
and heavy exercise that contributed to the rapid increase in MFQ
  at the onset of 
exercise. In support of the hypotheses, the 2OV
  response during moderate exercise 
was significantly accelerated by prior heavy exercise. As well, in heavy exercise 
both the 2OV
  and MFQ
  responses were accelerated not only by prior heavy but also 
by moderate warm-up exercise. Overall, these data showed that prior exercise can 
accelerate the phase II kinetics of 2OV
  at least in a population of very fit young 
men. The relatively large amplitude of Q and 2OV
  in the heavy exercise enabled 
discovery of significant links between O2 transport and O2 utilization. In moderate 
exercise, the amplitude of the Q and 2OV
  signals was smaller. A consequence of 
this was that alternative means of supplying O2 were available so that clear 
concluding statements cannot be made about the link between O2 transport and O2 
utilization. Thus, at least for heavy exercise the data suggest that enhanced O2 
delivery contributed along with greater metabolic activation (Tschakovsky & 
Hughson, 1999) to accelerate 2OV






Prolonged ischemia impairs blood flow and muscle oxygen uptake 
Dynamics during subsequent heavy exercise 
This chapter is the basis for the published paper:  
Faisal A, Dyson KS and Hughson RL. Prolonged ischemia impairs muscle blood 
flow and oxygen uptake dynamics during subsequent heavy exercise. J Physiol.588. 






















 Muscle oxygen uptake dynamics at the onset of exercise can be affected by 
prior heavy exercise. We tested the hypothesis that elevated FBF following prior 
circulatory occlusion would also be associated with accelerated mus2OV
 dynamics 
during subsequent heavy hand-grip exercise. Ten trained young men performed 5 
minutes of heavy hand-grip exercise at 30% MVC as a control [CON], and 4 
additional heavy bouts after brief recovery from: I) prior heavy exercise [Heavy A], 
II) heavy exercise followed by 2 minutes occlusion [Heavy B], III) 15 minutes 
occlusion [Heavy C], and IV) 5 minutes occlusion with1 minute of moderate 
exercise during occlusion [Heavy D]. FBF was measured by ultrasound and arterial 
venous oxygen content difference was calculated from venous blood samples to 
estimate mus2OV
 . FBF and mus2OV
 dynamics were quantified from the rise time. All 
priming conditions elevated FBF immediately before the start of subsequent heavy 
bout (Heavy A: 207.4 ± 92.8, B: 207.8 ± 75.8, C: 135.8 ± 59.2, D: 199.5 ± 59.0 vs. 
CON: 57.4 ± 16.6 ml min-1, P < 0.01). Unexpectedly, prior occlusion reduced FBF 
and O2 extraction at the onset of subsequent heavy exercise and consequently 
slowed mus2OV
 dynamics (Heavy C: rise time = 95.9 ± 28.9 vs. CON: 58.6 ± 14.3 s, P 
< 0.01). FBF and mus2OV
 dynamics were faster in Heavy A, B and D compared to 
CON (P < 0.05). Overall, there was a positive correlation between the rise times for 
mus2OV
 and FBF (r2 = 0.75) indicating that mus2OV
 dynamics during heavy forearm 
exercise are linked to O2 delivery in trained young men. To investigate a possible 
mechanism for slower adaptation of mus2OV
 following ischemia, the prior occlusion 
condition was repeated after ingesting a high dose of ibuprofen. This resulted in 
restoration of the FBF and mus2OV




mediated mechanism after occlusion retarded the adaptation of blood flow and O2 


























 During transitions of exercise to higher power output, faster activation of the 
aerobic energy supply system will result in a smaller O2 deficit and reduced 
homeostatic disturbance. Prior heavy exercise is an experimental paradigm that 
accelerates 2OV
 kinetics at the onset of subsequent exercise, potentially through 
several mechanisms that affect both O2 transport and utilization. These 
mechanisms include increased oxidative enzyme activity and elevated 
mitochondrial substrate availability (Gurd et al., 2006), increased muscle blood 
flow and right-shifting of the oxygen hemoglobin (HbO2) dissociation curve (Gerbino 
et al., 1996; MacDonald et al., 1997) and improved distribution of O2 delivery to O2 
requirement within the exercising muscle (DeLorey et al., 2007; Fukuba et al., 
2002). 
 Post circulatory occlusion is an alternative experimental model that could 
elevate muscle blood flow for several minutes prior to subsequent exercise bout 
(Carlsson et al., 1987). However, the changes in the metabolic environment during 
occlusion are much less pronounced than during prior heavy forearm exercise 
(Mole et al., 1985). Few studies have used the prior occlusion model to examine the 
factors that affect pulmonary 2OV

 kinetics during a subsequent exercise transition 
(Paganelli et al., 1989; Walsh et al., 2002), while no study has looked at blood flow 
and mus2OV
 responses at the onset of exercise that followed circulatory occlusion. 
Paganelli et al. (1989) reported that prior 5-10 min of forearm occlusion or 3 min of 
occlusion with moderate exercise reduced the half-time of pulmonary 2OV
 on-
response kinetics during subsequent heavy arm-cranking exercise by 15 and 50%, 




accelerated the overall pulmonary 2OV
 kinetics during subsequent heavy cycling 
exercise with no effects on the distinct primary phase kinetics (Walsh et al., 2002). 
But, in this latter study the circulatory occlusion was terminated within 5 s prior 
to the onset of the criterion exercise and the potential replenishment of O2 stores 
on the 2OV
 response and its impact on kinetics was not considered.  
 It has been shown previously that prior heavy exercise elevated FBF and 
mus2OV
 at the onset of subsequent heavy dynamic forearm exercise (MacDonald et 
al., 2001b), and that the kinetics of both leg blood flow and mus2OV
 were accelerated 
in the second of two heavy knee-extension exercise bouts (Fukuba et al., 2007). 
The purpose of the current study was to determine whether prior occlusion, with or 
without exercise, followed by brief recovery had similar effects as prior exercise on 
FBF and mus2OV

 kinetics during subsequent heavy forearm exercise in fit young 
men. We tested the hypothesis that all priming conditions (heavy exercise, heavy 
exercise followed immediately by occlusion, occlusion alone and occlusion with 
moderate exercise) would enhance FBF and mus2OV
 dynamics during the adaptive 
phase of subsequent heavy forearm hand-grip exercise. 
3.3 Methods 
 Twenty four men who regularly exercised their forearm muscles were 
recruited for this study. The participants were divided into three groups: group A 
(10 varsity hockey players, age: 23.0 ± 1.4 years; height: 180.5 ± 7.1 cm, weight: 
85.1 ± 8.5 kg, maximal voluntary isometric contraction strength [MVC]: 54.0 ± 6.2 
kg), group B (8 varsity athletes, age: 24.6 ± 3.6 years; height: 186.1 ± 8.9 cm, 




24.3 ± 2.7 years; height: 179.5 ± 7.9 cm, weight: 82.5 ± 12.0 kg, MVC: 47.0 ± 3.6 
kg). One subject participated in both group A and B, and another subject 
participated in both group B and C. MVC was determined from the best of three 
attempts taken in the supine position. The study was approved by the Office of 
Research Ethics at the University of Waterloo, and all subjects provided written, 
informed consent following full description of the protocols. 
3.3.1 Experimental design 
 Group A reported to the laboratory on 4 non-consecutive days to perform 
the different exercise protocols (Fig.3.1). The protocols were designed to test the 
effect of the prior exercise, occlusion, or exercise and occlusion on FBF, (a-v)DO2 
and mus2OV

 responses during subsequent heavy rhythmic hand-grip exercise. 
Protocol A consisted of 2 heavy hand-grip exercise bouts separated by 6 minutes of 
passive recovery. Protocol B consisted of a bout of heavy hand-grip exercise 
immediately followed by 2 minutes of forearm circulatory occlusion, 6 minutes of 
recovery then another bout of heavy hand-grip exercise.  Protocol C consisted of a 
15 minutes period of forearm circulatory occlusion followed by 3 minutes of 
recovery then a bout of heavy hand-grip exercise.  Protocol D consisted of a 5 
minutes period of forearm circulatory occlusion that included one minute of 
moderate (15% MVC, 7.6 ± 1.0 kg) dynamic hand-grip exercise followed by 3 
minutes of recovery then a bout of heavy hand-grip exercise. The protocols were 
applied in a supine position using the dominant arm extended at the heart level. 
The first heavy bout in protocol A served as a control (CON) and the testing heavy 




 Group B completed a control heavy exercise trial (the first bout in protocol 
A), and 2 trials of the prior 15 minutes occlusion protocol (protocol C) on 3 non-
consecutive days. One of the prior occlusion trials was performed after ingesting 
800 mg of ibuprofen (IB) (2 doses of 400 mg, one 3 hours prior, and one 1 hour 
prior to the start of the protocol), while the other was performed after a placebo 
(PL)(same capsule as ibuprofen, filled with sodium bicarbonate). 
 Group C completed protocol A, and 2 trials of protocol C on 3 non-
consecutive days. The 2 occlusion trials (protocol C) were performed after ingesting 
ibuprofen and placebo exactly as described above in group B. All groups visited the 
laboratory for a familiarization session before the start of the real study. 
All the rhythmic hand-grip exercise bouts lasted for 5 minutes at ≈ 30% MVC 
(group A: 13.7 ± 1.7 kg, group B: 12.5 ± 1.1 kg, group C: 11.8 ± 1.0 kg). The 
participants were required to raise the weight for 0.5 s and lower it for 0.5 s 
through a distance of 5 cm with a 1 s pause before the next contraction. 
 The protocols were assigned in randomized order and the sessions were 
separated by at least 48 hours. Testing was performed at least 24 h following the 
participants’ last exercise regimen and 72 h following an intense strength training 
session. The participants arrived in the laboratory in a rested state at least 2 h 
after eating and they were asked to abstain from caffeine 12 h and alcohol 24 h 
before testing. The participants were rested in supine position for 30 minutes 
before initiation of the protocols. The tests were completed in a quiet, air-





Figure 3.1: Prior exercise and occlusion testing protocols.  
Four different testing protocols employed to examine the influence of (A) prior 
heavy exercise, ( B)  prior heavy exercise followed by 2 min occlusion, (C) 15 min of 
occlusion and (D) 5 min of occlusion including 1 min of moderate exercise on 
mus2OV
 and FBF responses during a subsequent heavy exercise bout. The specific 
heavy bouts are named based on the testing protocol, Heavy A, Heavy B, Heavy C, 






3.3.2 Forearm circulatory occlusion  
 In the occlusion protocols, brachial artery blood flow was arrested by rapid 
inflation (E-20 Rapid Cuff Inflator, D. E. Hokanson, Issaquah, USA) of a standard 
BP cuff to ~ 250 mmHg. The occlusion cuff was placed just distal to the elbow. The 
occlusion period was terminated by rapid deflation of the occlusion cuff.  
3.3.3 Data acquisition  
 Brachial artery MBV, BP and HR were measured beat by beat. Brachial 
artery MBV responses were determined by pulsed- Doppler ultrasound (500V, 
Multigon Industries, Yonkers, N.Y.). A 4-MHz Doppler probe was fastened above 
the brachial artery proximal to the cubital fossa with strips of surgical tape. The 
signal was directed 45° relative to the skin and the ultrasound gate was adjusted to 
encompass the total width of the artery. MBV, BP measured by 
photoplethysmograph finger blood pressure cuff in the non-exercising hand 
(Finometer, Finapres Medical System, Arnhem, the Netherlands) and 
electrocardiogram (Pilot 9200, Colin Medical Instruments, San Antonio, TX) were 
sampled at 1 kHz (PowerLab, AD Instruments, Colorado Springs, CO). The brachial 
artery was imaged continuously approximately 5 cm proximal to the 4 MHz probe 
during rest and exercise using a linear 7.5-MHz probe (Micromaxx, Sonosite, 
Seattle, WA) operating in M mode. The imaged data were stored on videotape then 
digitized and vessel diameters were measured by custom edge-detection software.  
Venous blood sampling 
A catheter was inserted in an antecubital vein in a retrograde fashion 
(Mottram, 1955) to maximize collection of blood from deep veins draining the finger 
flexor muscles.  Blood samples (1 ml) were drawn in heparinized syringes at 




second minute to end exercise). The samples were immediately put in an ice bath 
and analyzed by CO-oximeter (Stat Profile pHOx, Nova Biomedical, Waltham, MA) 
for O2 saturation and hemoglobin content from which O2 content was calculated. 
The CO-oximeter was calibrated at regular intervals during the analyses. Blood 
samples (3 ml) were drawn in non- heparinized syringes at rest and during the last 
30 s of each exercise and recovery period for immediate lactate [La-] analysis 
(Lactate Pro, Hurstville, Australia).  
Skin blood flow 
Relative forearm SBF was estimated continuously by a laser Doppler probe 
(MoorLAB, Moor Instruments Ltd, Devon, UK) placed 5cm distal to the occlusion 
cuff , on the volar aspect of the exercising forearm. SBF was measured only in 
group C. Baseline SBF was measured for at least 5 minutes before the actual start of the 
protocols.  SBF data were represented as a percentage of baselines. 
3.3.4 Data analysis 
 FBF was calculated from brachial artery MBV and cross sectional area as 
FBF = MBV × πr2, where r is the vessel radius. MBV was calculated beat by beat at 
rest and was averaged over the contraction to contraction cycle (duty cycle ~ 2 s) 
during exercise (Fig. 3.2). Brachial artery diameters were obtained by automated 
edge detection software from M-mode images, averaged over 3 full cardiac cycles 
matching the time points of blood sampling. Exercise FBF values were then 
calculated from the brachial artery diameter and the average MBV over 3 
contraction/relaxation cycles (~ 6 s window) centered on the time points of blood 
withdrawal. Forearm mus2OV
 was determined from the quantitative estimates of FBF 
and (a-v)DO2 using the Fick equation, mus2OV




calculated based on the assumption that arterial hemoglobin was equivalent to 
that of the venous sample and arterial O2 saturation remained constant at 97%, as 
shown by pulse oximetry (Hampson & Piantadosi, 1988) and blood gas analyzer 
(Wilkins et al., 2008). Intracellular partial pressure of oxygen (PaO2) was estimated 
at 90 mmHg based on the HbO2 dissociation curve with estimated arterial O2 
content (mlO2 l-1 blood) = (1.38 [hemoglobin (g/l)] × O2 saturation) + 0.0031 × PaO2 
(mmHg) (Nordmeyer et al., 2007). (A-v)DO2 was calculated by subtracting the 
measured venous O2 content from estimated arterial O2 content (Hughson et al., 
1996; MacDonald et al., 2001b; van Beekvelt et al., 2001). Measures taken to 
represent the value at the start of exercise were obtained during the 15 s 
immediately prior to exercise onset. 
 In addition to the comparison between the absolute values for and 
FBF at the time points of blood sampling through the exercise bouts, we 
characterized and FBF kinetics responses during exercise transitions. To 
estimate the kinetics, the areas under the curves (AUC) of and FBF were 
calculated using the first order hold method. and FBF kinetics were 
quantified from the rise time () based on the calculation of AUC and the given 
amplitude assuming a first order linear dynamic system. The rise time for 
and FBF were estimated from the following equation  
   AUC(Y) = A [(tf  - ts) + τ (e- ( tf / τ) - e- ( ts / τ))] 
where, AUC(Y) is the numerical value calculated from the first order hold method 
for the and FBF curves, A is the end exercise amplitude, tf  is the final time 


















FBF. For , values were obtained at the blood sampling points, with ts = 0. 
FBF values were the 6 s windows as described above, and kinetics were calculated 
starting from ts = 12 s of exercise to eliminate the impact of the rapid increase in 
blood flow due to mechanical factors during the first seconds of exercise onset 
(Shoemaker et al., 1998). 
3.3.5 Statistical analysis 
 A two-way ANOVA with repeated measures was used to determine 
significant differences over all the heavy bouts across the time points of blood 
sampling. When significant effects were observed, the contrast adjusted test was 
used for comparisons. A one-way ANOVA with repeated measures was used to 
define significant differences in the rise times for and FBF, baseline and 
end exercise [La-] across the heavy bouts. When significant effects were observed, 
the Tukey post hoc test was used for comparisons. Regression analyses compared 
FBF and kinetics to each other. All data are expressed as means ± SD and a 
probability of P < 0.05 was accepted as statistically significant. The data were 















Figure 3.2: Representative tracing of MBV and SBF during resting and reactive 
hyperemia (A) and heavy dynamic handgrip exercise (B). 
During resting the MBV and SBF were averaged beat to beat synchronized with the 
ECG signal. During exercise MBV was averaged over the duty cycle (contraction to 
contraction). Beat to beat averages during exercise would not be representative of 
the true MBV, as the duty cycles were not synchronized to the ECG. SBF was 





3.4.1 Group A 
 There were no differences in any physiological variable between the first 
heavy bout in protocol A and the first heavy bout in protocol B across all the time 
points (P ranged from 0.08 to 0.96); therefore we chose the first heavy bout in 
protocol A to serve as a control condition to the heavy testing bouts (Heavy A-D). 
Across the 4 testing days there were no significant differences at baseline values of 
any testing variable (Table 3.1).  
Forearm Blood Flow 
 All priming conditions (exercise, exercise followed by occlusion, occlusion, 
occlusion with exercise) resulted in a significantly higher FBF at the start of 
subsequent testing bouts (Heavy A, B, C, D) compared to Con (Heavy A: 207.4 ± 
92.8, B: 207.8 ± 75.8, C: 135.8 ± 59.2, D: 199.5 ± 59.0 vs. Con: 57.4 ± 16.6 
ml/min, P < 0.01 for all). FBF was significantly higher at the start of Heavy A, B 
and D compared to Heavy C (P < 0.01 for all). During heavy exercise bouts, FBF 
progressively increased to steady state. There was significantly higher FBF through 
the first 2 min of exercise in Heavy A, B and D compared to CON and Heavy C (Fig. 
3.3). By the end of exercise there were no significant differences between all bouts 
(Con: 404.6 ± 104.9, A: 445.1 ± 122.2, B: 416.2 ± 142.8, C: 410.7 ± 109.7, D: 
435.0 ± 109.5 ml/min, P > 0.05). FBF kinetics were faster in Heavy A, B, and D 
compared to CON as shown by a shorter rise time ()(Heavy A: 47.6 ± 14.2, B: 39.6 
± 18.4, D: 50.4 ± 15.8 vs. Con: 65.6 ± 13.0 s, P < 0.05). Prior occlusion resulted in 






Arterial-venous oxygen content difference 
 Each of the prior conditions elicited a significantly lower (a-v)DO2 at the 
start of subsequent heavy exercise bouts compared to Con (Heavy A: 31.5 ± 10.5, 
B: 37.7 ± 22.3, C: 13.8 ± 7.1, D: 31.2 ± 7.2 vs. Con: 57.2 ± 15.1 mlO2/l blood, P < 
0.01 for all). With the initiation of exercise, (a-v)DO2 increased rapidly and by 30s 
there were no differences between Heavy A, B and D and Con. Only prior occlusion 
resulted in a lower (a-v)DO2 through the first 90 s of exercise in Heavy C compared 
to Con (Fig. 3.4). There was an overshoot response in (a-v)DO2 during CON and 
Heavy A bouts with a significantly greater value at 90s than end exercise (P = 0.05). 
This overshoot response was not present following the prior conditions that 
included occlusion.  
Muscle oxygen uptake 
 Immediately prior to the start of exercise mus2OV
 tended to be greater in the 
conditions that included prior exercise but individual variability precluded 
significance (Con: 3.3 ± 1.3, A: 6.1 ± 2.1, B: 7.5 ± 4.8, C: 2.0 ± 1.4, D: 6.3 ± 2.6 
ml/min, P range: 0.16 - 0.66). Within the first minutes of exercise, mus2OV
 was 
higher in Heavy A and Heavy B compared to Con, however prior occlusion 
depressed the mus2OV
 response in Heavy C (Fig.3.5). By the end of exercise, mus2OV

was not different between Heavy B, Heavy C and Heavy D and Con. However, 
Heavy A was slightly higher than Con and Heavy C (P = 0.04). Prior heavy exercise 
or occlusion plus exercise resulted in faster rise time for mus2OV
  in Heavy A, B and 
D compared to Con (Heavy A: 41.6 ± 11.5, B: 40.7 ± 10.5, D: 43.6 ± 13.4 s vs. Con: 
58.6 ± 14.3 s, P < 0.05). Prior occlusion resulted in a slower mus2OV
 kinetics in 




all the heavy bouts (Con, Heavy A, B, C, D), there was a positive correlation 
between the rise time of FBF and mus2OV
  (Fig.3.6; r2 = 0.75, P < 0.001).  
Mean arterial pressure (MAP) 
 The extent of MAP elevation at the start of exercise was dependent on the 
priming condition. In Heavy A, 6 min resting was able to recover MAP to prior Con 
level (Con: 88.9 ± 5.8 vs. Heavy A: 91.2 ± 4.8 mmHg, P > 0.05). With ischemic 
loading during the priming condition, MAP was elevated at the start of subsequent 
heavy exercise compared to Con (Heavy B: 99.3 ± 6.2, C 100.8 ± 8.3, D: 101.0 ± 
13.8 mmHg, P < 0.01 for all compared to Con). Throughout all testing bouts (Heavy 
A-D) MAP was significantly higher than Con; by the end of exercise MAP was 
(Heavy A: 119.7 ± 12.9, B: 124.7 ± 8.6, C: 123.5 ± 9.7, D: 126.9 ± 10.2 vs. Con: 
112.5 ± 11.1 mmHg, P < 0.01 for all) (Fig.3.7). 
Lactate 
 The baseline [La-] immediately prior to exercise was higher in the heavy 
exercise bouts Heavy A: 3.0 ± 1.0, Heavy B: 3.6 ± 0.7 and Heavy D: 3.4 ± 0.9 than 
CON: 1.3 ± 0.4 and Heavy C: 1.5 ± 0.3 mmol/l; P < 0.01 for all. At the end of 
exercise, there were no significant differences between all the heavy bouts (Con: 4.4 










Table 3.1: Baselines values in the four testing days 
Parameters 
 
Heavy A Heavy B Heavy C Heavy D P  Values 
HR, bpm 
 
61.4 ± 3.7 65.4 ± 9.2 60.5 ± 9.2 61.9 ± 8.1 0.10 – 0.86 
MAP, mmHg 89.1 ± 5.6 91.1 ± 6.1 93.0 ± 6.6 92.0 ± 7.0 0.09 – 0.65 
mus2OV
 , ml/min 3.2 ± 1.3 3.1 ± 1.8 3.0 ± 0.9 3.1 ± 1.4 0.70 – 0.96 
FBF, ml/min 57.4  ± 16.6 48.1 ± 18.3 50.3 ± 17.4 47.8 ± 21.3 0.11 – 0.96  
(A-v)DO2, ml/l 56.4 ± 15.6 62.8 ± 18.3 61.6 ± 11.3 65.3 ± 13.5 0.16 – 0.84 
[La-], m.mol/l 1.3 ± 0.4 1.3 ± 0.3 1.2 ± 0.4 1.3 ± 0.4 0.36 – 1.00 
 
Mean ± SD, n = 10 












Figure 3.3: FBF responses during exercise in the four Heavy bouts (Heavy A-D) 
compared to the Control.  
All priming conditions resulted in higher FBF at the start of subsequent heavy 
exercise (bouts Heavy A-D) compared to Con, however by the end of exercise there 
were no differences. During exercise, Heavy A, B, and D all showed higher FBF 
compared to the Con.  Data points are the average responses of 10 subjects. 





Figure 3.4: (A-v)DO2 responses during exercise in the four Heavy bouts (A-D) 
compared to the Control.  
All priming conditions resulted in lower (a-v)DO2 at the start of the subsequent 
heavy exercise (bouts Heavy A-D) compared to the Con.  By 45 s of exercise there 
were no significant differences in (a-v)DO2 between Con and Heavy A, B, and D.  
However (a-v)DO2 was lower up to 90 s of exercise in Heavy C compared to Con. 
There was an overshoot of (a-v)DO2 at 90 s of exercise in Con and Heavy A 
compared to end exercise. Data points are the average responses of 10 subjects. 






 responses during exercise in the four Heavy bouts (A-D) 
compared to the Control.   
At the start of exercise, mus2OV
  in all conditions was not different compared to the 
Con. mus2OV
 in Heavy A was significantly higher than Con from the 1st  minute 
through the end of exercise. mus2OV
 in Heavy B was significantly higher during 
exercise onset (from 30 s through 2 minutes). mus2OV
 in Heavy C was depressed 
during exercise onset, but reached the same level as Con by the 4th minute of 
exercise. Heavy D was not different from the Con condition.  Data points are the 





Figure 3.6: Rise time correlation for
 mus2
OV and FBF. 
Across all conditions, the rise time () for mus2OV
 was significantly correlated to the 
rise time ( for FBF ( mus2OV











Figure 3.7: MAP responses during exercise in the four Heavy bouts (A-D) 
compared to the Control. 
 MAP was significantly higher in all Heavy conditions, both prior to and throughout 
exercise, except for the baseline of Heavy A. Data points are the average responses 






3.4.2 Group B 
Post occlusion responses with ibuprofen and placebo 
 Following 15 min of occlusion, ibuprofen resulted in a significantly higher 
FBF between 30 and 60s of hyperemia compared to placebo (Fig.3.8 A). At 30 and 
60 s, FBF with IB were 621.34 ± 169.55, 539.58 ± 157.07 vs. PL 545.04 ± 178.26, 
440.77 ± 160.38 ml/min, respectively, P < 0.05).  No differences were seen between 
the effect of IB and PL on (a-v)DO2 during post occlusion period. Although there 
were significant differences in FBF between the 30 and 60 s, the slightly lower     
(a-v)DO2 in IB at these time points negate the ability to detect any significant 
differences in mus2OV
 (Fig. 3.8 B and C). The effect of IB on MAP was maintained 
lower following release of the occlusion cuff. MAP was significantly lower at all time 
points of hyperemia compared to PL (Fig.3.9 A). After cuff release MAP with IB was 
91.86 ± 4.18 vs. PL 97.49 ± 4.64 mmHg, P < 0.05. By 3 min of hyperemia, MAP 
with IB was 93.88 ± 3.49 vs. 99.83 ± 5.32 mmHg, P < 0.05. As a result of higher 
FBF and lower MAP with ibuprofen, FVC was significantly elevated from cuff 
release through to 90s of the reactive hyperemia with IB (Fig.3.9 B). At 0 and 90 s 
of hyperemia, FVC with ibuprofen were 6.07 ± 1.36, 3.96 ± 1.12 vs. placebo 5.09 ± 
1.21, 3.03 ± 1.07 ml/min/mmHg, respectively, P < 0.05). Over the 3 min of reactive 
hyperemia, there were a significantly greater FBF and FVC areas with IB compared 
to PL (FBF: 1160.58 ± 289.69 vs. 998.55 ± 284.66 ml/min; FVC: 12.71 ± 3.18 vs. 
10.49 ± 3.23 ml/min/mmHg, P < 0.05) but no changes in mus2OV






Figure 3.8: FBF (A), (a-v)DO2 (B) and mus2OV
 (C) responses during the reactive 
hyperemia in placebo and ibuprofen trials.  
FBF was significantly higher from 30 s to 60 s in ibuprofen trial compared to 
placebo, but there were no differences between ibuprofen and placebo trials in     
(a-v)DO2 or mus2OV
 throughout the 3 min that followed prior occlusion. Data points 





Figure 3.9: MAP (A) and FVC (B) responses during the reactive hyperemia in 
placebo and ibuprofen trials.  
MAP was significantly higher throughout the 3 min of recovery following occlusion 
in the placebo trial compared to ibuprofen trial. FVC was significantly higher 
within the first 90 s following occlusion in the ibuprofen trial than placebo. Data 





 Priming occlusion with IB or PL resulted in a significantly higher FBF at the 
start of subsequent heavy exercise bouts compared to Control (IB: 134.05 ± 39.03, 
PL: 143.17 ± 39.82 vs. Control: 54.82 ± 11.31 ml/min, P < 0.01 for both) (Fig.3.10 
A). During exercise, FBF response in Control was in between the IB and PL curves 
and was not different from either of them. However, FBF with IB was significantly 
higher through 1 to 3 min of exercise compared to PL. At 1 and 3 min of exercise, 
FBF with IB were 378.96 ± 96.84, 479.70 ± 103.60 vs. PL 312.16 ± 88.46, 425.82 ± 
98.36 ml/min, P < 0.05.  
 Priming occlusion with IB or PL elicited a significantly lower (a-v)DO2 
compared to control at the start of exercise ( IB: 15.04 ± 6.48, PL: 17.01 ± 6.21.vs. 
Con: 51.30 ± 10.39 mlO2/l blood, P < 0.01) as well through the first 3 min of 
subsequent heavy exercise bouts (at 3 min; IB: 105.38 ± 6.87, PL 106.24 ± 8.19 vs. 
Control: 115.98 ± 5.14 mlO2/l blood, P < 0.01 for all points) (Fig.3.10 B). There 
were no differences between IB and PL at any time point. There was an overshoot 
response in (a-v)DO2  during the Control bout with a significant difference between 
90s and end exercise (P = 0.05). This overshoot response was not present following 
occlusion.  
 mus2OV
 was calculated from FBF and (a-v)DO2 . Only prior occlusion with PL 
resulted in a depressed mus2OV

 from 15s through 3 min of exercise compared to 





Figure 3.10: FBF (A), (a-v)DO2 (B) and mus2OV
 (C) responses during exercise in 
placebo and ibuprofen trials compared to control. 
 Prior occlusion with or without ibuprofen resulted in higher FBF and lower (a-
v)DO2 at the start of the subsequent heavy exercise (Placebo and Ibuprofen) 
compared to Control. During exercise in the placebo condition FBF, (a-v)DO2 and 
mus2OV
 responses were lower than Control up to 3 min, while with ibuprofen        
(a-v)DO2 was lower than control through the first 3 min with no differences in 
mus2OV
 . Data points are the average responses of 8 subjects. (Means ± SE) * P 




 At 15 s and 3 min of exercise, 
mus2OV
 following occlusion with PL was    
10.80 ± 5.49, 45.58 ± 12.54 vs. Con: 17.31 ± 5.69, 53.77 ± 12.67 ml/min, 
respectively, P < 0.05). There were no differences between the 3 conditions in FBF, 
(a-v)DO2 and mus2OV
 by the end of exercise. 
 MAP was significantly higher following the occlusion with PL compared to 
CON and occlusion with IB at the start of exercise ( PL: 99.89 ± 5.17 vs. Con: 93.08 
± 8.44; IB: 94.14 ± 3.51, P < 0.05) . The changes over the course of exercise were 
similar between the 3 conditions; MAP with occlusion and PL was maintained at an 
elevated level compared to CON and IB at all the time points (Fig.3.11 A). FVC was 
calculated from FBF and MAP. FVC was lower through the exercise in PL compared 






Figure 3.11: MAP (A) and FVC (B) responses during exercise in placebo and 
ibuprofen trials compared to control.  
Prior occlusion without ibuprofen resulted in higher MAP and lower FVC 
throughout subsequent heavy exercise (Placebo) compared to Control and 
Ibuprofen. Data points are the average responses of 8 subjects. (Means ± SE) * P 




3.4.3 Group C 
 There were no differences between the baseline SBF across the three testing days 
(Protocol A: 0.21± 0.11, Ibuprofen: 0.26 ± 0.11, Placebo: 0.27 ± 0.16 AU, P > 0.05). 
Relative SBF was slightly greater in placebo compared to ibuprofen in both reactive 
hyperemia and during the exercise; this was in contrast to the total blood flow response 
during exercise seen with groups B. Prior occlusion elevated SBF in placebo with peak 
values of 6.5 fold vs. 5.5 in ibuprofen (P = 0.22), that decreased in placebo to approximately 
3.5 fold vs. 2.5 fold in ibuprofen (P = 0.04) at the onset of subsequent exercise (Fig. 3.12). 
With the onset of exercise, SBF increased slightly to higher level in placebo (5 folds) 
compared to control, Heavy A and Ibuprofen (4, 3.5 and 3.5 folds, respectively; P > 0.05 for 
all, Fig. 3.12). 
 
Figure 3.12: SBF responses during reactive hyperemia (RH), exercise and recovery 





 Our results provided a unique observation that the mus2OV
 response at the 
onset of heavy forearm exercise was depressed when exercise began 3 minutes 
after 15 minutes of forearm circulatory occlusion even though FBF was elevated at 
the start of exercise. The slower mus2OV
 kinetics response in Heavy C was due to no 
improvement in FBF above the control condition once exercise commenced and 
smaller (a-v)DO2. These differences were even more pronounced when contrasted 
with protocols that included prior exercise with or without additional circulatory 
occlusion, where FBF and mus2OV
 kinetics were faster than control. Thus, our 
hypothesis that FBF and mus2OV
 kinetics would be enhanced in a heavy bout of 
forearm hand-grip exercise that followed heavy exercise and/or occlusion was only 
partially supported. All priming conditions achieved elevated FBF immediately 
before the start of the subsequent heavy exercise bouts, but FBF and mus2OV

kinetics were enhanced only when the prior conditions included exercise. Our 
results contrast with other research that measured pulmonary 2OV
 during exercise 
that followed circulatory occlusion (Paganelli et al., 1989; Walsh et al., 2002). 
Overall though, our results demonstrated a strong linear relationship between the 
delivery of O2 as reflected by the kinetics of FBF and the rate of increase in 
oxidative metabolism reflected by the kinetics of mus2OV
 at the onset of heavy 
forearm exercise. 
3.5.1 Methodological considerations 
 The primary objective of the current research was complement previous 




muscle blood flow prior to the onset of exercise. We selected 15 minutes prior 
circulatory occlusion with 3 minutes recovery period to achieve a relatively stable, 
elevated FBF similar to that shown with studies of prior exercise (Fukuba et al., 
2007; MacDonald et al., 2001b). Shorter periods of occlusion caused the hyperemia 
to decline more rapidly toward baseline (Carlsson et al., 1987). Previous research 
that examined muscle oxygenation and/or PCr concentrations during various 
combinations of occlusion and exercise provides information on the probable 
metabolic state of the muscle at the onset of exercise in our occlusion only 
protocol. During occlusion of the resting forearm muscle, O2 stores were depleted 
within 5-6 minutes (Blei et al., 1993; Boushel et al., 1998) then increased above 
the resting state within 1 minute of reactive hyperemia, and returned to baseline 
level 3 minutes after cuff release (Hampson & Piantadosi, 1988). Muscle phosphate 
to PCr ratio was only slightly changed after 10 minutes occlusion and recovered to 
baseline within 2 minutes (Boushel et al., 1998). PCr concentration was depleted 
less than 15% by 15 minutes of occlusion and, based on the measured time 
constant, would be expected to be within 5% of baseline with 3 minutes of recovery 
(Blei et al., 1993). The rather modest changes in PCr after occlusion contrast for 
example with the 46% reduction with 3 minutes of repeated hand-grip contractions 
with intact circulation (Mole et al., 1985). From these data we expect muscle O2 
stores to be no lower than baseline and PCr stores, as an indication of enzyme 
activity, within 5% of baseline. These conditions would allow us to achieve our 
objective of a high flow state with minimal metabolic disturbance at the onset of 
the heavy forearm exercise in protocol Heavy C.   
The model of prior 5 minutes heavy exercise with 6 minutes recovery (Heavy A) is 




influence both blood flow and metabolic state (Gurd et al., 2006; MacDonald et al., 
2001b; Rossiter et al., 2001).  
 In Heavy B protocol, the priming heavy exercise bout was followed 
immediately by 2 minutes of circulatory occlusion to determine if the occlusion 
period modified the response to prior heavy exercise. The protocol of Heavy D 
incorporated the prior moderate exercise within the period of circulatory occlusion. 
It has been demonstrated that rapid depletion of PCr occurred when exercise was 
performed within occlusion and that recovery did not occur until circulation was 
restored (Blei et al., 1993). Performing 1 minute of moderate exercise during the 5 
minutes occlusion would be expected to elevate FBF through the 3 minutes after 
release of occlusion while inducing a relatively mild change in the metabolic 
environment that would have partially recovered by the start of the heavy exercise. 
 The kinetic response characteristics in the current study were quantified by 
calculation of the rise time () from the transient responses of FBF and mus2OV
 . This 
calculation was based on the property of a linear first order system in which the 
time constant can be determined from the rate of increase of a variable toward the 
plateau value (Barstow & Mole, 1991). When calculated in this way the rise time is 
equivalent to the mean response time reported in other studies (Hughson et al., 
1996; MacDonald et al., 1997) and includes the possibility of the appearance of a 
“slow component” with heavier exercise. A precise kinetics with multi-component 
exponential modeling is not possible in studies such as this without a marked 
increase in blood sampling frequency. Therefore, the rise time provides an estimate 
of the overall kinetics response and permits comparisons between FBF and mus2OV




 Brachial artery blood velocity and diameter were measured with the 
occlusion cuff placed distal to the elbow to avoid the potential influence of ischemia 
(Ramsey et al., 1996) or myogenic dilation (Folkow, 1949) on arterial diameter. 
Proximal cuff placement has been shown to induce greater brachial diameter 
dilation than distal occlusion (Agewall et al., 2001; Betik et al., 2004; Guthikonda 
et al., 2007). Further, distal occlusion provides a more accurate assessment of 
endothelial function compared to proximal occlusion (Guthikonda et al., 2007; 
Peretz et al., 2007). 
3.5.2 Prior heavy exercise  
 The finding of faster FBF and mus2OV
  kinetics in Heavy A than Con condition  
( group A) confirms previous research with both hand-grip (MacDonald et al., 
2001b) and knee-extension (Fukuba et al., 2007; Hughson et al., 2003; Krustrup et 
al., 2001) exercise. However, some studies of knee-extension exercise have shown 
faster pulmonary 2OV

 kinetics without a change in leg blood flow kinetics (Endo et 
al., 2005; Fukuba et al., 2004; Koga et al., 2005). A combination of several 
interacting mechanisms was likely responsible for the observed higher FBF and
mus2OV
 in Heavy A and Heavy B protocols (Figs. 3.3 and 3.5). Ferreira et al. (2005a) 
have shown a tight coupling between the kinetics of capillary blood flow estimated 
from near-infrared spectroscopy (NIRS) and mus2OV
 during both moderate and heavy 
cycling exercise.    
 Improved O2 delivery might have been achieved by accumulation of 
vasoactive metabolites from previous warm-up that enhances vasodilation 
increasing blood flow to exercising muscles and possibly promoting a right shift of 




Prior warm-up exercise might reduce or abolish regional heterogeneities in muscle 
microvascular perfusion optimizing the match between O2 delivery to O2 utilization 
(DeLorey et al., 2007; Fukuba et al., 2002). Greater O2 delivery can improves the 
oxidative phosphorylation contribution to energy production, while reducing the O2 
deficit and cellular homeostasis disturbance. The proposed mechanism involves an 
increase in the intracellular PO2 (Hughson et al., 2001; Tschakovsky & Hughson, 
1999) and a subsequent reduction in PCr degradation and substrate level 
phosphorylation (Rossiter et al., 2001).  
 The (a-v)DO2 was significantly smaller at the start of exercise and at the first 
15 s sample point in Heavy A and Heavy B than the Con condition, while there 
were no differences in (a-v)DO2 after this time point. These results are in contrast 
to the findings of higher O2 extraction during the second heavy bout of hand-grip 
(MacDonald et al., 2001b) or leg extension (Krustrup et al., 2001) exercise.  The 
discrepancy may be due to the differences in subject characteristics.  The present 
study examined highly trained varsity athletes who likely have higher O2 extraction 
fraction during exercise (Kalliokoski et al., 2001) that might not be further 
enhanced  by a prior warm-up. Further, it has been reported that enhanced PDHa 
activity by prior heavy exercise can affect O2 extraction during moderate (Gurd et 
al., 2006) but not heavy (Bangsbo et al., 2002) exercise. Thus, the faster mus2OV
  
kinetics in the prior heavy exercise conditions was attributable to the faster 
increase in FBF that facilitated greater O2 delivery to the exercising forearm 
muscles. The patterns of FBF, (a-v)DO2 and mus2OV
  responses were similar in 
Heavy A and Heavy B bouts, with the small exception that the mus2OV
 was 




3.5.3 Prior ischemia  
 Previous research that employed circulatory occlusion prior to the start of 
exercise suggested that pulmonary 2OV
  kinetics were faster after the occlusion 
(Paganelli et al., 1989; Walsh et al., 2002). These results contrast with our findings 
of slower mus2OV
  kinetics due to slower increase in FBF and smaller (a-v)DO2 in the 
occlusion only condition (Heavy C), but could be explained by major differences in 
methodology. In the study by Walsh et al. (2002) the circulatory occlusion was 
released within 5 s prior to the onset of subsequent exercise and this condition 
resulted in a faster increase in 2OV
  than the Con condition. However, the authors 
were unable to evaluate the contribution of 2OV
  for the restoration of O2 stores in 
blood and tissues compared to 2OV
  for oxidative phosphorylation. When both 
arms were occluded for 5-10 minutes prior to heavy arm-cranking exercise in the 
study by Paganelli et al. (1989) there was a small decrease (from 53 to 45 s) in the 
half time of 2OV

 on-response kinetics. Our observation that 15 minutes 
circulatory occlusion followed by 3 minutes recovery period significantly altered 
FBF and metabolic responses to subsequent heavy exercise (Heavy C) was 
unexpected and contrasted with our hypothesis that prior occlusion would 
facilitate a more rapid increase in FBF, O2 delivery and mus2OV
  at the onset of 
heavy forearm exercise. 
 The mechanisms responsible for the ischemic effects on muscle blood flow 
and metabolic responses are unknown. It appears that some factor associated with 
prolonged ischemia impaired FBF response at the onset of subsequent exercise. 




hyperemia after 5 minutes circulatory occlusion that included heavy exercise in a 
control (placebo) condition compared to similar occlusion with the PGs synthesis 
inhibitors ibuprofen and  indomethacin. These authors speculated that the smaller 
reactive hyperemia in the placebo condition might have been due to the release of 
vasoconstrictor PGs or activation of platelet aggregation during the ischemic 
period. Interestingly, Shoemaker et al. (1996b) reported that PGs play no role in 
regulating FBF during forearm exercise, thus suggesting a unique ischemic effect 
on FBF control during a subsequent exercise. 
 To verify this surprising finding of slower  during the transition 
phase in Heavy C, and in an attempt to determine a possible mechanism for 
reduced FBF, group B completed 2 trials of protocol C after ingesting ibuprofen or 
placebo. The responses of slower and reduced (a-v)DO2 observed in Heavy C 
with group A were mirrored in the placebo trial in group B, whereas ibuprofen was 
able to restore to the control level primarily as a consequence of improved 
FBF with no difference in (a-v)DO2 between placebo and ibuprofen, suggesting that 
altered O2 extraction might be independent of a prostaglandin mechanism 
(Fig.3.10). In addition during the ibuprofen trial, the MAP response was identical to 
control while it was elevated with placebo in group B (Fig. 3.11) as seen in protocol 
C with group A (Fig. 3.9). These results suggested that 15 minutes of  ischemia 
may activate a prostaglandin-mediated mechanism that had both local and 
systemic effects such as the observed release of thromboxane A2 following 10 
minutes of forearm circulatory occlusion (Mathieson et al., 1983) causing some 










onset of the subsequent heavy exercise 3 minutes after the release of occlusion, 
reducing FBF. 
 The selective perfusion of active muscle fibers is dependent upon several 
factors that constrict blood vessels to non-active regions and dilate vessels to active 
regions(Rowell, 1993). As reactive hyperaemia following ischemia includes blood 
flow to both the skin and muscle, it was important to consider how these two 
components might contribute to the total flow and O2 extraction that we measured 
with and without inhibition of PGs in another group of subjects (group C).  The oral 
administration of aspirin, COX (PGs) inhibitor, has markedly reduced SBF during 
reactive hyperemia (Binggeli et al., 2003), suggesting that short period of occlusion 
might result in redistributions of blood to the periphery al and by consequence 
reducing FBF in subsequent exercise bout. However, local infusion of ketorolac, 
similar non-specific COX inhibitor, has shown increase (Medow et al., 2007) or no 
changes (Lorenzo & Minson, 2007; McCord et al., 2006) in SBF during reactive 
hyperemia. Likewise the study of Binggeli et al. (2003), SBF slightly reduced during 
reactive hyperemia and the subsequent heavy exercise after the oral administration 
of high dose of ibuprofen compared to placebo (Fig. 3.12). Yet, FBF was higher 
throughout the reactive hyperemia and subsequent exercise with ibuprofen 
suggesting that ischemia might have disparate effects on different tissue perfusion.  
 Venous blood was collected from the deep antecubital vein with the catheter 
oriented in a retrograde fashion (Mottram, 1955). Previous anatomical studies 
combined with an investigation in which increased SBF was induced by remote 
body heating suggested that the SBF would have minimal impact on O2 saturation 
in the deep vein (Roddie et al., 1956).The fact that there are differences in SBF 




similar (a-v)DO2 patterns (group B, Fig. 3.4)  provide further evidence that SBF is 
not affecting the (a-v)DO2 calculation in the current study. However, care should be 
applied in interpretation of reduced (a-v)DO2 during reactive hyperemia and 
exercise after occlusion. 
 The period of reactive hyperemia is associated with increased vascular 
conductance with dilation of the resistance vessels in skeletal muscle. O2 stores are 
rapidly replaced during the hyperemic period as indicated by NIRS (Boushel et al., 
1998; Hampson & Piantadosi, 1988) as well as the marked reduction in the         
(a-v)DO2 prior to the onset of exercise in the current study. What was unexpected 
in the current study was the continued reduction in (a-v)DO2 over the first 90 s of 
hand-grip exercise in Heavy C in group A(Fig. 3.4)and group B (Fig. 3.10). It is not 
known if this was a consequence of blood flow being diverted away from the active 
muscle fibers, possibly to the skin, or if there was an alteration in the metabolic 
pathways that delayed the adaptation of oxidative phosphorylation. There was no 
difference in the end exercise [La-] as a consequence of the delayed FBF and mus2OV
  
response so these data do not contribute to understanding potential metabolic 
differences. Future research is required to establish the mechanism for the altered 
(a-v)DO2 after 15 minutes circulatory occlusion.  
 In the Heavy D protocol, where prior 5 minutes circulatory occlusion 
combined with 1 minute of moderate exercise, we cannot provide information on 
the internal metabolic state of the muscle when the subsequent heavy exercise 
bout started 3 minutes after release of circulatory occlusion. However, FBF was 
elevated to approximately the same value as in Heavy A and Heavy B protocols and 




as the other exercise protocols. As well as, in Heavy D FBF and mus2OV
 were 
accelerated to same extent as in Heavy A and Heavy B protocols. The decrease in 
the rise time of mus2OV
  in Heavy D is in agreement with Paganelli et al.(1989) who 
reported 50% reduction in the half response time of pulmonary 2OV

 kinetics 
during the heavy arm-cranking exercise bout after prior 3 minutes of circulatory 
occlusion combined with moderate arm-cranking exercise.  
3.6 Limitations 
 Forearm mus2OV
 was estimated from the Fick equation as the product of FBF 
and (a-v)DO2. Venous blood was sampled from a deep forearm vein; however we 
were not able to measure arterial oxygen content to directly determine (a-v)DO2. We 
assumed constant arterial O2 content during steady state forearm exercise, as 
shown in both moderate (MacDonald et al., 2000) and intense knee-extension 
exercise (Bangsbo et al., 2000). We used a retrograde venous catheter to maximize 
the collection of blood from the confluence of venous drainage from the deep veins 
of the forearm extensor muscles; however, there is a possibility of contamination 
from other vascular beds (Corcondilas et al., 1964). Our results show a similar 
pattern of change in the (a-v)DO2 as seen in previous studies with directly 
measured arterial and venous O2 content (Bangsbo et al., 2002; Bangsbo et al., 
2000; Grassi et al., 1996), or from venous blood samples with the assumption of 
constant arterial O2 saturation (Hughson et al., 1996; van Beekvelt et al., 2001). 
 A limitation in all studies examining O2 delivery and O2 utilization is that 
there are no precise measurements of microvascular perfusion within the complex 
geometry of human muscle recruitment during voluntary exercise and the 




speculated. Even with direct measures of muscle blood flow it is not feasible to 
determine whether perfusion and O2 extraction are matched within the 
metabolically active regions of the muscles (Grassi et al., 1996; Hughson et al., 
1996; MacDonald et al., 2001b). The selective perfusion of active muscle fibers is 
dependent upon several factors that constrict blood vessels to non-active regions 
and dilate vessels to active regions (Rowell, 1993). Within the active muscle, 
microvascular perfusion related to local vasodilation and muscle O2 consumption 
appears to follow complex dynamics (Iversen & Nicolaysen, 1989) as supported by 
recent data from multiple sites with near infrared spectroscopy (Koga et al., 2007). 
However, during high intensity exercise, as was employed in the present study, 
there is relatively homogeneous recruitment of muscle fibers (Krustrup et al., 
















 We demonstrated differences between prior active warm-up with “heavy 
exercise” and “occlusion plus exercise” compared to passive warm-up with 
“occlusion” only on the dynamic adaptation of mus2OV
  at the onset of heavy forearm 
exercise. Our findings exposed differences in the mechanisms regulating mus2OV

with the active warm-ups resulting in a higher FBF but no changes in O2 extraction 
to yield the faster increase in mus2OV
 at the onset of subsequent heavy forearm 
exercise bouts. In contrast, prior occlusion slightly retarded the increase in FBF 
and significantly reduced O2 extraction thus delaying mus2OV

 
kinetics. Over all 
there was a strong correlation between the rates of increase in FBF and oxidative 
metabolism suggesting that the acceleration of mus2OV
  kinetics at the onset of 
heavy forearm exercise is linked to O2 delivery in trained young men. Prolonged 
ischemia invoked a prostaglandin-mediated mechanism that affected FBF and O2 
extraction delaying the adaptation of oxidative metabolism during subsequent 
heavy exercise; but, the reduction in FBF was reversed by inhibition of 







Priming exercise induced attenuation of the 2OV
 slow component during 
heavy exercise and increased oxygen cost during moderate exercise are 























4.1 Overview  
 The precise mechanisms for the development of the 2OV
 slow component 
during heavy exercise and the increase in O2 cost during moderate exercise that 
follows heavy warm-up remain uncertain. We tested the hypothesis that changes in 
muscle activity are related to changes in slow component amplitude during heavy 
exercise and elevated steady state 2OV
 during moderate exercise following a heavy 
warm-up. Eight male endurance athletes performed two repetitions of two cycling 
protocols involving 6-min bouts of heavy and moderate intensity. 2OV
 was 
measured breath-by-breath and muscle activity was assessed by surface EMG. 
During heavy exercise, prior moderate and heavy exercise had a graded effect, 
attenuating the slow component amplitude by 19% and 40%, (prior moderate: 455 
± 52; prior heavy: 341 ± 54 vs. no warm-up: 564 ± 71 ml/min; P < 0.01 for both). 
Similarly, prior warm-up modified EMG activity between the 2nd and 6th min of 
exercise, shifting the increase in integrated EMG (iEMG) during control, to a 
smaller increase after a moderate bout and a decrease after heavy exercise. 
Principle components analysis showed a significant positive correlation between 
the slow component amplitude and the changes in iEMG of the knee extensor 
muscles (r = 0.45, P = 0.03). During moderate exercise, mean power frequency 
(MPF) was augmented by one or two prior heavy bouts, but no changes in iEMG 
were observed. The attenuation of slow component amplitude by moderate and 
heavy warm-up and the elevated moderate exercise steady state 2OV
 following a 
heavy warm-up appear to be related to some changes in surface EMG activity and 






 During constant-load heavy exercise above the ventilatory threshold (VT), 
pulmonary 2OV
 continues to rise above the fundamental exponential kinetic 
response with a superimposed delayed origin (≈ 90-150 s) termed the “slow 
component” (Whipp, 1994; Whipp & Wasserman, 1972). A large amount of the 2OV

slow component can be attributed to the exercising muscles (Poole et al., 1991; 
Rossiter et al., 2002b), but the specifics of muscle activation patterns are still 
unclear. Several converging lines of evidence point to a progressive recruitment of 
muscle fibres potentially the less efficient type II muscle fibres as the principal 
mechanism by which O2 consumption increases during the 2OV
 slow component. 
First, the amplitude of the 2OV
 slow component has been shown to be more 
pronounced in subjects with a high proportion of type II muscle fibres (Barstow et 
al., 1996; Garland et al., 2006; Pringle et al., 2003). Also, Krustrup et al. (2004) 
have shown a marked depletion in the quadriceps muscle (mixed fibre type) PCr 
and glycogen from 3 to 6 minutes during heavy cycling exercise. Furthermore, 
investigations employing magnetic resonance imaging (MRI) have shown that 
changes in muscle recruitment are characteristic of the slow component (Endo et 
al., 2007; Saunders et al., 2000). However, studies using surface EMG are more 
varied and controversial (Bailey et al., 2009b; Burnley et al., 2002b; Cannon et al., 
2007; Garland et al., 2006; Osborne & Schneider, 2006; Perrey et al., 2001; 
Sabapathy et al., 2005; Saunders et al., 2000; Scheuermann et al., 2001; 




 Almost universally in previous research which applied a prior heavy warm-
up, the amplitude of the 2OV
 slow component in the second heavy exercise bout 
was shown to be attenuated (Bailey et al., 2009b; Burnley et al., 2002b; Koppo & 
Bouckaert, 2000; Tordi et al., 2003). However, the associated changes in EMG 
activity during the 2OV
  slow component are inconsistent (Burnley et al., 2002b; 
Perrey et al., 2003b; Scheuermann et al., 2001; Tordi et al., 2003). Burnley et al. 
(2002b) showed a reduction in integrated EMG (iEMG) across several muscles in 
conjunction with a smaller 2OV

 slow component in the second heavy bout. 
 Similarly, when Bailey et al. (2009b) investigated EMG and its relation to the 
2OV
 slow component following different heavy warm-ups, they observed 
attenuation in the 2OV
 slow component amplitude and iEMG in the vastus 
lateralus (VL) muscle. Conversely, Scheuermann et al. (2001) observed a reduction 
in the slow component but no change in iEMG or mean power frequency (MPF) in 
VL muscle. Prior moderate exercise has also been shown to reduce the 2OV
 slow 
component amplitude during subsequent heavy exercise to a smaller extent than 
prior heavy exercise (Koppo & Bouckaert, 2000). However, there are no data 
available regarding the EMG responses in a heavy exercise bout that follows a 
single moderate warm-up bout. Therefore, investigating the 2OV
 slow component 
following moderate and heavy priming exercise in concert with EMG may provide 
useful information on the underlying mechanisms. 
 While muscle recruitment patterns have been thoroughly investigated as a 
potential mechanism for the 2OV
 slow component during heavy exercise, the role of 




exercise remains undefined. Gonzales and Scheuermann (2008) reported that 
elevated O2 cost in moderate exercise after a heavy warm-up is not the result of 
additional recruitment of motor units or an appreciable recruitment of type II 
muscle fibres. In the current study, we employed repeated cycling protocols 
involving both moderate and heavy exercise transitions while measuring breath-by-
breath 2OV
 concurrent with EMG activity in multiple leg muscles to examine the 
relation between the changes in muscle activity (as assessed by iEMG and MPF) 
and 1) the magnitude of the 2OV
 slow component during heavy exercise following 
both heavy and moderate warm-up; 2) the elevated O2 cost in the moderate 

















 Eight recreationally active (
peak2
OV > 55 ml/kg/min) men (age: 23.2 ± 3.0 
years, height: 176.0 ± 6.9 cm, weight: 70.3 ± 5.1 kg, 
peak2
OV : 4190 ± 342 
ml/min; mean ± SD) recruited from those who completed the first study (Chapter 
2), participated in this study following informed consent. This study was approved 
by the Office of Research Ethics at the University of Waterloo.  
4.3.2 Experimental design     
 Participants visited the laboratory on 4 occasions (non-consecutive days), to 
perform 2 sessions of each experimental protocol (Fig.4.1). 
peak2
OV and VT were 
determined from the incremental cycling test described previously in chapter 2. 
The experimental protocols involved a combination of three 6-min cycling bouts at 
moderate (M; 80% VT: 138 ± 25 W) and heavy (H; 85%
peak2
OV : 257 ± 24 W) 
intensities, interspersed with 6-min bouts at 20 W. Within each protocol, the three 
6-min exercise bouts were labeled according to intensity, bout number and 
protocol letter, as follows: Protocol A = moderate (M1A), heavy (H2A), and moderate 
(M3A); Protocol B = heavy (H1B), heavy (H2B), and moderate (M3B); Protocols started 
immediately after 2 min of unloaded (0 W) cycling. 2OV
 and EMG from the lower 
limb musculature were measured continuously throughout the rides. The same 
procedures for the cycle ergometer set up and testing sessions were applied as 





Figure 4.1: Two different cycling protocols.  
Two different testing protocols employed to examine the relation between the 
changes in 2OV
 slow component amplitude during heavy exercise, increase O2 cost 




4.3.3 Breath-by-breath oxygen uptake 
 The set up of the breath-by-breath system and 2OV
 data collection were 
exactly the same as described in chapter 2. Non-interpolated, breath-by-breath 
2OV
 data were blocked into 10-s windows and averaged together to yield a single 
data set for each subject in each protocol (Fig.4.2). The 2OV

 slow component 
amplitude was assessed by calculating the differences (∆) in 2OV
 between the 2nd 
and 6th min [ )26(2OV 
 ]. The 2nd min was calculated from 90 s to 150 s and was 
selected for the start of this analysis as curve-fitting analyses in chapter 2 have 
shown small 2 in these subjects, as well previous work has shown that the slow 
component started in the 2nd min of heavy exercise (Cannon et al., 2007). In 
addition, the kinetics parameters of the 2OV
 slow component during heavy exercise 
bouts and the Gain1+2 in both heavy and moderate exercise bouts (Fig. 4.3) for the 
8 subjects were calculated from the rides they performed in the first study. Gain1+2 
was calculated as follows (∆ 2OV
 /∆WR), where ∆ 2OV
  is equal to the summation of 
phase I and phase II amplitudes             ( A1+A2)and ∆WR is equal to the difference 
between the work rate applied during exercise and 20 W baseline. 
4.3.4 Electromyographic activity 
 EMG was obtained from the vastus lateralis (VL), vastus medialis (VM), 
rectus femoris (RF) and biceps femoris (BF) muscles. Prior to each session, EMG 
was recorded during 2 min of unloaded cycling (0 W). EMG was measured on the 
left leg using surface disposable pre-gelled EMG Ag-AgCl electrodes (Blue Sensor, 
Medicotest, Inc., Ølstykke, Denmark) with an inter-electrode distance of 2 cm. Skin 




electrodes were fixed to the skin in a bipolar configuration along the mid-line of the 
proximal and distal tendons.  A reference electrode was placed over the anterior 
iliac crest. Electrode wires were taped to the skin to reduce movement artifacts. 
Electrode placement was marked with permanent ink to ensure consistent 
positioning during subsequent sessions. Raw EMG was amplified (Custom built 
amplifier, Waterloo, ON, Canada; bandwidth = 20 – 500 Hz, common mode 
rejection rate > 90 db, input impedance = 2 MΩ) and collected at 1000 Hz using a 
16-bit A/D card with a ± 5 V range. To identify baseline muscle activity, the 
rectified signal was passed through a dual second-order Butterworth digital filter 
with a 5 Hz cut off frequency. Muscular contraction was considered to begin when 
the rectified signal exceeded the mean of the baseline EMG plus three standard 
deviations, and end when the signal fell below that level. Integrated EMG (iEMG) 
was calculated as the area under the rectified signal for each burst, blocked into 
10-s windows throughout each protocol. Mean power frequency (MPF) was 
calculated using fast Fourier transformation analysis on the raw signal (95% of the 
total power was considered). Due to inter-subject variability and day to day 
variation in EMG signal, iEMG and MPF were normalized to the baseline activity 
measured during the first 2 min of unloaded cycling prior to each protocol. 
Differences in iEMG activity between the 2nd (90-150 s) and 6th (300-360 s) min     
(∆ iEMG (6-2)) were determined for comparison with ∆ )26(2OV 






  time series throughout heavy (A, top) and moderate (B, bottom) 
exercise bouts.  
Data are the average of 10-s windows (± SE) from all 8 participants. The 





Figure 4.3: Aerobic gain time series throughout heavy (A) and moderate (B) 
exercise.  
Data were averaged across all 8 participants with at least 4 repetitions per 
condition. ∆ 2OV




4.3.5 Blood sampling 
 Blood samples were drawn from the antecubital vein during the two rides of 
each protocol to measure lactate [La-] concentrations by fluorometric assay (Lowry 
& Passonneau, 1972). Blood was drawn at rest, and between 5.5 and 6 minutes of 
each of the three work rates: 20 W, moderate, and heavy. 
4.3.6 Statistical analysis 
 The effects of prior exercise on 2OV
 kinetics during subsequent moderate 
and heavy exercise were analyzed using one-way repeated measures ANOVA. The 
effects of prior exercise on one minute average values of iEMG and MPF during 
moderate and heavy bouts were analyzed using two-way repeated measures 
ANOVA. When significant effects were observed, the Tukey post hoc test was used 
for comparisons. T Test was used to examine the differences in MPF between the 
first 10 s and end exercise, and the differences in iEMG between the 2nd and 6th 
min of exercise in each heavy exercise condition. Principal components analysis 
(PCA) (Coste et al., 2005) and regression analysis, which accounts for the 
correlation within subjects due to repetitions, were used to examine the relation 
between ∆ iEMG (6-2) and 2OV
  slow component. All data were expressed as mean ± 
SD. The data were analyzed using Statistical Analysis Software (SAS) package 9.2 








4.4.1 Oxygen uptake kinetics 
 The fitting parameters of the 2OV
 kinetics during heavy and moderate 
exercise were modified by the warm-up bouts (Tables 4.1 and 4.2). The time 
constant (2) during heavy exercise was significantly faster after either prior 
moderate (H2A, 23.1 ± 2.2 s) or heavy (H2B, 22.7 ± 2.3 s) warm-up compared to 
control (H1B 27.0 ± 1.9 s). Similarly, τ2 values were significantly lower in a 
moderate exercise bout that followed either one (M3A) or two (M3B) heavy bouts 
than during control (M1A) (Table 4.2). Neither moderate nor heavy priming exercise 
affected the amplitude of 2OV
 during phase I (A1) or phase II (A2) in the subsequent 
bouts of moderate or heavy exercise (Tables 4.1 and 4.2). Prior moderate or heavy 
cycling exercises had a graded effect in attenuating the slow component amplitude 
(A3) of subsequent heavy exercise (H2A: 541 ± 103; H2B: 385 ± 63 vs. H1B: 610 ± 
114 ml/min, P < 0.01 for both). This was also reflected by ∆ )26(2OV 
 . The ∆ )26(2OV 

during heavy exercise was 19 % lower following a moderate intensity warm up, and 
40 % lower following a heavy intensity warm-up, than observed during the control 
bout (H2A: 455 ± 52; H2B: 341 ± 54 vs. H1B: 564 ± 71 ml/min; P < 0.01 for both). 
There was greater attenuation with increasing intensity of the warm-up, such that 
the amplitude of slow component in H2B was significantly lower than in H2A for 
both the kinetics analyses and ∆ )26(2OV 
  (P < 0.05 for both). Prior moderate and 
heavy exercise reduced the time to initiate the slow component (TD3) during 
subsequent heavy exercise to a similar extent compared to control (H2A: 81.4 ± 
13.1; H2B: 73.3 ± 10.6 vs. H1B: 102.7 ± 10.4 s; P < 0.01 for both). Prior warm-up 




compared to their respective controls (Moderate, M3A: 9.2 ± 0.4; M3B: 9.4 ± 0.5 vs. 
M1A: 9.9 ± 0.4 ml/min/W; P < 0.01 for both; Heavy, H2A: 8.8 ± 0.3; H2B: 9.1 ± 0.5 
vs. H1B: 8.9 ± 0.6 ml/min/W; P > 0.05) (Fig. 4.3).   
4.4.2 Lactate 
 The baseline [La-] leading into heavy exercise was elevated following a prior 
heavy bout compared to that following a prior moderate bout or no warm-up 
exercise (H2B: 4.8 ± 0.7 vs. H2A = 1.1 ± 0.2; H1B: 0.8 ± 0.2 mmol/l, P < 0.001 for 
both). At the end of the heavy exercise bouts, [La-] remained significantly lower in 
H1B (4.2 ± 1.2 mmol/l) than H2B (6.3 ± 1. 2 mmol/l, P < 0.01). Also, it tended to 
stay lower in H2A (4.9 ± 1.0 mmol/l, P = 0.06) compared to H2B. Immediately prior 
to moderate exercise, the baseline [La-] was higher for bouts following a heavy 
intensity warm-up than the bout with no warm up (M3A: 4.7 ± 1.0; M3B: 5.4 ± 1.3 
vs. M1A: 0. 9 ± 0. 2 mmol/l, P < 0.01 for both).  At the end of the moderate exercise 
bouts that followed a heavy warm-up, [La-] was lower than baseline (M3A: 3.3 ± 0.9 














Table 4.1: Fitting parameters during heavy exercise bouts 
 
Mean ± SD, n = 8  
* P < 0.01 H1B vs. H2A-H2B; † P < 0.05 H1B vs. H2A-H2B;  
‡ P < 0.01 H2A vs. H2B; § P < 0.05 H2A vs. H2B 
Amplitude parameters A0, A1, A2 and A3 for the baseline, phase I, phase II and 
phase III (slow component ) respectively; time constants (τ2, τ3) and time delays 
(TD2, TD3) for the corresponding phases; end bout is the average 2OV
  in the last 
minute of each exercise bout. The heavy bouts for protocols A and B are shown in 









A0, ml/min  987 ± 50 1021 ± 76 1155 ± 48 *‡ 
A1, ml/min  447 ± 148 463 ± 107 424 ± 103 
A2, ml/min  1661 ± 201 1610 ± 166 1733 ± 245 
A1+A2, ml/min  2108 ± 273 2074 ± 219 2157 ± 275 
A3, ml/min  610 ± 114 541 ± 103 385 ± 63 
 2, s  27.0 ± 1.9 23.1 ± 2.2 * 22.7 ± 2.3 * 
3, s  154.3 ± 36.3 144.6 ± 35.8 141.4 ± 27.2 
TD2, s  11.5 ± 1.9 11.7 ± 1. 5 10.2 ± 1.0 †§ 
TD3, s  102.7 ± 10.4 81.4 ± 13.1 * 73.3 ± 10.6 * 
Gain1+2, ml/min/W  8.9 ± 0.6 8.8 ± 0.3 9.1 ± 0.5 




Table 4.2: Fitting parameters during moderate exercise bouts 
 
Mean ± SD, n = 8 
* P < 0.01 M1A vs. M3A - M3B; † P < 0.05 M1A vs. M3A - M3B; 
 ‡ P < 0.01 M3A vs. M3B; § P < 0.05 M3A vs. M3B 
 
Amplitude parameters A0, A1 and A2 for the baseline, phase 1 and phase 2 
respectively; time constant (τ2) and time delay (TD2) for the primary phase; end 
bout is the average 2OV
 in the last minute of each exercise bout. The moderate 












A0, ml/min  990 ± 48 1159 ± 73 * 1196 ± 66 * 
A1, ml/min  304 ± 130 255 ± 79 279 ± 87 
A2, ml/min  861 ± 141 837 ± 176 834 ± 191 
A1+A2, ml/min  1165 ± 254 1092 ± 228 1112 ± 259 
 2, s  23.7 ± 4.4 19.3 ± 3.4 † 17.0 ± 2.9 * 
TD2, s  13.2 ± 1.2 12.9 ± 1.9 14.3 ± 1.7 
Gain1+2, ml/min/W  9.9 ± 0.4 9.2 ± 0.4 † 9.4 ± 0.5 † 





 The baseline EMG was not different between days and protocols in all 
muscles (iEMG Protocol A vs. Protocol B, VL: 12.3 ± 2.6 vs. 12.6 ± 2.7, VM: 14.4 ± 
6.6 vs. 13.9 ± 6.5, RF: 10.8 ± 1.6 vs. 11.6 ± 2.4 and BF: 24.8 ± 17.6 vs. 27.2 ± 22.2 
mV, P > 0.05 for all; MPF Protocol A vs. Protocol B, VL: 56.0 ± 3.8 vs. 55.1 ± 2.7, 
VM: 54.4 ± 6.0 vs. 54.7 ± 3.8, RF: 57.1 ± 2.5 vs. 58.6 ± 4.2 and BF: 64.5 ± 7.9 vs. 
63.7 ± 10.1 Hz, P > 0.05 for all). There were also no differences in iEMG or MPF 
between the 20 W baselines that preceded each moderate and heavy condition 
(Table 4.3), or the end exercise iEMG within the moderate and heavy conditions 
(Table 4.4). During heavy exercise, MPF (Fig. 4.4) was significantly lower in all the 
extensor (agonist) muscles at the end of exercise compared to the first 10 s (P < 
0.05 for all comparisons, Tables 4.5 – 4.7). However, MPF in the flexor (antagonist) 
BF muscle was slightly but not significantly higher at the end of exercise [H1B: 
101.4 ± 8.6 vs. 106.5 ± 11.7, H2A: 101.2 ± 6.7 vs. 105.6 ± 7.4 and H2B: 107.7 ± 9.1 
vs. 108.4 ± 9.4 % of baseline MPF; P > 0.05 for all comparisons, Fig. 4.5]. Prior 
heavy exercise significantly elevated MPF throughout the subsequent heavy bout 
(H2B) compared to the control heavy bout (H1B) in all the extensor VL, VM and RF 
muscles (over the 6 minutes of exercise P values were less than 0.05, Tables 4.5 – 
4.7), however, no effect was observed in the antagonist BF muscle. Prior moderate 
exercise resulted in a significantly higher MPF in VL and VM muscles throughout 
the first minutes in subsequent heavy bout (H2A) compared to control (P < 0.05, 




Table 4.3:  Baseline iEMG and MPF during 20W cycling prior to heavy and moderate bouts  
 
Mean ± SD, n = 8 








H1B H2A H2B M1A M3A M3B 
VL – iEMG 
 
 
126.5 ± 22.7 133.5 ± 19.9 134.2 ± 37.3 
 
 
132.2 ± 18.8 133.5 ± 19.9 136.1 ± 42.8 
VM - iEMG 124.9 ± 20.2 129.7 ± 42.9 128.3 ± 30.5 127.2 ± 33.6 128.1 ± 26.1 131.5 ± 24.5 
RF - iEMG 103.6 ± 26.1 116.2 ± 24.7 112.3 ± 22.4 113.2 ± 18.9 116.4 ± 24.7 113.3 ± 26.9 
BF - iEMG 122.0 ± 24.6 109.5 ± 25.4 127.8  ± 35.2 117.4 ± 14.9 119.6 ± 24.1 115.9 ± 22.3 
VL - MPF 97.3 ± 2.3 98.7 ± 3.5 98.7 ± 5.4 98.0 ± 3.9 98.0 ± 7.1 102.9 ± 8.4 
VM - MPF  96.7 ± 8.6 94.7 ± 11.3  96.9 ± 5.4  96.6 ± 9.3 95.9 ± 10.8 102.8 ± 9.9 
RF - MPF  96.4 ± 7.9 100.9 ± 7.4 97.7 ± 8.1  100.1 ± 5.6 101.3 ± 6.4 101.8 ± 10.0 




Table 4.4: End exercise iEMG during heavy and moderate bouts 
 
Mean ± SD, n = 8 











H1B H2A H2B M1A M3A M3B 
VL – iEMG 
 
 
617.2 ± 29.5 591.0 ± 22.7 585.5 ± 28.0 
 
 
339.7 ± 9.6 348.6 ± 8.7 305.0 ± 10.3 
VM - iEMG 598.7 ± 18.1 560.3 ± 21.0 572.7 ± 24.1 315.5 ± 11.6 301.6 ± 8.2 330.7 ± 11.7 
RF - iEMG 419.6 ± 21.6 392.8 ± 18.5 392.3 ± 19.3 230.7 ± 10.0 238.5 ± 9.6 234.9 ± 11.5 





Figure 4.4: MPF time series throughout heavy cycling bouts.  
Muscle activity is shown from vastus lateralis (VL), vastus medialis (VM) and rectus 
femoris (RF) muscles. MPF is reported as a percentage of unloaded cycling (0 W). 




Table 4.5: MPF in VL muscle during heavy and moderate exercise bouts 
 
Mean ± SD, n = 8 
* P < 0.05 H1B vs. H2A and H2B; M1A vs. M3A and M3B 
† P < 0.05 M3A vs. M3B 
‡ P < 0.05 10 s vs. Min 6 in each heavy and moderate exercise condition 






H1B H2A H2B M1A M3A M3B 
MPF – 10 s 
 
 
110.2 ± 5.7 ‡ 113.8 ± 6.3 ‡ 114.2 ± 6.7 ‡ 
 
 
106.9 ± 6.6 109.9 ± 6.2 110.9 ± 7.1 * 
MPF - Min 1 105.7 ± 5.8 109.5 ± 5.6 * 111.5 ± 6.5 * 104.5 ± 4.3 110.6 ± 6.7 * 112.4 ± 6.5 * 
MPF - Min 2 102.2 ± 5.0 105.1 ± 4.7 * 107.4 ± 6.9 * 103.8 ± 3.6 109.4 ± 5.1 * 112.6 ± 6.7 *† 
MPF - Min 3 102.1 ± 5.1 104.4 ± 4.5 107.1  ± 6.5 * 103.6 ± 4.1 109.2 ± 5.8 * 112.5 ± 5.5 *† 
MPF - Min 4 101.8 ± 5.9 104.0 ± 4.4 106.7 ± 6.1 * 104.2 ± 4.3 109.3 ± 6.7 * 113.3  ± 5.8 *† 
MPF - Min 5  102.0 ± 5.5 104.8 ± 5.1  106.3 ± 6.5 *  104.7 ± 4.1 109.0 ± 6.5 * 113.6 ± 6.3 *† 




Table 4.6: MPF in VM muscle during heavy and moderate exercise bouts 
 
Mean ± SD, n = 8 
* P < 0.05 H1B vs. H2A and H2B; M1A vs. M3A and M3B 
† P < 0.05 H2A vs. H2B; M3A vs. M3B 
‡ P < 0.05 10 s vs. Min 6 in each heavy and moderate exercise condition 






H1B H2A H2B M1A M3A M3B 
MPF – 10 s 
 
 
111.7 ± 7.0 ‡ 114.9 ± 7.9 ‡ 116.3 ± 10.2 ‡ 
 
 
109.3 ± 7.1 111.0 ± 11.7 118.0 ± 10.6 *† 
MPF - Min 1 107.2 ± 7.5 112.3 ± 7.0 * 114.5 ± 9.4 * 107.1 ± 8.2 110.2 ± 10.6  117.5 ± 10.6 *† 
MPF - Min 2 104.7 ± 7.4 109.0 ± 5.5 * 112.3 ± 9.2 *† 104.1 ± 9.2 109.6 ± 9.3 * 115.6 ± 10.5 *† 
MPF - Min 3 104.3 ± 7.3 108.4 ± 5.6 * 111.7  ± 9.4 *† 103.6 ± 7.3 108.8 ± 8.5 * 116.0 ± 9.8 *† 
MPF - Min 4 104.6 ± 7.8 107.8 ± 5.0 111.3 ± 10.2 *† 103.3 ± 7.1 109.5 ± 10.3 * 115.4  ± 9.5 *† 
MPF - Min 5  105.2 ± 7.9 108.6 ± 5.5  111.4 ± 10.3 *  104.0 ± 7.4 110.2 ± 9.8 * 115.2 ± 10.2 *† 




Table 4.7: MPF in RF muscle during heavy and moderate exercise bouts 
 
Mean ± SD, n = 8 
* P < 0.05 H1B vs. H2A and H2B; M1A vs. M3A and M3B 
† P < 0.05 H2A vs. H2B; M3A vs. M3B 
‡ P < 0.05 10 s vs. Min 6 in each heavy and moderate exercise condition 






H1B H2A H2B M1A M3A M3B 
MPF – 10 s 
 
 
116.0 ± 11.4 ‡ 118.1 ± 10.5 ‡ 120.7 ± 11.3 ‡ 
 
 
104.1 ± 7.2 110.8 ± 8.0 * 115.6 ± 9.1 *† 
MPF - Min 1 111.0 ± 11.6 113.5 ± 10.1 118.4 ± 10.2 *† 103.9 ± 7.1 108.8 ± 7.0 * 114.4 ± 7.4 *† 
MPF - Min 2 107.4 ± 7.4 109.1 ± 6.7 115.7 ± 6.5 *† 103.4 ± 6.4 109.5 ± 7.4 *  112.1 ± 8.8 * 
MPF - Min 3 107.8 ± 5.6 107.0 ± 4.4 112.3 ± 6.2 *† 102.4 ± 6.2 108.5 ± 8.7 * 112.4 ± 8.0 * 
MPF - Min 4 107.4 ± 5.1 108.3 ± 4.2 111.8 ± 4.2 * 101.9 ± 5.8 108.7 ± 8.6 * 111.6 ± 7.8 * 
MPF - Min 5  106.8 ± 4.5 107.3 ± 5.8 111.9 ± 4.2 *†  101.6 ± 5.6 109.7 ± 9.2 * 111.4  ± 8.1 * 





Figure 4.5: MPF (A) and integrated EMG (B) activity in BF muscle.  
Time series for MPF and iEMG are reported as a percentage of unloaded cycling    






 There were no significant differences in iEMG activity at any time point 
between the three heavy exercise conditions in all muscles. There were also no 
significant differences in iEMG activity between the 2nd and 6th min of exercise 
within the three exercise conditions in all extensor muscles (Fig. 4.6) and flexor 
muscle (Fig.4.5). The ∆ iEMG(6-2) in the control heavy bout (H1B) were positive in the 
extensor muscles during [ VL (5.1 %), VM (4.9 %) and RF (5.2 %)]. This response 
was altered by warm-up exercise, such that in H2A ∆ iEMG(6-2) were less than 
control in VL (3.1 %) and VM (3.8 %), and was negative in RF (-2.1 %). There was 
an even more dramatic shift in H2B, where the ∆ iEMG(6-2) were negative in all three 
muscles [VL (-1.5 %), VM (-2.2 %) and RF (-6.3 %); Fig. 4.6]. In the flexor 
(antagonist) BF muscle, iEMG was slightly decreased in H1B (-3.5 %), unchanged in 
H2A (1.0 %) and further decreased in H2B (-13.6 %) (Fig. 4.5). Including all the 
muscles in PCA retained 53% of the variation of the 2OV
 slow component. However, 
excluding the flexor BF muscle (eigenvalue < 1) from PCA showed that ∆ iEMG(6-2) 
in the extensor VL, VM and RF muscles explained 74% of the variation in 2OV
 slow 
component. Therefore, the three extensor muscles were used in PCA to retain a 
single factor for the correlation. There were no significant correlation between        
∆ )26(2OV 
 and ∆ iEMG(6-2) in all three heavy bout conditions, while when the data 
from all subjects and conditions were clustered, there was a moderate but 
significant correlation between ∆ )26(2OV 
 and ∆ iEMG(6-2) in VL, VM and RF muscles 
(r = 0.45, P = 0.029). 
  In all moderate bouts, there were no changes in MPF throughout the 6 min 
of exercise. Yet, prior one or two heavy bouts significantly elevated MPF in the 




exercise in a graded manner (Fig. 4.7, Tables 4.5 – 4.7). Relative to the control 
bout, average MPF throughout the exercise bout was elevated during M3A in VL 
(4.9 %), VM (5.1 %) and RF (6.5 %) muscles, and during M3B in VL (6.8 %), VM 
(13.0 %) and RF (10.8 %) muscles. MPF was significantly higher in VL and VM 
muscles through the 6 min of exercise after two heavy bouts (M3B) compared to 
after one heavy bout (M3A) (P < 0.05; Fig. 4.7). There were no changes in iEMG 
throughout the 6 min of moderate exercise. Also, there were no significant 
differences in iEMG activity at any time point between the three exercise conditions 















Figure 4.6: Integrated EMG time series throughout heavy cycling bouts.  
Muscle activity is shown from vastus lateralis (VL), vastus medialis (VM) and rectus 
femoris (RF) muscles. MPF is reported as a percentage of unloaded cycling (0 W). 





Figure 4.7: MPF time series through moderate cycling bouts. 
Muscle activity is shown from vastus lateralis (VL), vastus medialis (VM) and rectus 
femoris (RF) muscles. MPF is reported as a percentage of unloaded cycling (0 W). 





Figure 4.8: Integrated EMG time series through moderate cycling bouts.  
Muscle activity is shown from vastus lateralis (VL), vastus medialis (VM) and rectus 
femoris (RF) muscles. MPF is reported as a percentage of unloaded cycling (0 W). 





 The results of this study clearly demonstrate the capacity of prior heavy and 
moderate exercise to diminish the amplitude of the 2OV
 slow component in 
addition to the important findings that: 1) the attenuation in slow component 
amplitude appears to be related to some changes in muscle activity, as measured 
by surface EMG; and 2) the higher O2 cost of moderate exercise is associated with 
higher MPF which may suggest changes in fibre types recruitment during moderate 
exercise after a heavy warm-up. 
4.5.1 Methodological considerations 
 Two minutes of unloaded cycling was employed prior to each protocol to 
serve as baseline condition in order to compare all changes in EMG activity within 
and between the testing protocols on different days. This allowed comparison of the 
different 20W baselines, as well as between the moderate and heavy bouts. The 
normalization of EMG data to the unloaded baseline condition did not impact the 
analyses as the baseline EMG was identical between days and protocols. As well 
as, no differences were shown in EMG activity between the 20 W baselines that 
precede each moderate and heavy condition (Table 4.3).  
 The principal components analysis (PCA) (Coste et al., 2005) was used to 
examine the relation between changes in iEMG activity and 2OV
 slow component. 
The central idea of using PCA is to aggregate the EMG activity measured in all 
muscles into one factor. PCA with VARIMAX rotation was used on the 4 muscles 
and eigenvalues greater than one were used to decide the number of muscles that 
show the most variation to be included in the analysis (Jolliffe, 2002).  This method 




discern how they may contribute in concert to the development of 2OV
 slow 
component. However, the PCA was not able to detect the significant relationships 
between the changes in iEMG and slow component amplitude in the individual 
heavy exercise conditions. This might have been due to small number of 
participants, but could also reflect the inability of iEMG to relate to the mechanism 
involved for the increased 2OV
  slow component. 
  Finally, the 2OV
  slow component was calculated as the increase in 
amplitude between the 2nd and 6th min of the exercise bout. While some previous 
work has used the 3rd-6th min (Whipp & Wasserman, 1972; Whipp & Wasserman, 
1986), the slow component was shown to generally begin to manifest within the 
last 30 s of the second minute in our fitting analysis (Chapter 2), which has been 
shown in previous work (Cannon et al., 2007).  
4.5.2 Potential sources of the 2OV

 slow component 
 Consistent with previous work (Gerbino et al., 1996; MacDonald et al., 1997; 
Whipp, 1994) we observed the development of a 2OV
 slow component during heavy 
exercise that was not present during moderate exercise. Several hypotheses, 
including peripheral and central factors, have been proposed to explain the excess 
of 2OV
  during the slow component. Direct measurements of (a-v)DO2 have shown 
that the exercising legs are responsible for approximately 86% of the 2OV
 slow 
component (Poole et al., 1991); therefore, the pulmonary 2OV
 slow component 
reflects to a large extent the changes in O2 cost of the exercising muscles. However, 
increased cardiorespiratory work may still play a role (Aaron et al., 1992; Carra et 





  during the slow component appears to be the skeletal muscle, the 
precise mechanisms which account for the majority of excess 2OV
  remain unclear.  
 The prevailing hypothesis, originally posited by Shinohara and Moritani 
(1992), asserts that as Type I fibres fatigue, the recruitment of Type II muscle fibres 
increases in order to maintain appropriate force production. Since then, many 
supportive (Barstow et al., 1996; Burnley et al., 2002b; Krustrup et al., 2004; 
Pringle et al., 2003; Sahlin et al., 2005) and contradictory (Cannon et al., 2007; 
Garland et al., 2006; Perrey et al., 2003b; Scheuermann et al., 2001) findings have 
been reported regarding the role of additional muscle fibre recruitment in the 
development the slow component. 
 In support of the progressive recruitment hypothesis, Sahlin et al. (1997) 
showed marked increase in the degradation of PCr and rise of energy requirement 
by the end of submaximal cycling exercise at 75% 2OV
 max.  Furthermore, at the 
whole body level, both proportion of Type II fibres (Barstow et al., 1996) and plasma 
[NH3+], a marker of Type II fibre activation (Sabapathy et al., 2005), were correlated 
with slow component amplitudes. Additional support for the progressive 
recruitment hypothesis comes from studies examining half-relaxation time (T2) 
using MRI. Saunders et al. (2000) observed an increase in the O2 cost per unit of 
active muscle during high intensity, but not moderate intensity exercise, 
suggesting the recruitment of less efficient Type II muscle fibres. Furthermore, 
Endo et al. (2007) showed that in 10 muscles of the thigh, there is an increasing 
difference in the activation of muscles between the 3rd and 6th minute of exercise as 
intensity progressed from moderate, to heavy, to severe, and that this correlated 
significantly with 2OV




 It has been suggested previously that agonist-antagonist co-activation might 
increase as exercise duration increases, resulting in reduced efficiency, increased 
internal work rate and elevated O2 cost (Kellis, 1998). However, Borrani et al. 
(2003) showed that slow component is not a result of a change in external or 
internal mechanical work with fatigue and, in the current study, there was no 
evidence of increased co-activation as there was a decrease  in the iEMG activity of 
the antagonistic BF muscle (Fig. 4.5). In trained subjects, co-activation may 
actually decrease with the progress of exercise (Hautier et al., 2000). These 
subjects may have learned to use their agonist and antagonist muscles more 
efficiently to lower the O2 demand and attenuate the 2OV
 slow component 
amplitude during the second exercise bout. 
 Another possible mechanism suggested for the development of the 2OV
 slow 
component is the accumulation of [La-] with exercise progression. A high 
correlation between the increase in blood [La-] and the excess of 2OV
 slow 
component has been observed (Roston et al., 1987); however, similar to other 
studies (Koppo & Bouckaert, 2000; Poole et al., 1994; Sahlin et al., 2005) our data 
quite convincingly show that lactic acidosis could not be a factor, since blood  [La-]  
levels were significantly elevated throughout the second heavy bout (H2B), despite 
the fact that the slow component amplitude was significantly reduced (Table 4.1). 
Sahlin et al. (2005) showed no changes in muscle or blood [La-] from 3 to 10 min of 
heavy exercise where the slow component was manifested. Moreover, there were no 
correlations observed between changes in muscle and blood [La-] and the 
amplitude of the 2OV




4.5.3 Effects of warm-up exercise on the 2OV
  slow component and EMG 
 Using a prior exercise model described in Chapter 2, there were graded 
reductions in the amplitude of the slow component by 22% and 49% when the 
heavy exercise bout was preceded by moderate and heavy exercise, respectively. It 
was hypothesized that changes in muscle recruitment might explain the graded 
attenuation in slow component amplitude following moderate and heavy exercise; 
therefore, in this study the same protocols were repeated in concert with surface 
EMG measurements. In this study, prior moderate and heavy exercise resulted in 
19% and 40% reductions in the slow component amplitude [∆ )26(2OV 
 ] during 
subsequent heavy exercise bouts, respectively. 
 As noted in some previous studies (Burnley et al., 2002b; Garland et al., 
2006; Scheuermann et al., 2001), cycling exercise involves activation of a large 
group of muscles within the thigh, making it necessary to examine EMG in more 
than one muscle; therefore, EMG activity was measured in multiple thigh muscles. 
It was observed that the moderate ∆ iEMG (6-2) across the three knee extensor 
muscles in the control heavy bout (H1B) was attenuated in a graded fashion during 
the H2A and H2B bouts following moderate and heavy warm-ups, respectively (Fig. 
4.6). Principal components analysis was also employed in order to discern if 
alterations in recruitment within this muscle group as a whole may account for the 
development of the slow component. Although there were no significant differences 
in iEMG between the 2nd and 6th min of exercise, prior warm-up exercise slightly 
attenuated the overall activation increase (∆ iEMG (6-2)), and this attenuation was 
moderately correlated with slow component amplitudes. This correlation between 




all three thigh muscles provides some evidence that lower muscle activation in the 
second half of the bout may be associated with attenuation of the slow component. 
On the other hand, it cannot be overlooked that no significant change was noted in 
iEMG between the 2nd and 6th min suggesting that other factors, such as 
redistribution of the blood flow to the periphery and mismatching between O2 
supply and demand  (Tordi et al., 2003), reduced efficiency (Sahlin et al., 2005) or 
elevated temperature (Krustrup et al., 2001), likely play a role to the development 
of slow component in addition to changes in muscle fibre recruitment. 
Furthermore, the iEMG activities during the 20W baselines prior to each heavy and 
moderate bouts (Table 4.3) as well as, at the end of exercise during moderate 
exercise (Table 4.4) were the same between conditions, when 2OV
 was significantly 
higher after prior heavy warm-up (Table 4.1 and 4.2), and slightly elevated at the 
end of moderate exercise that  followed the heavy warm-ups (Table 4.2) indicating 
that changes in muscle recruitment are insufficient to explain all differences in 
2OV
  during exercise. 
 In this study, the attenuation of iEMG during a second heavy exercise bout 
following short periods of recovery from moderate and heavy warm-up is consistent 
with another study that examined EMG activity (Bailey et al., 2009b). However, the 
additional observation of a high correlation between ∆ iEMG (6-2) and the slow 
component may be explained by differences in analysis methods. Fitting analysis 
(Table 4.1) and the calculation of )26(2OV 
 clearly showed that the 2OV
  slow 
component amplitude was truly diminished without changes in the primary phase 
amplitude. In contrast, other studies have observed larger primary phase 




increased iEMG, early in exercise (Burnley et al., 2002b; Sahlin et al., 2005).        
In this study, there was also a reduction in the slow component amplitude even 
after a short bout of moderate exercise, similar to that shown after a longer period 
of moderate exercise (Koppo & Bouckaert, 2000; Koppo & Bouckaert, 2002). 
 While iEMG data provide some evidence of changes in muscle fibre 
recruitment, the MPF data could not discern the types of muscle fibres being 
recruited.  Additionally, there was a decreasing trend in MPF for all extensor 
muscles within heavy bouts (Fig. 4.4). This trend and the lack of correlation 
between MPF and the slow component is in contrast to a temporal relationship 
observed between the beginning of the slow component and increases in MPF in 
trained runners (Borrani et al., 2001). The graded increases between each 
condition are suggestive of increasing fibre recruitment throughout the exercise 
bout from start to finish. It was interesting that in heavy exercise MPF tended to 
decrease early in exercise and then leveled off in contrast to moderate exercise 
where no changes occurred throughout the exercise. The early decrease in MPF 
observed during the heavy bouts may be due to a greater force needed to overcome 
the inertia of the cycle ergometer at the onset. Indeed, MPF toward the end of the 
control bouts was similar between moderate and heavy exercise. 
 The graded reductions in the 2OV
  slow component were observed to occur 
in concert with accelerated primary phase kinetics. It was shown in Chapter 2 that 
the acceleration of primary phase 2OV
  kinetics during heavy exercise was related, 
in part, to improved O2 delivery, since Q  kinetics were similarly accelerated by 
both moderate and heavy warm-ups. If bulk O2 delivery and matching of O2 supply 




important implications for any putative fibre type recruitment shift, since the 
energetic state of the cell is determined by the interplay of oxygen partial pressure, 
enzyme/substrate levels, and ADP concentrations (Hughson, 2009; Hughson et al., 
2001; Tschakovsky & Hughson, 1999). Reduced metabolic fatigue early in exercise 
might generate a lower demand for additional fibre recruitment, and therefore 
reduce the 2OV
 slow component. Burnley et al. (2002b) suggested that greater 
recruitment of Type II muscle fibres early in exercise might reduce the force 
demand and metabolic strain per single fibre; however, this response was not 
observed in this study or recent studies from the same group (Bailey et al., 2009b; 
DiMenna et al., 2008). Additionally, Layec et al. (2009) showed that during second 
heavy exercise bout, muscle oxygenation, as measured by NIRS, was higher and 
muscle [ADP], measured by 31P-MRS, was lower while ATP production remained 
similar to control. These authors raised the possibility that this could enhance the 
phosphorylation potential of ATP compared to control conditions. The improved 
metabolic conditions may limit the reduction in contractile efficiency (Rossiter et 
al., 2001; Zoladz et al., 2008), thereby reducing the O2 cost of force production and 
resulting in a smaller slow component. 
4.5.4 Impact of prior exercise on moderate exercise oxygen consumption 
 As expected, during moderate exercise there was no evidence of the 2OV
  
slow component and no changes in MPF (Fig. 4.8) and iEMG (Fig. 4.9) throughout 
the exercise bouts with and without prior heavy warm-up. There was; however, a 
graded and constant increase in MPF after one (M3A) and two (M3B) heavy warm-
ups bouts compared to control (Fig. 4.8). While Gonzales and Scheuermann (2008) 




heavy warm-up exercise, they saw no associations with changes in 2OV
 or 2OV
  
gain. In contrast in the current study, a consistent increase in MPF was observed 
in all muscles studied. Subjects with a higher proportion of Type II fibres tend to 
show lower gain during moderate exercise transitions (Pringle et al., 2003). The 
higher absolute 2OV
  during moderate exercise after heavy warm-up (Table 4.2) 
could be explained by fatigue resulting in higher O2 cost per ATP generated 
(Rossiter et al., 2001) or the recruitment of additional muscle fibres which have a 
lower phosphate to O2 ratio (Crow & Kushmerick, 1982).  
 There may be several possible reasons for observing a larger gradation in 
MPF compared to the heavy exercise bouts. First, due to the size principle of motor 
unit recruitment (Henneman et al., 1965) it would be expected that fewer Type II 
fibres would be employed during control moderate exercise, so any increase in 
muscle fibre recruitment after heavy exercise might then have a more dramatic 
effect on overall MPF.  Secondly, the warm-ups involved for heavy bouts were one 
moderate or one heavy bout; whereas the moderate bouts were preceded by one 
moderate plus one heavy bout, or two heavy bouts possibly resulting in elevated 
muscle temperature (Krustrup et al., 2001) that could have increased conduction 
velocity (Bigland-Ritchie & Woods, 1984).  
4.6 Limitations 
 While surface EMG is a well-established method for measuring electrical 
activation of muscle fibres and a tight relationship between iEMG and O2 
consumption has been observed (Bigland-Ritchie & Woods, 1974), there are several 
considerations that should be made when employing its various derivatives to 




component. First, as with breath-by-breath 2OV
  measurements, surface EMG 
measures contain significant variability, which needs to be reduced in order to 
discern any real physiological changes (Farina & Mesin, 2005). The use of repeated 
measures on both 2OV
  and EMG increases the confidence that our results might 
represent true changes in muscle recruitment and that the relation to VO2 2OV
  is 
accurate. Still, the resolution of EMG does not necessarily allow the ability to 
discern small changes in motor unit recruitment. Electrode placement between 
days may have been different and therefore may have affected EMG signals, 
however the baseline EMG did not vary between days and protocols verify that care 
was taken in precise electrode placement. From a theoretical standpoint, an 
increase in MPF measured at the surface should correspond to an increase in 
conduction velocity within the muscle (Stulen & DeLuca, 1981), indicating the 
recruitment of larger, faster muscle fibres (Kupa et al., 1995). However, any 
increase in conduction velocity related to increased recruitment of fast Type II 
fibres may be overwhelmed by the MPF depressing effects of higher extracellular 
[K+], leading to no change in overall MPF measured at the surface (Fortune & 
Lowery, 2009).  Additionally, intramuscular temperature increases greatly during 
exercise and changes in muscle temperature could certainly affect MPF by 
increasing conduction velocity (Gamet et al., 1993). Therefore, it is unclear how 
much of the gradation in MPF responses were due to actual changes in recruitment 
and to what degree changes in body temperature influenced the frequency, since 







 It was observed that the 2OV
 slow component amplitude and increase in 
iEMG during heavy cycling exercise were attenuated in a graded manner following 
moderate and heavy warm-up. There was a moderate correlation between the 
attenuation in the 2OV

 slow component and the simultaneous changes of iEMG 
across the extensor muscles of the thigh when all the data from all subjects across 
all exercise conditions were clustered. Pooling of results from principal components 
analysis across conditions might not be appropriate so further work is required to 
explore the hypothesis that changes in progressive fibre recruitment during heavy 
exercise could affect the amplitude of the 2OV
 slow component. Furthermore, the 
increased O2 cost of moderate exercise after a heavy warm-up was associated with 
a higher MPF of contractions in the thigh extensor muscles. However, the effect of 
temperature on increased MPF during moderate exercise following prior heavy 
exercise should be taken in consideration. Despite some limitations, measurement 
of leg muscle EMG may provide some evidence for increased muscle fibre 









General discussion and future considerations 
5.1 General discussion 
 Oxygen uptake kinetics reflect the dynamic balance between O2 transport 
and utilization mechanisms affecting muscle energetics during work rate 
transitions. The rate of increase in oxidative phosphorylation at the onset of 
exercise has been debated to be limited by the adaptations of O2 transport and O2 
utilization mechanisms (Grassi, 2001; Hughson, 2009; Poole et al., 2008; 
Tschakovsky & Hughson, 1999; Whipp et al., 2005). Interventions that can 
accelerate 2OV
 kinetics will increase the proportional contribution of oxidative 
metabolism to the total energy demands and could lead to enhanced exercise 
performance. Prior heavy exercise is an experimental paradigm that accelerates 
2OV
 kinetics at the onset of subsequent exercise, potentially through several 
mechanisms that affect both O2 transport (Faisal et al., 2010; Gerbino et al., 1996; 
MacDonald et al., 1997) and O2 utilization (Bangsbo et al., 2000; Grassi et al., 
1996; Gurd et al., 2006). Alternatively, prior circulatory occlusion is an 
intervention that elevates muscle blood flow prior to the onset of subsequent 
exercise (Carlsson et al., 1987) and has been shown to accelerate pulmonary 2OV

kinetics (Paganelli et al., 1989; Walsh et al., 2002). 
 The main observation of this thesis is that simultaneous measurements of 
O2 transport and O2 utilization can provide considerable insight into the control 
mechanisms regulating 2OV
 kinetics at the onset of exercise. In Chapter 2 the time 
course of the increase in Q and O2 uptake during the transition to heavy and 




was applied to examine whether these interventions would result in more rapid 
2OV
 and Q responses in subsequent moderate and heavy exercise. An interesting 
finding from this study was that the temporal responses of Q and alveolar O2 
uptake seemed to parallel each other at the onset of heavy exercise, and to a lesser 
extent during moderate exercise. This finding is in agreement with a tight coupling 
between the kinetics of capillary blood flow measured by near-infrared 
spectroscopy (NIRS) and mus2OV
 during both moderate and heavy cycling exercise 
(Ferreira et al., 2005a).  
 Contrary to the majority of previous cycling studies (i.e. Burnley et al., 2000; 
Gerbino et al., 1996; Jones et al., 2006; Koppo et al., 2003), in this study there was 
actual acceleration in 2OV
 kinetics during the second heavy bout as shown by a 
smaller 2. For the first time, prior moderate exercise was shown to accelerate the 
2OV
 kinetics and reduce 2 in subsequent heavy exercise in endurance athletes. 
Faster 2OV
 kinetics following prior moderate and heavy exercise were coupled with 
similar acceleration in Q kinetics. A faster increase in Q at the onset of heavy 
exercise can impact the regulation of O2 uptake. Greater O2 delivery can improve 
the oxidative phosphorylation contribution to energy production, while reducing 
the O2 deficit and cellular homeostasis disturbance (MacDonald et al., 1997). The 
proposed mechanism involves an increase in PaO2 as a function of increased O2 
delivery (Hughson, 2009; Tschakovsky & Hughson, 1999) and a subsequent 
reduction in PCr degradation and substrate level phosphorylation (Rossiter et al., 
2001). The acceleration of 2OV
  kinetics at the onset of moderate exercise that 




(a-v)DO2 differences. These results do not rule out the potential role of prior 
exercise to stimulate the O2 utilization machinery and regulate 2OV
 kinetics during 
moderate exercise. Gurd et al. (2006) showed that prior heavy exercise accelerated 
the VO2 kinetics during a subsequent moderate bout (2 reduced from 24 to 19 s) 
due to faster activation of pyruvate dehydrogenase. 
 Numerous non-invasive techniques such as foreign gas rebreathing (Bell et 
al., 2003; Hunt et al., 1997; Johnson et al., 2000), Doppler echocardiography (Ihlen 
et al., 1987) and vascular impedance cardiography (Perrey et al., 2003a; Yoshida & 
Whipp, 1994), have been applied to measure Q during exercise. However, these 
techniques were limited to steady state exercise. The finger cuff Modelflow 
technique (Wesseling et al., 1993) offered a continuous beat-to-beat estimate of SV 
and Q during transitions to moderate and heavy cycling exercise with a high time 
resolution thereby providing valuable  information on the acute time course of 
changes inQ . ModelFlow Q
 estimation was validated during steady-state exercise 
using C2H2 rebreathing (Faisal et al., 2009). One of the most interesting findings in 
this study was the observation of a rapid SV overshoot at the onset of moderate 
and heavy exercise. The SV overshoot reflects the sudden increase in venous return 
mediated primarily by the action of the muscle pump during upright cycling 
exercise (Sheriff et al., 1993; Tschakovsky et al., 1996). 
 The observation of accelerated 2OV
 and Q  during heavy cycling exercise 
following prior moderate and heavy exercise shown in the first study (Chapter 2) 
led to further investigations into the impact of elevated muscle blood flow prior to 
the onset of heavy exercise on blood flow and mus2OV




dynamic responses of FBF, measured directly by Doppler ultrasound, and mus2OV

during the transition to heavy hand-grip exercise were investigated following prior 
heavy exercise and circulatory occlusion to examine whether these interventions 
would result in a similar rapid blood flow response and acceleration in mus2OV

during subsequent heavy exercise. In agreement with previous studies that 
employed a prior heavy exercise paradigm (Fukuba et al., 2007; Hughson et al., 
2003; MacDonald et al., 2001b), it was observed that prior heavy exercise resulted 
in a faster increase in muscle blood flow and mus2OV
 at the onset of a subsequent 
heavy exercise bout (Faisal et al., 2010). This finding supported the original 
hypothesis that increased oxidative metabolism at the onset of exercise is linked to 
increased O2 delivery to the working muscles. It has been shown that the degree of 
tissue oxygenation may play a role in modulating the levels of other regulators of 
oxidative phosphorylation such that altered tissue oxygenation by reduced PaO2 
will result in a greater change in the regulators of cellular respiration (e.g. 
phosphocreatine, ADP) to achieve a given mus2OV
 (Haseler et al., 1998; Hogan et al., 
1992). There was a direct linear relationship between the PCr degradation and the 
magnitude of the O2 deficit during submaximal exercise while breathing gases with 
varying inspired PaO2 (Linnarsson et al., 1974). Additionally, Hughson (2005; 2009) 
suggested theoretical models that illustrate the impact of dynamic changes in the 
PaO2 on enzyme activity, metabolic substrates and how the oxidative metabolism at 
the onset of exercise is modulated by a dynamic interaction between O2 delivery 
and utilization mechanisms. 
 Chapter 3 also presented results from an alternative model designed to 




circulatory occlusion. Although prior occlusion elevated blood flow prior to exercise 
onset, blood flow and O2 extraction were depressed in the early phase of exercise, 
resulting in slower mus2OV
 dynamics with the onset of heavy exercise (Faisal et al., 
2010). These results contrast with previous studies that reported faster pulmonary
2OV
  kinetics following circulatory occlusion (Paganelli et al., 1989; Walsh et al., 
2002). Based on previous observations that post-occlusion reactive hyperaemia 
was significantly elevated by indomethacin and ibuprofen, inhibitors of 
cycloxygenase (Naylor et al., 1999), it was speculated that vasoconstrictor PGs 
might have contributed to the suppression of muscle blood flow during exercise 
following ischemia.  Ingestion of a high dose of ibuprofen prior to the circulatory 
occlusion protocol was able to restore FBF and mus2OV
 to control levels, although 
(a-v)DO2 remained suppressed relative to the control condition. These results 
suggest that blood flow was influenced by a vasoconstrictor prostaglandin 
mechanism, and perhaps prior occlusion had an independent effect on muscle 
metabolism.  
 Chapter 4 described a study designed to investigate whether changes in 
muscle activity as assessed by EMG are related to changes in 2OV
 slow component 
amplitude and increased O2 cost during moderate exercise after heavy warm-up. 
Although there was no change in iEMG activity during each of the heavy and 
moderate exercise conditions, there was a significant increase in O2 consumption 
between the 2nd and 6th min of heavy exercise and throughout moderate exercise 
after prior heavy warm-up. This observation may suggest that additional factors 
other than the progressive recruitment of muscle fibres may be involved in the 





 during moderate exercise after the heavy warm-up. Interestingly, applying the 
principal component analysis to aggregate the EMG activity in all muscles into one 
factor showed a significant correlation between ∆ iEMG (6-2) activity in the knee 
extensor muscles and 2OV
 slow component amplitude. Additionally, the increase of 
O2 cost during moderate exercise following the heavy warm-up was associated with 
increase in MPF. These later observations provide some evidence for the 
progressive recruitment of type II muscle fibres during the slow component and 
throughout the moderate exercise following the heavy warm-up.  
 This thesis focused on the study of O2 transport and O2 utilization 
mechanisms in highly fit young men; therefore, the data might not reflect the 
general population, but rather a particular subset of the population with well-
adapted cardiovascular and metabolic responses. Training status might be an 
important factor that has rarely been addressed in the studies employing 
experimental models designed to improve O2 availability (i.e. prior exercise or prior 
ischemia) in examining blood flow and 2
OV kinetics. There is some evidence that 
subjects of higher fitness (Knight et al., 1993) are more sensitive to O2 delivery 
limitations than subjects of lower fitness (Cardus et al., 1998)to improve their 
maximal oxygen uptake. Although, untrained healthy individuals with slower 2OV

kinetics have shown greater acceleration of 2 during moderate exercise after prior 
heavy warm-up than those who have fast 2OV
 kinetics (Gurd et al., 2005). Elite 
athletes might be more susceptible to limitations in oxygen delivery at the onset of 
heavy exercise. Endurance athletes tend to show fast 2OV
 kinetics (Berger et al., 




that may slightly be enhanced by prior warm-up. Tordi et al. (2003) reported a 
faster primary component of 2OV
 kinetics (2 reduced from 29 to 22 s) during 
subsequent heavy cycling exercise following prior multiple-sprint exercise in well 
trained athletes because O2 delivery was also enhanced. Similarly, endurance 
athletes in the current study have shown an acceleration in 2OV
 and Q  kinetics (2 
reduced from 27 to 22 s). Although individuals show large variation in matching 
blood flow to mus2OV
  at the onset of exercise, endurance athletes tend to have a 
better matching between muscle blood flow and mus2OV
 than untrained men 
(Kalliokoski et al., 2005). More recently, Hernandez et al. (2010) showed that a 
prior bout of contractions speeds blood flow and mus2OV
 onset kinetics during a 
subsequent bout in highly oxidative skeletal muscle. Additionally, Bailey et al. 
(2010) have shown that 4 weeks of inspiratory muscle training were able to reduce 
the respiratory muscles fatigue, increased blood flow to the exercising muscle and 
improved 2OV
 kinetics following the onset of high intensity exercise suggesting that 
enhanced O2 delivery enabled the increase of oxidative phosphorylation during the 
transition to heavy exercise. Therefore, it could be inferred that O2 delivery will play 
a greater role to accelerate 2OV
 kinetics in trained humans who have a well 









 In summary, the results of the studies presented in this thesis clearly 
provided evidence that enhanced O2 supply to the exercising muscles following 
prior exercise enabled a faster increase in the rate of oxidative phosphorylation 
during the transition to heavy exercise in trained humans. On the other hand, 
prior circulatory occlusion depressed mus2OV

 
kinetics by retarding the increase in 
muscle blood flow and reducing O2 extraction. The surface electromyography 
provided partial evidence for the role of muscle fibre recruitment to the 
development of slow component and increased O2 cost during moderate exercise 
following a heavy warm-up.  
 Warm-up intervention is a regular routine to enhance the performance 
during subsequent training sessions or during competition. Although trained 
subjects would be expected to show small acceleration in 2OV
 kinetics following 
prior warm-up, this increase may provide a boost to the performance during an 
Olympic medal or world record attempt. Therefore, the investigation of different 
warm-up interventions that could accelerate the rate of oxidative phosphorylation 









5.3 Future considerations 
 The studies enclosed in this thesis addressed mechanisms regulating 2OV

kinetics at the onset of exercise. Several interventions were applied to manipulate 
the rate of increase in O2 delivery prior to exercise. The measurements of O2 
transport were primarily non-invasive in nature. The following recommendations 
address specific methodological issues in this thesis. 
 In Chapter 2, estimates of Q were obtained during cycling exercise by the 
beat-to-beat method of finger arterial blood pressure by the Modelflow algorithm. 
The derived kinetics of Q were used as a surrogate marker for leg blood flow 
kinetics during cycling exercise. Increased Q  after heavy warm-up indicated a 
partial redistribution of blood flow to serve thermoregulatory demands, and 
therefore one cannot be sure of the flow to the working muscle. However, previous 
studies (Hughson et al., 2003; Krustrup et al., 2001; MacDonald et al., 2001b) as 
well as the current research in Chapter 3 have directly measured an increase in 
blood flow to the muscle following a heavy warm-up, which supports the notion 
that at least some of the increase in Q  observed in the present study is directed to 
the working muscle. Additionally, ModelFlow Q  was validated during “steady state” 
phases of exercise; it was not possible to calibrate Modelflow Q  during dynamic 
transitions at the onset of exercise. The validation of Modelflow Q during exercise 
transition will be of great advantage in the exercise modalities where direct 
measurements of blood flow is not possible; though we know of no method by 




 In Chapter 3 of this study, muscle blood flow and O2 extraction were 
depressed following prolonged circulatory occlusion.  Oral administration of a 
prostaglandin synthase inhibitor was able to restore muscle blood flow at the onset 
of exercise that followed prolonged circulatory occlusion to the control level (Faisal 
et al., 2010), and others have demonstrated marked reductions in SBF during 
reactive hyperemia (Binggeli et al., 2003). These observations suggest that ischemia 
might have disparate effects on perfusion in different tissues. It will be interesting 
to examine whether circulatory occlusion, with the potential release of the 
vasoconstrictor thromboxane A2 (Mathieson et al., 1983) has a systemic effect on 
tissue perfusion by measuring muscle and SBF during exercise when ischemia 
followed by reperfusion has been applied to a distant, non-exercising limb.  
 Repeated episodes of ischemia followed by reperfusion (ischemic 
preconditioning) represent an endogenous protective mechanism that delays cell 
injury. Recent observations have shown that remote ischemic preconditioning 
improved endothelial function (Kharbanda et al., 2002), decreased myocardial 
infarction effect (Botker et al., 2010) as well as, increased maximal O2 consumption 
and maximal power output during subsequent incremental cycling test (de Groot et 
al., 2010). It would be interesting to examine muscle blood flow and mus2OV

 
kinetics responses following short periods of intermittent occlusion rather than 
prolonged period of ischemia. 
 Furthermore, changes in the metabolic environment and PaO2 during and 
after intermittent and prolonged ischemia as well as during subsequent exercise 
also deserve future attention. Magnetic resonance spectroscopy is a powerful, non-




biochemistry. This technique would help to assess PaO2 and provide a clear picture 
about the time course of PCr degradation during exercise transition following 
prolonged ischemia. Duplicating the prolonged ischemia study using magnetic 
resonance spectroscopy would provide more precise information about the 
metabolic environment and the mechanisms that could contribute to the depressed 







Oxygen uptake and blood pressure regulation at the onset of exercise: 
Interaction of circadian rhythm and priming exercise 
 
This appendix is the basis for the manuscript accepted (September 28, 2010) for 
publication in the American Journal of Physiology - Heart and Circulation.  




















 Circadian rhythm has an influence on several physiological functions that 
contribute to athletic performance. We tested the hypothesis that circadian rhythm 
would affect BP responses but not 2OV
 kinetics during the transitions to moderate 
and heavy cycling exercises. Nine male athletes (
peak2
OV : 60.5 ± 3.2 ml/kg/min) 
performed multiple rides of two different cycling protocols, involving 6-minute 
bouts at moderate and heavy intensities, in the morning (7 am) and evening (5 pm). 
Breath-by-breath 2OV
  and beat-by-beat BP estimated by finger cuff 
plethysmography were measured simultaneously throughout the protocols. 
Circadian rhythm did not affect 2OV

 onset kinetics during either moderate (M) or 
heavy (H) exercise (2 M: morning 22.5 ± 4.6 s vs. evening 22.2 ± 4.6 s; 2 H: 
morning 26.0 ± 2.7 s vs. evening 26.2 ± 2.6 s; P > 0.05). Priming exercise induced 
the same robust acceleration in 2OV
 kinetics during subsequent moderate and 
heavy exercise in the morning and evening. A novel finding was an overshoot in the 
estimate of BP from finger cuff plethysmography in the first minutes of each 
moderate and heavy exercise bout. After the initial overshoot, BP declined in 
association with increasing SBF between the 3rd and 6th minute of the exercise 
bout. Priming exercise showed a greater effect in modulating the BP responses in 
the evening. These findings suggest that circadian rhythm interacts with priming 
exercise to attenuate BP responses during exercise with a greater influence in the 





 Circadian rhythm has shown potent affects on a wide range of 
cardiovascular functions (Guo & Stein, 2003).  However, only two studies have 
examined the effect of circadian rhythm on 2OV
 and BP during exercise. Circadian 
rhythm displays small effects on resting 2OV
 ; however, this influence weakens and 
disappears with increasing exercise intensity (Reilly & Brooks, 1990). The previous 
studies that examined the effect of circadian rhythm on 2OV
  kinetics have offered 
diametrically opposing results. Carter et al. (2002) reported no diurnal variation of 
2OV
  kinetics during either moderate or heavy exercise, while Brisswalter et al. 
(2007) showed a robust acceleration of 2OV
  kinetics and a higher steady-state 
2OV
  during moderate exercise in the evening. It is unclear, then, whether or not 
2OV
  kinetics are affected by circadian rhythm. It has been shown in Chapter 2 
that prior moderate and heavy exercise can accelerate 2OV
  kinetics in endurance 
athlete, but it is unknown if these responses would be affected by the time of day. 
 The circadian variation in BP has been known for over 100 years (Hill & 
Lond, 1898), with the lowest BP during sleeping, a morning “surge” around the 
waking hours and the highest BP at midday (Kario et al., 2003; Millar-Craig et al., 
1978; Verdecchia et al., 1990). Recent studies have shown a greater effect of 
circadian rhythm on post exercise BP responses in the afternoon (Jones et al., 
2008a; Jones et al., 2008b). However, no previous study has investigated the effect 
of circadian rhythm on BP during exercise transitions. Altered SBF may alter the 
control of arterial BP, particularly after warm-up when the thermoregulatory 




smaller temperature increases and larger cutaneous vasodilatory responses in the 
afternoon (Aldemir et al., 2000; Waterhouse et al., 2007) suggesting a potential for 
greater BP reduction in the afternoon. This attenuation of BP response may sustain 
through subsequent daily activity and exercise (MacDonald et al., 2001a). 
 2OV
 onset kinetics and beat-by-beat BP in association with SBF were 
examined at two different times of day (morning and evening) and during different 
protocols involving transitions from light exercise to moderate and heavy exercise. 
It has been hypothesized that circadian rhythm would attenuate the BP responses 
during moderate and heavy exercise in the evening due to greater thermoregulatory 
effects but would not affect 2OV
 kinetics during either moderate or heavy exercise. 
Additionally, prior moderate and heavy exercise would have different effects on BP 
responses during subsequent exercise in the morning compared to the evening, but 
would have the same effects on 2OV
 kinetics during subsequent exercise regardless 















 Nine men who regularly participated in endurance training activities (age: 
22.3 ± 2.7 years, height: 178.6 ± 7.8 cm, weight: 71.9 ± 6.5 kg, 
peak2
OV : 4325 ± 
516 ml/min; mean ± SD), same subjects participated in the study in Chapter 2, 
gave consent to participate in this study following full description of the protocols. 
To minimize the between-subject variability in aerobic fitness, an inclusion 
criterion of 
peak2
OV > 55 ml/kg/min was used during recruitment. This study was 
approved by the Office of Research Ethics at the University of Waterloo.  
Experimental design 
All subjects first performed an incremental exercise test to volitional 
exhaustion on an electrically-braked cycle ergometer (Excalibur, Lode, Groningen, 
Netherlands) to determine their 
peak2
OV and ventilatory threshold (VT) as 
described in Chapter 2. All subjects performed multiple rides of two different 
cycling protocols either in the early morning (7am) or early evening (5pm). Both 
protocols involved 6-minute bouts at moderate (M; 80% VT) and heavy (H; 85%
peak2
OV ) intensities (M; 146 ± 33 W and H; 266 ± 35 W) interspersed with 6-
minute bouts at 20 W. Moderate and heavy work rates were calculated from the 
incremental test and assigned names identifying the intensity, the bout number 
within the protocol, and the protocol itself as follows: Protocol A = moderate (M1A) 
followed by heavy (H2A) followed by moderate (M3A); Protocol B = heavy (H1B) 
followed by heavy (H2B) followed by moderate (M3B). The protocols were shown 




 Pedaling frequency was maintained at 80 rpm throughout each protocol and 
the same cycle ergometer and individual set up (handle bar and seat position) was 
used throughout the study. Subjects were asked to report to the laboratory in a 
rested, hydrated state and abstain from consuming caffeine for 12 h and alcohol 
for 24 h prior to test sessions. All rides were performed at least 24 h after the 
participants’ last exercise regimen and 36 h following their last study ride. The 
tests were completed in a quiet, air-conditioned laboratory at a temperature of 
~23°C. 
Breath-by-breath oxygen uptake 
 Pulmonary gas exchange was measured continuously in at least 4 rides of 
each protocol (morning and evening) on a breath-by-breath basis (First Breath, 
Waterloo, ON) by measuring inspired and expired concentrations of O2, CO2, and 
N2 via mass spectrometry (Innovision, Amis 2000, Odense, Denmark). Gas volumes 
and concentrations were measured as described in Chapter 2. 
Blood pressure and cardiac output 
 Arterial BP was measured continuously in all protocols using finger arterial 
pressure pulse wave analysis (Finometer, Finapres Medical System, Arnhem, 
Netherlands), which also estimated Q beat-by-beat. In order to minimize the effect 
of arm and hand movement on BP and Q signals, a sling apparatus supported the 
left arm slightly below heart level while subjects cycled. An appropriately sized cuff 
was wrapped around the distal end of the third or fourth digit to measure finger 
artery pressure, and a glycerin column and pressure transducer were used to 
correct for hydrostatic pressure differences between the level of the hand and the 
heart. The Finometer used a transfer function to estimate the brachial pressure 




calibration, using an automated arm-cuff, was used to further validate the 
transformed pressure waveform (Bos et al., 1996). To maintain signal validity 
throughout the rides, an automatic physiologic calibration (“physiocal”) was run 
periodically after ≤ 70 beats to calibrate the finger artery size at which finger cuff 
air pressure equals finger arterial blood pressure. The BP, Q and electrocardiogram 
(ECG) (Pilot 9200, Colin Medical Instruments, San Antonio, TX) signals were 
sampled at 1 kHz (PowerLab, AD Instruments, Colorado Springs, CO). The 
Finometer’s cardiac output estimations were validated against an acetylene 
rebreathing technique as described in Chapter 2. 
Skin blood flow 
 In one ride of each protocol (morning and evening), relative forearm SBF was 
estimated continuously by a laser Doppler probe (MoorLAB, Moor Instruments Ltd, 
Devon, UK) placed over the wrist extensors, 5cm distal to the lateral epicondyle. 
Data analysis 
Oxygen uptake kinetics 
 The analyses of 2OV
 kinetics were exactly the same as described in chapter 
2. The moderate and heavy bouts were curve fitted by two- (phases I and II) and 
three-component (phases I, II and III) exponential models respectively. 
Blood pressure and cardiac output  
 The Q  signal was shifted -1s and 1 beat backward in order to compensate 
for the Finometer’s internal digital signal processing delay. The BP, Q , and HR 
signals were linearly interpolated at 1-s intervals, and the rides were time aligned 
and averaged together to yield a single data set for each subject in each protocol at 




Total peripheral resistance and forearm skin blood flow 
 Total Peripheral Resistance (TPR) throughout the exercise tests was 
calculated as Q /MAP. The SBF signal was normalized to the average of resting 
SBF, measured over the 5 min immediately prior to the start of each exercise test. 
Statistical analysis 
 A two-way ANOVA with repeated measures was used to determine 
significant differences in 2OV
 kinetics and BP responses during all moderate and 
heavy bouts. When significant effects were observed, the Tukey post hoc test was 
used for comparisons. All data are expressed as means ± SD and a probability of P 
< 0.05 was accepted as statistically significant. The data were analyzed using 

















Oxygen uptake kinetics 
 The fitting parameters for 2OV
 kinetics in the heavy control (H1B) and 
moderate control (M1A) bouts were identical in the morning and evening sessions 
(Fig. A.1, Tables A.1 and A.2), revealing no effect of circadian rhythm on 2OV

kinetics in young trained men. Moreover, priming exercise modified the 2OV
  
kinetics in subsequent heavy and moderate bouts at 7am and 5pm to similar 
extents.  During a heavy exercise bout that followed either prior moderate (H2A, 
22.5 ± 4.0 s) or heavy (H2B, 21.8 ± 2.8 s) warm-up, 2OV
  kinetics were accelerated 
compared to control (H1B 26.0 ± 2.7 s) in morning sessions with similar results 
during the evening sessions, as shown by the significantly smaller τ2 values (Fig. 
A.2, Table A.1). Similarly, in a moderate exercise bout that followed either one 
(M3A) or two (M3B) heavy bouts, τ2 values were significantly lower than control 
(M1A) in both morning and evening sessions (Fig. A.3, Table A2). 
Blood pressure 
 During all heavy and moderate cycling exercise bouts (morning and 
evening), there was an overshoot of the peak BP response through the second 
minute of exercise with lower values by the end (6th minute) of exercise (Figs. A.4 
and A.5, Tables A.3 – A.8). The BP response tended to be lower throughout the last three 
minutes in both control moderate and heavy exercise bouts in the evening. Generally, there 
were no differences between the morning and evening sessions in the baseline, 
peak, or end exercise BP responses during the control bouts (H1B and M1A), the 
heavy bout that followed prior heavy exercise (H2B) or the moderate bout that 




between the morning and evening sessions in BP responses during the heavy bout 
that followed a moderate warm-up (H2A) where end exercise BP was lower during 
the evening compared to the morning (P < 0.05 for SBP, MAP and DBP, Fig. A.4, 
Tables A.3 – A.5), with greater decline in the SBP from the overshoot peak to end 
exercise during the evening compared to the morning (P < 0.05, Table A.3). In 
moderate exercise that followed one heavy bout (M3A), BP was more like exercise 
that followed two heavy bouts (M3B) in the evening (Fig. A.5). Peak MAP and DBP 
were significantly lower during the evening (P < 0.05 for both, Tables A.7 and A.8). 
At the end of the M3A exercise bout, SBP, MAP and DBP were all significantly lower 
in the evening compared to morning (P < 0.05, Tables A.6 – A.8). The decline in the 
SBP from the overshoot peak to end exercise in the control (M1A) was more evident 
during the evening compared to the morning (P < 0.05, Table A.6). Prior heavy 
warm-up had a greater effect on attenuating the initial rise in BP responses during 
subsequent heavy (H2B) and moderate (M3A and M3B) cycling in the morning 
(Tables A.3 – A.8). Prior moderate warm-up showed a similar effect as prior heavy 
exercise in attenuating the BP during subsequent heavy bouts in the evening. 
Likewise, prior one heavy bout showed the similar effect as prior two heavy bouts 
in attenuating the BP response during subsequent moderate bouts in the evening.  
Cardiac output 
 In both morning and evening sessions, baseline values for  MFQ

 were 
significantly elevated in a heavy bout that followed prior heavy exercise (H2B) 
compared to both control (H1B) and a heavy bout that was preceded by moderate 
exercise (H2A) (P < 0.05, Fig. A.6 and A.7, Table A.9). The moderate exercise bouts 






 than the no warm-up condition (M1A) (P < 0.05, Fig. A.8 and 
A.9, Table A.10). By the end of exercise, there were no differences between the 
three moderate bouts in the morning, but M3B had a higher MFQ
 than M1A in the 
evening (P < 0.05, Table A.10).  
Total peripheral resistance 
 Baseline values for TPR were significantly lower in a heavy bout that 
followed prior heavy exercise (H2B) compared to both control (H1B) and a heavy 
bout that was preceded by moderate exercise (H2A) (P < 0.05, Figs. A.6 and A.7, 
Table A.9). TPR remained lower in H2B compared to H1B until the end of exercise in 
both the morning and evening (Figs. A.6 and A.7); however, TPR was lower in H2B 
compared to H2A only in the morning. End exercise TPR was significantly lower in 
H2A in the evening compared to the morning (P < 0.05, Table A.9). Prior heavy 
warm-up (one and two heavy bouts) lowered baseline TPR in M3A and M3B, 
respectively, compared to the moderate control (M1A) (P < 0.05, Figs. A.8 and A.9, 
Table A.10). TPR remained significantly lower in M3A and M3B compared to M1A 
until the end of exercise (P < 0.05, Table A.10). End exercise TPR was significantly 
lower in M3A in the evening compared to the morning (P < 0.05, Table A.10). 
Skin blood flow 
 Resting SBF (immediately prior to the start of exercise protocols) was not 
significantly different in the evening compared to the morning (0.33 ± 0.18 vs. 0.27 
± 0.14 arbitrary units, P = 0.43). During the heavy exercise bouts, baseline SBF 
was significantly elevated in a heavy bout that followed prior heavy exercise (H2B) 
compared to both control (H1B) and a heavy bout that was preceded by moderate 




were no differences between H2A and H2B and both were significantly higher than 
H1B; the end exercise values for H2A and H2B were significantly higher in the 
evening compared to morning (P < 0.05, Table A.9). One and two prior heavy bouts 
resulted in a higher baseline SBF in M3A and M3B than in the no warm-up 
condition (M1A) (P < 0.05, Figs. A.8 and A.9, Table A.10). The SBF responses 
remained significantly higher in M3A and M3B throughout the bout and until the 
end of exercise compared to M1A (P < 0.05, Table A.10). End exercise SBF was 





Table A.1: Morning and evening 2OV







H1B H2A H2B H1B H2A H2B 
A0, ml/min 
 
1016 ± 54 1019 ± 77 1192 ± 55 *† 
 
1014 ± 44 1038 ± 62 1172 ± 46 *† 
A1, ml/min 482 ± 132 454 ± 160 382 ± 155 403 ± 112 456 ± 142 374 ± 169 
A2, ml/min 1703 ± 240 1709 ± 216 1821 ± 209 *† 1748 ± 246 1687 ± 213 1808 ± 165 *† 
A1+A2, ml/min 2186 ± 341 2163 ± 327 2203 ± 333 2151 ± 327 2143 ± 332 2157 ± 306 
A0+A1+A2, ml/min 3203 ± 395 3182 ± 403 3395 ± 388 *† 3165 ± 371 3181± 395 3270 ± 335 *† 
A3, ml/min  651 ± 118 563 ± 124 * 404 ± 69 *†  621 ± 115 533 ± 133 † 405 ± 111 *† 
 2, s 
 
26.0 ± 2.7 22.5 ± 4.0 *  21.8 ± 2.8 * 
 
26.2 ± 2.6 22.0 ± 2.6 * 21.6 ± 4. 1 * 
3, s 153.0 ± 16.5 136.6 ± 20.0 128.4 ± 25.2 * 144.5 ± 19.6 137.9 ± 23.6 131. 2 ± 25.8 
TD2, s 11.4 ± 1. 9 11.3 ± 1.9 9.7 ± 1.9 *† 10.3 ± 2.5 11.4 ± 1.5 * 9.5 ± 2.0 *† 
TD3, s 96.7 ± 12.7 83.7 ± 14.8 * 74.6 ± 12.4 * 95.7 ± 14.3 79.6 ± 10.7 * 71.7 ± 16.1 * 
Gain, ml/min/W  8.9 ± 0.6 8. 8 ± 0.5 9.0 ± 0.4  8.7 ± 0.5 8.7 ± 0.3 8.8 ± 0.8 
End Bout, ml/min  3718 ± 409 3653 ± 390 3748 ± 385  3667 ± 375 3628 ± 356 3704 ± 362 




       Table A.2: Morning and evening 2OV







M1A M3A M3B M1A M3A M3B 
A0, ml/min 
 
981 ± 55 1157 ± 76 * 1210 ± 80 * 
 
1012 ± 54 1181 ± 66 * 1197 ± 53 * 
A1, ml/min 317 ± 137 273 ± 92 308 ± 137 322 ± 148 244 ± 98 269 ± 102 
A2, ml/min 924 ± 253 926 ± 297 884 ± 242  888 ± 261 925 ± 290 908 ± 263  
A1+A2, ml/min 1240 ± 364 1199 ± 351 1191 ± 365 1210 ± 340 1168 ± 343 1178 ± 354 




14.5 ± 3. 0 13.5 ± 1.3 14.4 ± 2.0 
 
 
14.1 ± 2.0 13.1 ± 1.8 13.7 ± 1.5 
Gain, ml/min/W 9.8 ± 0.5 9.5 ± 0.7 9.4 ± 0.6 9.6 ± 0.3 9.2 ± 0.5 9.3 ± 0.6 
End Bout, ml/min 2226 ± 354 2352 ± 356 * 2407 ± 373 * 2232 ± 375 2343 ± 351 * 2373 ± 352 * 
 






 time series data for the morning and evening responses in 
moderate (top, A) and heavy (bottom, B) exercise control conditions. 
Data are the average of all 9 participants with ≥ 4 repetitions per each exercise 






 time series data for the three heavy exercise bouts in the morning 
(top, A) and evening (bottom, B). 
 Data are the average of all 9 participants with ≥ 4 repetitions per each exercise 






 time series data for the three moderate exercise bouts in the 
morning (top, A) and evening (bottom, B). 
 Data are the average of all 9 participants with ≥ 4 repetitions per each exercise 










H1B H2A H2B H1B H2A H2B 
Baseline SBP, mmHg 
 
147.3 ± 9.8 146.1 ± 14.9 142.7 ± 10.3 
 
152.4 ± 13.3 148.2 ± 14.4 150.8 ± 13.5 
Peak SBP, mmHg 219.7 ± 15.5 220.6 ± 14.8 209.7 ± 14.1*† 219.7 ± 12.3 218.7 ± 13.4 211.0 ± 9.8 *† 
End Bout SBP, mmHg 199.6 ± 11.7 196.8 ± 17.2 183.8 ± 8.7 *† 197.5 ± 13.2 185.5 ± 16.8 *‡ 184.4 ± 12.6 * 
Peak - Baseline SBP, mmHg 72.4 ± 9.6 74.5 ± 11.0 67.0 ± 14.3 † 67.3 ± 9.7 70.5 ± 7.8 60.2 ± 9.3 *†‡ 
Peak - End SBP, mmHg  20.1 ± 7.8 23.8 ± 9.7 25.9 ± 8.2  22.2 ± 6.2 33.2 ± 10.2 *‡ 26.6 ± 8.9 † 
 
Mean ± SD, n = 9;  















H1B H2A H2B H1B H2A H2B 
Baseline MAP, mmHg 
 
103.8 ± 5.6 105.3 ± 10.1 103.3 ± 6.4 
 
105.1 ± 9.6 103.5 ± 8.2 104.3 ± 9.4 
Peak MAP, mmHg 145.8 ± 12.9 145.6  ± 13.4 140.0 ± 10.8 145.1 ± 8.4 141.7 ± 10.5 139.0 ± 7.5 
End Bout MAP, mmHg 134.9 ± 8.0 134.1 ± 11.2 127.3 ± 7.3 *† 132.2 ± 8.0 126.7 ± 9.5 *‡ 125.8 ± 7.2 * 
Peak - Baseline MAP, mmHg 42.0 ± 9.2 40.3 ± 10.8 36.7 ± 9.3 40.0 ± 8.9 38.2 ± 8.1 34.7 ± 5.6 
Peak - End MAP, mmHg  10.9 ± 5.9 11.5 ± 2.9 12.7 ± 4.7  12.9 ± 2.6 15.0 ± 5.9 13.2 ± 4.5 
 
Mean ± SD, n = 9;  















H1B H2A H2B H1B H2A H2B 
Baseline DBP, mmHg 
 
77.4 ± 3.0 80.2 ± 7.4 78.6 ± 3.8 
 
77.9 ± 7.0 77.4 ± 4.9 78.1 ± 6.9 
Peak DBP, mmHg 107.1 ± 10.5 106.5 ± 10.7 100.9 ± 9.0 *† 104.8 ± 6.2 103.0 ± 7.3 99.4 ± 5.5 * 
End Bout DBP, mmHg 96.5 ± 5.7 96.1 ± 9.4 90.0 ± 5.8 *†  93.6 ± 5.7 89.5 ± 7.3 ‡ 87.4 ± 5.3 * 
Peak - Baseline DBP, mmHg 29.7 ± 8.7 26.3 ± 7.8 * 22.3 ± 8.14 *† 26.9 ± 6.5 25.6 ± 6.7 21.3 ± 5.0 *† 
Peak - End DBP, mmHg  10.6 ± 5.4 10.4 ± 2.4 10.9 ± 4.6  11.2 ± 1.8 13.5 ± 4.9 12.0 ± 3.9 
 
Mean ± SD, n = 9;  





Figure A.4: SBP, MAP and DBP time series responses during the three heavy exercise conditions in the morning (A) 
and evening (B).  
Data lines are the 5 s moving average for all 9 participants with ≥ 4 repetitions per each exercise condition. Solid 
line: H1B, heavy control - no prior warm-up; dashed line: H2A, prior moderate warm-up; dotted line: H2B, prior 










M1A M3A M3B M1A M3A M3B 
Baseline SBP, mmHg 
 
141.9 ± 13.5 140.8 ± 13.0 132.4 ± 8.8 *† 
 
142.9 ± 13.6 136.5 ± 11.2 135.9 ± 11.9 * 
Peak SBP, mmHg 186.4 ± 23.7 172.4 ± 22.9 * 156.8 ± 16.2 *†  189.5 ± 16.6 166.2 ± 17.2 * 162.3 ± 19.0 * 
End Bout SBP, mmHg 166.7 ± 21.4 152.9 ± 19.8 * 140.8 ± 14.0 *† 162.4 ± 17.8 144.6 ± 15.3 *‡ 142.9 ± 15.4 * 
Peak - Baseline SBP, mmHg 44.5 ± 16.2 31.6 ± 12.9 * 24.4 ± 11.2 *† 46.6 ± 14.7 29.7 ± 10.6 * 26.4 ± 12.5 * 
Peak - End SBP, mmHg  19.7 ± 9.0 19.5 ± 8.4 16.0 ± 6.1  27.1 ± 11.0 ‡ 21.6 ± 5.7 * 19.4 ± 5.3 * 
 
Mean ± SD, n = 9;  















M1A M3A M3B M1A M3A M3B 
Baseline MAP, mmHg 
 
101.7 ± 8.8 103.5 ± 9.8 98.6 ± 7.6 † 
 
99.7 ± 6.9 99.1 ± 7.6 98.6 ± 9.1 
Peak MAP, mmHg 124.5 ± 15.9 119.5 ± 15.6 111.6 ± 11.1 *† 123.7 ± 10.6 114.0 ± 10.5 *‡ 112.1 ± 12.8 * 
End Bout MAP, mmHg 114.5 ± 14.6 109.0 ± 15.0 * 101.9 ± 10.0 *† 110.0 ± 10.6 102.4 ± 10.9 *‡  101.0 ± 11.2 * 
Peak - Baseline MAP, mmHg 22.8 ± 10.9 16.0 ± 7.2 * 13.0 ± 6.9 * 24.0 ± 9.3 14.9 ± 5.5 * 13.5 ± 5.7 * 
Peak - End MAP, mmHg  10.0 ± 2.8 10.5 ± 4.2 9.7 ± 3.7  13.7 ± 5.1 ‡ 11.6 ± 3.0 11.1 ± 3.2 
 
Mean ± SD, n = 9;  















M1A M3A M3B M1A M3A M3B 
Baseline DBP, mmHg 
 
77.0 ± 6.0 80.1 ± 7.4 76.9 ± 5.6 
 
74.6 ± 3.7 75.6 ± 4.9 75.9 ± 6.4 
Peak DBP, mmHg 93.5 ± 11.3 92.3 ± 11.6 87.3 ± 9.0 *† 90.7 ± 6.8 87.3 ± 8.4 ‡ 85.7 ± 8.8 * 
End Bout DBP, mmHg 85.2 ± 10.7 82.2 ± 12.4 76.5 ± 7.6 *† 80.7 ± 7.3 ‡ 76.3 ± 8.1 *‡ 74.9 ± 8.6 * 
Peak - Baseline DBP, mmHg 16.5 ± 8.0 12.2 ± 5.8 * 10.4 ± 6.1 * 16.1 ± 6.7 11.7 ± 4.8 * 9.8 ± 4.1 * 
Peak - End DBP, mmHg  8.3 ± 1.9 10.1 ± 4.3 10.8 ± 3.8  10.0 ± 3.6 11.0 ± 3.2 10.8 ± 4.0 
  
Mean ± SD, n = 9;  





Figure A.5: SBP, MAP and DBP time series responses during the three moderate exercise conditions in the morning 
(A) and evening (B).  
Data lines are the 5 s moving average for all 9 participants with ≥ 4 repetitions per each exercise condition. Solid 





Table A.9: Morning and evening MFQ






H1B H2A H2B H1B H2A H2B 
Baseline Q, l/min  10.2 ± 1.0 10.4 ± 0.6 11.8 ± 1.2 *†    10.4 ± 0.9 10.7 ± 0.8 12.6 ± 0.6 *† 
End Bout Q, l/min 
 
22.3 ± 1.8 22.5 ± 1.8 23.9 ± 1.8 *†  
 
23.4 ± 1.7 23.1 ± 0.9 24.6 ± 1.6 *† 
Baseline TPR, mmHg/l/min 10.4 ± 1.0 10.3 ± 0.9 9.0 ± 0.8 *† 10.0 ± 1.5 9.8 ± 0.5 8.4 ± 0.9 *† 
End Bout TPR, mmHg/l/min  6.1 ± 0.6 6.0 ± 0.8 5.4 ± 0.6 *†  5.7 ± 0.6 5.5 ± 0.5 ‡ 5.2 ± 0.5 *  
Baseline SBF, % Baseline  169 ± 26 170 ± 38 269 ± 101 *†  149 ± 42 209 ± 41 341 ± 134 *†  
End Bout SBF, % Baseline  352 ± 135 555 ± 144 * 655 ± 198 *  463 ± 150 815 ± 319 *‡ 937 ± 215 *‡ 
 
Mean ± SD, n = 9 for MFQ
 and TPR, n = 8 for SBF; 






Figure A.6: MAP (A), MFQ
  (B), TPR (C), and SBF (D) time series responses during the three heavy exercise conditions 
in the morning.  
MAP, MFQ
  and TPR data are the 5 sec moving average for all 9 participants with ≥ 4 repetitions per each exercise 
condition. SBF data are the 5 sec moving average from one ride for 8 participants. Solid line: H1B, heavy control - 





Figure A.7: MAP (A), MFQ
  (B), TPR (C), and SBF (D) time series responses during the three heavy exercise conditions 
in the evening.  
 MAP, MFQ
  and TPR data are the 5 sec moving average for all 9 participants with ≥ 4 repetitions per each exercise 
condition. SBF data are the 5 sec moving average from one ride for 8 participants. Solid line: H1B, heavy control - 






Table A.10: Morning and evening MFQ






M1A M3A M3B M1A M3A M3B 
Baseline Q, l/min 
 
9.74 ± 0.91 10.78 ± 0.63 * 10.70 ± 0.93 * 
 
9.65 ± 0.90 11.02 ± 0.60 * 11.54 ± 0.40 *‡ 
End Bout Q, l/min 15.80 ± 1.07 16.24 ± 1.20 16.46 ± 2.00  16.16 ± 1.39 16.36 ± 1.37  17.10 ± 1.40 * 
Baseline TPR, mmHg/l/min 10.64 ± 1.11 9.68 ± 0.84 * 9.31 ± 0.87 *  10.59 ± 0.87 9.08 ± 0.50 * 8.59 ± 0.59 * 
End Bout TPR, mmHg/l/min  7.24 ± 0.69 6.73 ± 0.86 * 6.27 ± 0.91 *†  6.81 ± 0.40 6.27 ± 0.41*‡ 5.93 ± 0.62 * 
Baseline SBF, % Baseline  152 ± 29 369 ± 125 * 473 ± 135 *  183 ± 47 477 ± 125 * 580 ± 143 *  
End Bout SBF, % Baseline  234 ± 47 581 ± 160 * 633 ± 190 *  274 ± 94 785 ± 224  *‡ 753 ± 229 * 
 
 Mean ± SD, n = 9;  









Figure A.8: MAP (A), MFQ
  (B), TPR (C), and SBF (D) time series responses during the three moderate exercise 
conditions in the morning.  
MAP, MFQ
  and TPR data are the 5 sec moving average for all 9 participants with ≥ 4 repetitions per each exercise 
condition. SBF data are the 5 sec moving average from one ride for 8 participants. Solid line: M1A, moderate control 





Figure A.9: MAP (A), MFQ
  (B), TPR (C), and SBF (D) time series responses during the three moderate exercise 
conditions in the evening.  
MAP, MFQ
  and TPR data are the 5 sec moving average for all 9 participants with ≥ 4 repetitions per each exercise 
condition. SBF data are the 5 sec moving average from one ride for 8 participants. Solid line: M1A, moderate control 
- no prior warm-up; dashed line: M3A, one prior heavy bout; dotted line: M3B, two prior heavy bouts. 
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A.5 Discussion  
 The current research has confirmed our previous findings of significant 
speeding of 2OV
 kinetics during both moderate and heavy exercise following 
priming exercise (Chapter 2) and has shown that these responses were identical in 
the morning and evening. Thus, our results concerning possible circadian 
influence on O2 transport-utilization mechanisms contrast with those reported by 
Brisswalter et al.(2007) but supported our hypothesis and were in agreement with 
the only other study of circadian effects on 2OV
 kinetics (Carter et al., 2002). In 
addition, this is the first study to report several key findings regarding the BP 
response to exercise. First, there was a consistent overshoot in BP during the first 
two minutes of both moderate and heavy exercise, then BP declined in association 
with increasing SBF between the 3rd and 6th minute of exercise. This overshoot 
response seems to be controlled by the feed forward central command mechanism 
(Gallagher et al., 2006; Rowell & O'Leary, 1990) independent of circadian rhythm. 
Second, the BP response was shown to be lower throughout the last three minutes 
in both control moderate and heavy exercise bouts in the evening, suggesting an 
influence of time of day on BP response during exercise after the initial BP 
resetting. Third, BP responses during both moderate and heavy exercise were 
significantly affected by priming exercise, and the effects of prior moderate and 
heavy exercise differed between the morning and evening. One or two bouts of prior 
heavy exercise caused graded reductions in BP during subsequent moderate 
exercise in the morning while the effects were similar in the evening. During heavy 




while it reduced BP to a similar degree as prior heavy exercise in the evening. 
Fourth, the BP overshoot magnitude and the subsequent BP reduction were 
modulated to a greater extent by priming exercise in the evening due to a larger 
increase in SBF. 
Circadian rhythm and 2OV
 kinetics 
 Despite considerable research into 2OV
 kinetics, very little has been done to 
investigate the effect of circadian rhythm on breath-by-breath 2OV
 during exercise 
transitions. We observed no differences in any parameter of 2OV
 kinetics during 
the control moderate (M1A) and heavy (H1B) cycling exercise bouts between the 
morning and afternoon sessions (Fig. A1, Tables A.1 and A.2). These findings agree 
with the only previous study that examined circadian effects on 2OV
 kinetics during 
treadmill running at moderate and heavy intensities (Carter et al., 2002). 
Additionally, priming exercise exhibited the same robust effects on 2OV
 kinetics 
during subsequent moderate and heavy exercise bouts irrespective of time of day. 
 Both moderate and heavy warm-ups accelerated 2OV
 kinetics in subsequent 
heavy exercise (Fig. A.2 and Table A.1), and one or two prior heavy bouts 
accelerated the 2OV
 kinetics in subsequent moderate exercise (Fig. A.3 and Table 
A.2). The effects of prior exercise on 2OV
 kinetics have been discussed extensively 
in Chapter 2. Conversely, our results strongly contrast with those of Brisswalter et 
al. (2007) who reported a 50% improvement in 2OV





 amplitude, and a 3% increase in net efficiency during 80%VT cycling 
exercise in the afternoon. While Brisswalter et al. (2007) used a simple mono-
exponential model fitted to data collected using a COSMED device, even these 
methodological differences seem inadequate to explain the magnitude changes 
observed and the disparity with our results and those of Carter et al. (2002).  
 In addition to the 2OV
 kinetics results, there were no differences in 2OV

during either the initial 20W periods, steady state moderate exercise, or at the end 
of exercise during heavy bouts at different times of day. While resting 2OV
 has 
been observed to follow the circadian rhythm of core temperature, with resting 
values achieving their peak in the early evening (Reilly & Brooks, 1990), the 
rhythm, if detected, becomes weaker during light exercise and disappears during 
moderate and heavy exercise (Deschenes et al., 1998; Reilly & Brooks, 1990; Reilly 
& Garrett, 1998). Therefore our results are consistent with previous literature in 
showing no circadian effect on 2OV
 during exercise. 
Circadian rhythm and the blood pressure response to exercise 
 In contrast with finding no circadian effect on 2OV
 , we observed novel 
circadian effects on the regulation of BP during exercise that add to the established 
circadian pattern on resting BP (Millar-Craig et al., 1978), as well as the recent 
observations of differences in the post-exercise hypotension (PEH) (Jones et al., 
2008a; Jones et al., 2008b). BP displays a consistent circadian rhythm with the 




afternoon and during sleep, and a morning “surge” in the hours before and 
following waking (Kario et al., 2003; Millar-Craig et al., 1978; Verdecchia et al., 
1990). Additionally, the response of BP after exercise is altered by the time of day, 
with greater PEH achieved in the afternoon than in the morning (Jones et al., 
2008a; Jones et al., 2008b; Jones et al., 2009). However, no research has focused 
on the circadian effects on BP during exercise transitions. Using beat-by-beat 
measurement of BP by finger plethysmography, we observed a lower BP response 
throughout the last three minutes in both control moderate (M1A) and heavy (H1B) 
exercise bouts in the evening. Elevated Q and SBF during exercise in the evening, 
consistent with reports of altered thermoregulation (Aldemir et al., 2000; Jones et 
al., 2008a; Jones et al., 2008b; Waterhouse et al., 2007), could have contributed to 
the lower arterial BP during exercise in the evening.  
 Notably, we observed a distinct overshoot of BP within the first minutes of 
both moderate and heavy exercise, which was followed by a slow decline between 
the 3rd and 6th minute of each exercise bout. The BP overshoot was consistent in all 
moderate and heavy bouts, morning and evening, regardless of whether or not 
warm-up exercise was performed. This rapid overshoot in BP has been observed 
previously in humans via intra-arterial catheterization during supine kicking 
exercise in humans (MacDonald et al., 1998). Additionally, sphymomanometry BP 
measurements during cycling show the largest response early in exercise, then a 
slow decline up to 15 min of exercise (MacDonald et al., 1999; Nakas-Icindic et al., 




moderate and heavy cycling exercise is consistent with these previous 
observations. Peak BP values reported in the tables are slightly greater than the 
response pattern in the figures due to small differences between individuals in the 
time to peak response. 
Effect of prior exercise on blood pressure during subsequent exercise 
 The BP responses following priming exercise at different times of day could 
be influenced by large increases in relative SBF, reductions in TPR, and in some 
cases, increases in Q . Prior heavy but not moderate exercise caused sustained 
elevations in Q  prior to and throughout the subsequent heavy exercise bout (H2B) 
in both the morning and evening. TPR was reduced only after prior heavy exercise 
and SBF was elevated to a greater extent in the evening after heavy and moderate 
exercise (Fig.A.7). One or two prior heavy bouts elevated Q  prior to subsequent 
moderate bouts in the both morning and evening, but Q  was only elevated at the 
end of the moderate bout (M3B) after two prior heavy bouts in the evening. 
Simultaneously, TPR was reduced and SBF was increased following one or two 
bouts of prior heavy exercise (Figs. A.8 and A.9). SBF increases to a greater extent 
during exercise in the evening compared to morning, these observations may be 
closely linked to differences in thermoregulatory processes at different times of day. 
The “body clock”, located in the suprachiasmatic nucleus of the hypothalamus, 
induces circadian rhythmicity of core temperature which is generated via heat gain 
and heat loss modes in the morning and evening, respectively (Aldemir et al., 2000; 




may raise core temperature more and faster in the morning (Aldemir et al., 2000) in 
association with smaller increases in SBF (Aldemir et al., 2000; Waterhouse et al., 
2007). These results align with our observation of attenuated SBF responses to 
exercise in the morning compared to the evening. Thus, the greater effect of 
priming exercise in modulating/lowering BP responses during subsequent exercise 
in the evening appears to be linked to the enhanced thermoregulatory response in 
the evenings compared to the morning. Athletes generally have better responses to 
thermal stress with larger SBF increases for a given change in temperature 
(Fritzsche & Coyle, 2000; Johnson, 1998; Lenasi & Strucl, 2004), which may imply 
that the robustness of response we observed is a result of the subjects’ fitness. 
While the observed attenuation of BP during subsequent exercise following warm-
up seems to be a unique physiological response, it is prudent to compare this 
phenomenon to similar studies involving PEH. Importantly, our results are 
consistent with those of MacDonald et al. (2001a) who observed that PEH, 
measured intra-arterially, is maintained in subsequent rest, exercise, and 
simulated activities of daily living. Our results also bear striking similarity to a 
series of previous studies examining the response of BP after exercise at different 
points in the circadian cycle (Jones et al., 2008a; Jones et al., 2008b; Jones et al., 
2009). These studies showed that after a continuous exercise bout, normotensive 
subjects only experienced PEH in the afternoon. Our observations expand upon 
these previous results and show that in trained subjects, BP is lowered during 
subsequent exercise, but requires a greater exercise stimulus in the morning to 




has been shown to be more effective than continuous exercise in altering post 
exercise BP response. Jones et al.(2009) have observed greater PEH immediately 
following an intermittent exercise protocol similar to our protocols, involving three 
10 min exercise periods interspersed with 10 min of rest. Furthermore, the use of 
intermittent exercise was able to induce reductions in BP in the morning, where 
continuous exercise could not. These observations provide evidence that the 
recovery period in between bouts of exercise may play an important role in 
reducing BP during subsequent exercise bouts. Additional study is necessary to 
determine whether or not the recovery period, or simply exercise intensity, play a 
critical role in lowering the BP responses during subsequent exercise. 
Implications to blood pressure control during exercise 
 At the initiation of exercise the arterial baroreflex response curve is reset to 
a higher BP, though the maximal gain remains essentially unchanged (Bevegard & 
Shepherd, 1966; Dicarlo & Bishop, 1992; Melcher & Donald, 1981; Ogoh et al., 
2003; Walgenbach & Donald, 1983). The immediate resetting of arterial 
baroreceptors at the exercise onset is likely achieved through the feed forward 
central command mechanism (Dicarlo & Bishop, 1992; Gallagher et al., 2006; 
Ludbrook & Graham, 1985; Rowell & O'Leary, 1990). We observed the same peak 
BP during the overshoot in the control moderate (M1A) and heavy (H1B) bouts, 
irrespective of time of day, consistent with an immediate resetting by central 
command that is dependent on motor neural output (Gallagher et al., 2001; Potts 
et al., 1993; Rowell & O'Leary, 1990) independent of circadian rhythm. However, 




vasodilation in trained subjects (Fritzsche & Coyle, 2000) might influence the 
dynamic resetting of the arterial baroreceptors, potentially through the 
cardiopulmonary baroreflex (Ogoh et al., 2006) leading to an adjustment in the BP 
set-point to lower values after just a few minutes of exercise. 
 Priming exercise, which generates heat stress, and the time of day may 
interact to alter the regulation of SBF and arterial BP during exercise. Passive heat 
stress shifted the carotid-vascular baroreflex response curves downward to the 
prevailing cardiovascular conditions with a reduction in maximal gain (Crandall, 
2000). The impact of the priming exercise might also be through residual effects 
that have been observed as reductions in baroreflex sympathetic outflow (Hara & 
Floras, 1992), vascular responsiveness (Halliwill et al., 1996) and arterial baroreflex 
operating point (Chandler et al., 1998) during the period of PEH.  
 The current research demonstrating a reduction in exercise BP with time 
and after prior exercise was conducted with trained, physically fit subjects. The 
results could have important implications for exercise prescription and for the 
post-exercise hypotension (Piepoli et al., 1994; Quinn, 2000) in the general 
population and for individuals at risk for cardiovascular disease. It is important, 
however, to replicate these studies in these other groups to determine if the BP 






 We observed that circadian rhythm does not impact 2OV
 kinetics, end 
exercise 2OV
 in moderate or heavy exercise, or the acceleration of 2OV
 kinetics by 
prior warm-up during moderate and heavy exercise in trained humans. However, 
we did find that BP overshoots early in both moderate and heavy exercise and then 
steadily falls in association with increases in SBF, a phenomenon that was 
influenced by both prior exercise and time of day. The effects of prior moderate and 
heavy exercise were different between the morning and evening. In the evening, 
moderate exercise and a single prior heavy warm-up had greater attenuating 
influences on the BP response of subsequent heavy and moderate exercise, 
respectively.
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